"","title","geo_accession","status","submission_date","last_update_date","type","channel_count","source_name_ch1","organism_ch1","characteristics_ch1","characteristics_ch1.1","characteristics_ch1.2","characteristics_ch1.3","characteristics_ch1.4","characteristics_ch1.5","characteristics_ch1.6","characteristics_ch1.7","molecule_ch1","extract_protocol_ch1","label_ch1","label_protocol_ch1","taxid_ch1","source_name_ch2","organism_ch2","characteristics_ch2","molecule_ch2","extract_protocol_ch2","label_ch2","label_protocol_ch2","taxid_ch2","hyb_protocol","scan_protocol","description","description.1","data_processing","platform_id","contact_name","contact_email","contact_laboratory","contact_department","contact_institute","contact_address","contact_city","contact_zip/postal_code","contact_country","supplementary_file","data_row_count"
"GSM497679","N_001_RAP_27k_h1","GSM497679","Public on Jun 14 2010","Jan 15 2010","Jan 19 2010","RNA","2","Normal urinary bladder sample N_001","Homo sapiens","sample histology: Normal bladder","","","","","","","","total RNA","Tissue homogenization and RNA recovery using TRIzol reagent (Invitrogen), followed by purification of total RNA using RNeasy kit (Qiagen).","Cy3","1.5 microrgram of sample and reference aRNA, amplified using the MessageAmp aRNA Kit (Ambion), were labeled using the CyScribe Post-Labeling Kit (Amersham Biosciences) followed by purification using the Cyscribe GFX Purification Kit (Amersham)","9606","Stratagene Universal Human Reference","Homo sapiens","reference: RNA pooled from ten human cell lines","total RNA","Tissue homogenization and RNA recovery using TRIzol reagent (Invitrogen), followed by purification of total RNA using RNeasy kit (Qiagen).","Cy5","1.5 microrgram of sample and reference aRNA, amplified using the MessageAmp aRNA Kit (Ambion), were labeled using the CyScribe Post-Labeling Kit (Amersham Biosciences) followed by purification using the Cyscribe GFX Purification Kit (Amersham)","9606","Samples were dissolved in 42 microliter Universal Hybridization Solution (Corning) and hybridizations were carried out in a CMT-Hybridization Chamber (Corning) for 18 h at 42°C. Pre-hybridization of slides and post-hybridization washes were performed as described in the Universal Hybridization Kit (Corning)","Fluorescence was recorded using an Agilent G2565AA microarray scanner (Agilent Technologies). Image analysis on scanned arrays was performed with GenePix 4.0 (Axon Instruments)","N_001_ureter_RAP_27k_h1","","Data was processed in the BioArray Software Environment (BASE). For each channel, the Mean FG - Median BG intensity value was used. Features flagged bad, missing or saturated during image analysis were removed. Poorly measured features with ch1 or ch2 intensities <15 were removed. Data was normalized using pin-based LOWESS algorithm.","GPL3883","David,,Lindgren","david.lindgren@med.lu.se","Molecular Pathology","Dep of Laboratory Medicine. Malmö","Lund University","Entrance 78, 3rd floor, UMAS","Malmö","SE-20502","Sweden","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM497nnn/GSM497679/GSM497679.gpr.gz","19889"
"GSM497680","N_002_RAP_27k_h1","GSM497680","Public on Jun 14 2010","Jan 15 2010","Jan 19 2010","RNA","2","Normal urinary bladder sample N_002","Homo sapiens","sample histology: Normal bladder","","","","","","","","total RNA","Tissue homogenization and RNA recovery using TRIzol reagent (Invitrogen), followed by purification of total RNA using RNeasy kit (Qiagen).","Cy3","1.5 microrgram of sample and reference aRNA, amplified using the MessageAmp aRNA Kit (Ambion), were labeled using the CyScribe Post-Labeling Kit (Amersham Biosciences) followed by purification using the Cyscribe GFX Purification Kit (Amersham)","9606","Stratagene Universal Human Reference","Homo sapiens","reference: RNA pooled from ten human cell lines","total RNA","Tissue homogenization and RNA recovery using TRIzol reagent (Invitrogen), followed by purification of total RNA using RNeasy kit (Qiagen).","Cy5","1.5 microrgram of sample and reference aRNA, amplified using the MessageAmp aRNA Kit (Ambion), were labeled using the CyScribe Post-Labeling Kit (Amersham Biosciences) followed by purification using the Cyscribe GFX Purification Kit (Amersham)","9606","Samples were dissolved in 42 mul of Universal Hybridization Solution (Corning, Acton, MA, USA) and hybridizations were carried out in a CMT-Hybridization Chamber (Corning) for 18 h at 42°C. Pre-hybridization of slides and post-hybridization washes were performed as described in the Universal Hybridization Kit (Corning)","Fluorescence was recorded using an Agilent G2565AA microarray scanner (Agilent Technologies). Image analysis on scanned arrays was performed with GenePix 4.0 (Axon Instruments)","N_002_ureter_RAP_27k_h1","","Data was processed in the BioArray Software Environment (BASE). For each channel, the Mean FG - Median BG intensity value was used. Features flagged bad, missing or saturated during image analysis were removed. Poorly measured features with ch1 or ch2 intensities <15 were removed. Data was normalized using pin-based LOWESS algorithm.","GPL3883","David,,Lindgren","david.lindgren@med.lu.se","Molecular Pathology","Dep of Laboratory Medicine. Malmö","Lund University","Entrance 78, 3rd floor, UMAS","Malmö","SE-20502","Sweden","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM497nnn/GSM497680/GSM497680.gpr.gz","19889"
"GSM497681","N_003_RAP_27k_h1","GSM497681","Public on Jun 14 2010","Jan 15 2010","Jan 19 2010","RNA","2","Normal urinary bladder sample N_003","Homo sapiens","sample histology: Normal bladder","","","","","","","","total RNA","Tissue homogenization and RNA recovery using TRIzol reagent (Invitrogen), followed by purification of total RNA using RNeasy kit (Qiagen).","Cy3","1.5 microrgram of sample and reference aRNA, amplified using the MessageAmp aRNA Kit (Ambion), were labeled using the CyScribe Post-Labeling Kit (Amersham Biosciences) followed by purification using the Cyscribe GFX Purification Kit (Amersham)","9606","Stratagene Universal Human Reference","Homo sapiens","reference: RNA pooled from ten human cell lines","total RNA","Tissue homogenization and RNA recovery using TRIzol reagent (Invitrogen), followed by purification of total RNA using RNeasy kit (Qiagen).","Cy5","1.5 microrgram of sample and reference aRNA, amplified using the MessageAmp aRNA Kit (Ambion), were labeled using the CyScribe Post-Labeling Kit (Amersham Biosciences) followed by purification using the Cyscribe GFX Purification Kit (Amersham)","9606","Samples were dissolved in 42 mul of Universal Hybridization Solution (Corning, Acton, MA, USA) and hybridizations were carried out in a CMT-Hybridization Chamber (Corning) for 18 h at 42°C. Pre-hybridization of slides and post-hybridization washes were performed as described in the Universal Hybridization Kit (Corning)","Fluorescence was recorded using an Agilent G2565AA microarray scanner (Agilent Technologies). Image analysis on scanned arrays was performed with GenePix 4.0 (Axon Instruments)","N_003_ureter_RAP_27k_h1","","Data was processed in the BioArray Software Environment (BASE). For each channel, the Mean FG - Median BG intensity value was used. Features flagged bad, missing or saturated during image analysis were removed. Poorly measured features with ch1 or ch2 intensities <15 were removed. Data was normalized using pin-based LOWESS algorithm.","GPL3883","David,,Lindgren","david.lindgren@med.lu.se","Molecular Pathology","Dep of Laboratory Medicine. Malmö","Lund University","Entrance 78, 3rd floor, UMAS","Malmö","SE-20502","Sweden","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM497nnn/GSM497681/GSM497681.gpr.gz","19889"
"GSM497682","N_004_RAP_27k_h1","GSM497682","Public on Jun 14 2010","Jan 15 2010","Jan 19 2010","RNA","2","Normal urinary bladder sample N_004","Homo sapiens","sample histology: Normal bladder","","","","","","","","total RNA","Tissue homogenization and RNA recovery using TRIzol reagent (Invitrogen), followed by purification of total RNA using RNeasy kit (Qiagen).","Cy3","1.5 microrgram of sample and reference aRNA, amplified using the MessageAmp aRNA Kit (Ambion), were labeled using the CyScribe Post-Labeling Kit (Amersham Biosciences) followed by purification using the Cyscribe GFX Purification Kit (Amersham)","9606","Stratagene Universal Human Reference","Homo sapiens","reference: RNA pooled from ten human cell lines","total RNA","Tissue homogenization and RNA recovery using TRIzol reagent (Invitrogen), followed by purification of total RNA using RNeasy kit (Qiagen).","Cy5","1.5 microrgram of sample and reference aRNA, amplified using the MessageAmp aRNA Kit (Ambion), were labeled using the CyScribe Post-Labeling Kit (Amersham Biosciences) followed by purification using the Cyscribe GFX Purification Kit (Amersham)","9606","Samples were dissolved in 42 mul of Universal Hybridization Solution (Corning, Acton, MA, USA) and hybridizations were carried out in a CMT-Hybridization Chamber (Corning) for 18 h at 42°C. Pre-hybridization of slides and post-hybridization washes were performed as described in the Universal Hybridization Kit (Corning)","Fluorescence was recorded using an Agilent G2565AA microarray scanner (Agilent Technologies). Image analysis on scanned arrays was performed with GenePix 4.0 (Axon Instruments)","N_004_ureter_RAP_27k_h1","","Data was processed in the BioArray Software Environment (BASE). For each channel, the Mean FG - Median BG intensity value was used. Features flagged bad, missing or saturated during image analysis were removed. Poorly measured features with ch1 or ch2 intensities <15 were removed. Data was normalized using pin-based LOWESS algorithm.","GPL3883","David,,Lindgren","david.lindgren@med.lu.se","Molecular Pathology","Dep of Laboratory Medicine. Malmö","Lund University","Entrance 78, 3rd floor, UMAS","Malmö","SE-20502","Sweden","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM497nnn/GSM497682/GSM497682.gpr.gz","19889"
"GSM497683","N_005_RAP_27k_h1","GSM497683","Public on Jun 14 2010","Jan 15 2010","Jan 19 2010","RNA","2","Normal urinary bladder sample N_005","Homo sapiens","sample histology: Normal bladder","","","","","","","","total RNA","Tissue homogenization and RNA recovery using TRIzol reagent (Invitrogen), followed by purification of total RNA using RNeasy kit (Qiagen).","Cy3","1.5 microrgram of sample and reference aRNA, amplified using the MessageAmp aRNA Kit (Ambion), were labeled using the CyScribe Post-Labeling Kit (Amersham Biosciences) followed by purification using the Cyscribe GFX Purification Kit (Amersham)","9606","Stratagene Universal Human Reference","Homo sapiens","reference: RNA pooled from ten human cell lines","total RNA","Tissue homogenization and RNA recovery using TRIzol reagent (Invitrogen), followed by purification of total RNA using RNeasy kit (Qiagen).","Cy5","1.5 microrgram of sample and reference aRNA, amplified using the MessageAmp aRNA Kit (Ambion), were labeled using the CyScribe Post-Labeling Kit (Amersham Biosciences) followed by purification using the Cyscribe GFX Purification Kit (Amersham)","9606","Samples were dissolved in 42 mul of Universal Hybridization Solution (Corning, Acton, MA, USA) and hybridizations were carried out in a CMT-Hybridization Chamber (Corning) for 18 h at 42°C. Pre-hybridization of slides and post-hybridization washes were performed as described in the Universal Hybridization Kit (Corning)","Fluorescence was recorded using an Agilent G2565AA microarray scanner (Agilent Technologies). Image analysis on scanned arrays was performed with GenePix 4.0 (Axon Instruments)","N_005_ureter_RAP_27k_h1","","Data was processed in the BioArray Software Environment (BASE). For each channel, the Mean FG - Median BG intensity value was used. Features flagged bad, missing or saturated during image analysis were removed. Poorly measured features with ch1 or ch2 intensities <15 were removed. Data was normalized using pin-based LOWESS algorithm.","GPL3883","David,,Lindgren","david.lindgren@med.lu.se","Molecular Pathology","Dep of Laboratory Medicine. Malmö","Lund University","Entrance 78, 3rd floor, UMAS","Malmö","SE-20502","Sweden","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM497nnn/GSM497683/GSM497683.gpr.gz","19889"
"GSM497684","N_009_RAP_27k_h1","GSM497684","Public on Jun 14 2010","Jan 15 2010","Jan 19 2010","RNA","2","Normal urinary bladder sample N_009","Homo sapiens","sample histology: Normal bladder","","","","","","","","total RNA","Tissue homogenization and RNA recovery using TRIzol reagent (Invitrogen), followed by purification of total RNA using RNeasy kit (Qiagen).","Cy3","1.5 microrgram of sample and reference aRNA, amplified using the MessageAmp aRNA Kit (Ambion), were labeled using the CyScribe Post-Labeling Kit (Amersham Biosciences) followed by purification using the Cyscribe GFX Purification Kit (Amersham)","9606","Stratagene Universal Human Reference","Homo sapiens","reference: RNA pooled from ten human cell lines","total RNA","Tissue homogenization and RNA recovery using TRIzol reagent (Invitrogen), followed by purification of total RNA using RNeasy kit (Qiagen).","Cy5","1.5 microrgram of sample and reference aRNA, amplified using the MessageAmp aRNA Kit (Ambion), were labeled using the CyScribe Post-Labeling Kit (Amersham Biosciences) followed by purification using the Cyscribe GFX Purification Kit (Amersham)","9606","Samples were dissolved in 42 mul of Universal Hybridization Solution (Corning, Acton, MA, USA) and hybridizations were carried out in a CMT-Hybridization Chamber (Corning) for 18 h at 42°C. Pre-hybridization of slides and post-hybridization washes were performed as described in the Universal Hybridization Kit (Corning)","Fluorescence was recorded using an Agilent G2565AA microarray scanner (Agilent Technologies). Image analysis on scanned arrays was performed with GenePix 4.0 (Axon Instruments)","N_009_Urothel_RAP_27k_h1","","Data was processed in the BioArray Software Environment (BASE). For each channel, the Mean FG - Median BG intensity value was used. Features flagged bad, missing or saturated during image analysis were removed. Poorly measured features with ch1 or ch2 intensities <15 were removed. Data was normalized using pin-based LOWESS algorithm.","GPL3883","David,,Lindgren","david.lindgren@med.lu.se","Molecular Pathology","Dep of Laboratory Medicine. Malmö","Lund University","Entrance 78, 3rd floor, UMAS","Malmö","SE-20502","Sweden","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM497nnn/GSM497684/GSM497684.gpr.gz","19889"
"GSM497685","N_010_RAP_27k_h1","GSM497685","Public on Jun 14 2010","Jan 15 2010","Jan 19 2010","RNA","2","Normal urinary bladder sample N_010","Homo sapiens","sample histology: Normal bladder","","","","","","","","total RNA","Tissue homogenization and RNA recovery using TRIzol reagent (Invitrogen), followed by purification of total RNA using RNeasy kit (Qiagen).","Cy3","1.5 microrgram of sample and reference aRNA, amplified using the MessageAmp aRNA Kit (Ambion), were labeled using the CyScribe Post-Labeling Kit (Amersham Biosciences) followed by purification using the Cyscribe GFX Purification Kit (Amersham)","9606","Stratagene Universal Human Reference","Homo sapiens","reference: RNA pooled from ten human cell lines","total RNA","Tissue homogenization and RNA recovery using TRIzol reagent (Invitrogen), followed by purification of total RNA using RNeasy kit (Qiagen).","Cy5","1.5 microrgram of sample and reference aRNA, amplified using the MessageAmp aRNA Kit (Ambion), were labeled using the CyScribe Post-Labeling Kit (Amersham Biosciences) followed by purification using the Cyscribe GFX Purification Kit (Amersham)","9606","Samples were dissolved in 42 mul of Universal Hybridization Solution (Corning, Acton, MA, USA) and hybridizations were carried out in a CMT-Hybridization Chamber (Corning) for 18 h at 42°C. Pre-hybridization of slides and post-hybridization washes were performed as described in the Universal Hybridization Kit (Corning)","Fluorescence was recorded using an Agilent G2565AA microarray scanner (Agilent Technologies). Image analysis on scanned arrays was performed with GenePix 4.0 (Axon Instruments)","N_010_Urothel_RAP_27k_h1","","Data was processed in the BioArray Software Environment (BASE). For each channel, the Mean FG - Median BG intensity value was used. Features flagged bad, missing or saturated during image analysis were removed. Poorly measured features with ch1 or ch2 intensities <15 were removed. Data was normalized using pin-based LOWESS algorithm.","GPL3883","David,,Lindgren","david.lindgren@med.lu.se","Molecular Pathology","Dep of Laboratory Medicine. Malmö","Lund University","Entrance 78, 3rd floor, UMAS","Malmö","SE-20502","Sweden","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM497nnn/GSM497685/GSM497685.gpr.gz","19889"
"GSM497686","N_011_RAP_27k_h1","GSM497686","Public on Jun 14 2010","Jan 15 2010","Jan 19 2010","RNA","2","Normal urinary bladder sample N_011","Homo sapiens","sample histology: Normal bladder","","","","","","","","total RNA","Tissue homogenization and RNA recovery using TRIzol reagent (Invitrogen), followed by purification of total RNA using RNeasy kit (Qiagen).","Cy3","1.5 microrgram of sample and reference aRNA, amplified using the MessageAmp aRNA Kit (Ambion), were labeled using the CyScribe Post-Labeling Kit (Amersham Biosciences) followed by purification using the Cyscribe GFX Purification Kit (Amersham)","9606","Stratagene Universal Human Reference","Homo sapiens","reference: RNA pooled from ten human cell lines","total RNA","Tissue homogenization and RNA recovery using TRIzol reagent (Invitrogen), followed by purification of total RNA using RNeasy kit (Qiagen).","Cy5","1.5 microrgram of sample and reference aRNA, amplified using the MessageAmp aRNA Kit (Ambion), were labeled using the CyScribe Post-Labeling Kit (Amersham Biosciences) followed by purification using the Cyscribe GFX Purification Kit (Amersham)","9606","Samples were dissolved in 42 mul of Universal Hybridization Solution (Corning, Acton, MA, USA) and hybridizations were carried out in a CMT-Hybridization Chamber (Corning) for 18 h at 42°C. Pre-hybridization of slides and post-hybridization washes were performed as described in the Universal Hybridization Kit (Corning)","Fluorescence was recorded using an Agilent G2565AA microarray scanner (Agilent Technologies). Image analysis on scanned arrays was performed with GenePix 4.0 (Axon Instruments)","N_011_Urothel_RAP_27k_h1","","Data was processed in the BioArray Software Environment (BASE). For each channel, the Mean FG - Median BG intensity value was used. Features flagged bad, missing or saturated during image analysis were removed. Poorly measured features with ch1 or ch2 intensities <15 were removed. Data was normalized using pin-based LOWESS algorithm.","GPL3883","David,,Lindgren","david.lindgren@med.lu.se","Molecular Pathology","Dep of Laboratory Medicine. Malmö","Lund University","Entrance 78, 3rd floor, UMAS","Malmö","SE-20502","Sweden","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM497nnn/GSM497686/GSM497686.gpr.gz","19889"
"GSM497687","UC_0003_1_RAP_27k_h1","GSM497687","Public on Jun 14 2010","Jan 15 2010","Jan 19 2010","RNA","2","Urinary bladder tumor UC_0003_1","Homo sapiens","sample histology: Urothelial carcinoma","tumor stage: T1","tumor grade: G2","dead of disease: NO","follow up time (months): 69.9","tat1 progress^to minv/cystectomy/dead: YES^cystectomy","cystectomy: YES","","total RNA","Tissue homogenization and RNA recovery using TRIzol reagent (Invitrogen), followed by purification of total RNA using RNeasy kit (Qiagen).","Cy3","1.5 microrgram of sample and reference aRNA, amplified using the MessageAmp aRNA Kit (Ambion), were labeled using the CyScribe Post-Labeling Kit (Amersham Biosciences) followed by purification using the Cyscribe GFX Purification Kit (Amersham)","9606","Stratagene Universal Human Reference","Homo sapiens","reference: RNA pooled from ten human cell lines","total RNA","Tissue homogenization and RNA recovery using TRIzol reagent (Invitrogen), followed by purification of total RNA using RNeasy kit (Qiagen).","Cy5","1.5 microrgram of sample and reference aRNA, amplified using the MessageAmp aRNA Kit (Ambion), were labeled using the CyScribe Post-Labeling Kit (Amersham Biosciences) followed by purification using the Cyscribe GFX Purification Kit (Amersham)","9606","Samples were dissolved in 42 mul of Universal Hybridization Solution (Corning, Acton, MA, USA) and hybridizations were carried out in a CMT-Hybridization Chamber (Corning) for 18 h at 42°C. Pre-hybridization of slides and post-hybridization washes were performed as described in the Universal Hybridization Kit (Corning)","Fluorescence was recorded using an Agilent G2565AA microarray scanner (Agilent Technologies). Image analysis on scanned arrays was performed with GenePix 4.0 (Axon Instruments)","UC_0003_1_RAP_27k_h1","","Data was processed in the BioArray Software Environment (BASE). For each channel, the Mean FG - Median BG intensity value was used. Features flagged bad, missing or saturated during image analysis were removed. Poorly measured features with ch1 or ch2 intensities <15 were removed. Data was normalized using pin-based LOWESS algorithm.","GPL3883","David,,Lindgren","david.lindgren@med.lu.se","Molecular Pathology","Dep of Laboratory Medicine. Malmö","Lund University","Entrance 78, 3rd floor, UMAS","Malmö","SE-20502","Sweden","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM497nnn/GSM497687/GSM497687.gpr.gz","19889"
"GSM497688","UC_0005_1_RAP_27k_h1","GSM497688","Public on Jun 14 2010","Jan 15 2010","Jan 19 2010","RNA","2","Urinary bladder tumor UC_0005_1","Homo sapiens","sample histology: Urothelial carcinoma","tumor stage: Ta","tumor grade: G1","dead of disease: NO","follow up time (months): 79.8","tat1 progress^to minv/cystectomy/dead: NO","","","total RNA","Tissue homogenization and RNA recovery using TRIzol reagent (Invitrogen), followed by purification of total RNA using RNeasy kit (Qiagen).","Cy3","1.5 microrgram of sample and reference aRNA, amplified using the MessageAmp aRNA Kit (Ambion), were labeled using the CyScribe Post-Labeling Kit (Amersham Biosciences) followed by purification using the Cyscribe GFX Purification Kit (Amersham)","9606","Stratagene Universal Human Reference","Homo sapiens","reference: RNA pooled from ten human cell lines","total RNA","Tissue homogenization and RNA recovery using TRIzol reagent (Invitrogen), followed by purification of total RNA using RNeasy kit (Qiagen).","Cy5","1.5 microrgram of sample and reference aRNA, amplified using the MessageAmp aRNA Kit (Ambion), were labeled using the CyScribe Post-Labeling Kit (Amersham Biosciences) followed by purification using the Cyscribe GFX Purification Kit (Amersham)","9606","Samples were dissolved in 42 mul of Universal Hybridization Solution (Corning, Acton, MA, USA) and hybridizations were carried out in a CMT-Hybridization Chamber (Corning) for 18 h at 42°C. Pre-hybridization of slides and post-hybridization washes were performed as described in the Universal Hybridization Kit (Corning)","Fluorescence was recorded using an Agilent G2565AA microarray scanner (Agilent Technologies). Image analysis on scanned arrays was performed with GenePix 4.0 (Axon Instruments)","UC_0005_1_RAP_27k_h1","","Data was processed in the BioArray Software Environment (BASE). For each channel, the Mean FG - Median BG intensity value was used. Features flagged bad, missing or saturated during image analysis were removed. Poorly measured features with ch1 or ch2 intensities <15 were removed. Data was normalized using pin-based LOWESS algorithm.","GPL3883","David,,Lindgren","david.lindgren@med.lu.se","Molecular Pathology","Dep of Laboratory Medicine. Malmö","Lund University","Entrance 78, 3rd floor, UMAS","Malmö","SE-20502","Sweden","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM497nnn/GSM497688/GSM497688.gpr.gz","19889"
"GSM497689","UC_0006_2_RAP_27k_h1","GSM497689","Public on Jun 14 2010","Jan 15 2010","Jan 19 2010","RNA","2","Urinary bladder tumor UC_0006_2","Homo sapiens","sample histology: Urothelial carcinoma","tumor stage: T1","tumor grade: G2","dead of disease: NO","follow up time (months): 15.7","tat1 progress^to minv/cystectomy/dead: NO","","","total RNA","Tissue homogenization and RNA recovery using TRIzol reagent (Invitrogen), followed by purification of total RNA using RNeasy kit (Qiagen).","Cy3","1.5 microrgram of sample and reference aRNA, amplified using the MessageAmp aRNA Kit (Ambion), were labeled using the CyScribe Post-Labeling Kit (Amersham Biosciences) followed by purification using the Cyscribe GFX Purification Kit (Amersham)","9606","Stratagene Universal Human Reference","Homo sapiens","reference: RNA pooled from ten human cell lines","total RNA","Tissue homogenization and RNA recovery using TRIzol reagent (Invitrogen), followed by purification of total RNA using RNeasy kit (Qiagen).","Cy5","1.5 microrgram of sample and reference aRNA, amplified using the MessageAmp aRNA Kit (Ambion), were labeled using the CyScribe Post-Labeling Kit (Amersham Biosciences) followed by purification using the Cyscribe GFX Purification Kit (Amersham)","9606","Samples were dissolved in 42 mul of Universal Hybridization Solution (Corning, Acton, MA, USA) and hybridizations were carried out in a CMT-Hybridization Chamber (Corning) for 18 h at 42°C. Pre-hybridization of slides and post-hybridization washes were performed as described in the Universal Hybridization Kit (Corning)","Fluorescence was recorded using an Agilent G2565AA microarray scanner (Agilent Technologies). Image analysis on scanned arrays was performed with GenePix 4.0 (Axon Instruments)","UC_0006_2_RAP_27k_h1","","Data was processed in the BioArray Software Environment (BASE). For each channel, the Mean FG - Median BG intensity value was used. Features flagged bad, missing or saturated during image analysis were removed. Poorly measured features with ch1 or ch2 intensities <15 were removed. Data was normalized using pin-based LOWESS algorithm.","GPL3883","David,,Lindgren","david.lindgren@med.lu.se","Molecular Pathology","Dep of Laboratory Medicine. Malmö","Lund University","Entrance 78, 3rd floor, UMAS","Malmö","SE-20502","Sweden","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM497nnn/GSM497689/GSM497689.gpr.gz","19889"
"GSM497690","UC_0008_1_RAP_27k_h1","GSM497690","Public on Jun 14 2010","Jan 15 2010","Jan 19 2010","RNA","2","Urinary bladder tumor UC_0008_1","Homo sapiens","sample histology: Urothelial carcinoma","tumor stage: T1","tumor grade: G2","dead of disease: NO","follow up time (months): 78.6","tat1 progress^to minv/cystectomy/dead: NO","","","total RNA","Tissue homogenization and RNA recovery using TRIzol reagent (Invitrogen), followed by purification of total RNA using RNeasy kit (Qiagen).","Cy3","1.5 microrgram of sample and reference aRNA, amplified using the MessageAmp aRNA Kit (Ambion), were labeled using the CyScribe Post-Labeling Kit (Amersham Biosciences) followed by purification using the Cyscribe GFX Purification Kit (Amersham)","9606","Stratagene Universal Human Reference","Homo sapiens","reference: RNA pooled from ten human cell lines","total RNA","Tissue homogenization and RNA recovery using TRIzol reagent (Invitrogen), followed by purification of total RNA using RNeasy kit (Qiagen).","Cy5","1.5 microrgram of sample and reference aRNA, amplified using the MessageAmp aRNA Kit (Ambion), were labeled using the CyScribe Post-Labeling Kit (Amersham Biosciences) followed by purification using the Cyscribe GFX Purification Kit (Amersham)","9606","Samples were dissolved in 42 mul of Universal Hybridization Solution (Corning, Acton, MA, USA) and hybridizations were carried out in a CMT-Hybridization Chamber (Corning) for 18 h at 42°C. Pre-hybridization of slides and post-hybridization washes were performed as described in the Universal Hybridization Kit (Corning)","Fluorescence was recorded using an Agilent G2565AA microarray scanner (Agilent Technologies). Image analysis on scanned arrays was performed with GenePix 4.0 (Axon Instruments)","UC_0008_1_RAP_27k_h1","","Data was processed in the BioArray Software Environment (BASE). For each channel, the Mean FG - Median BG intensity value was used. Features flagged bad, missing or saturated during image analysis were removed. Poorly measured features with ch1 or ch2 intensities <15 were removed. Data was normalized using pin-based LOWESS algorithm.","GPL3883","David,,Lindgren","david.lindgren@med.lu.se","Molecular Pathology","Dep of Laboratory Medicine. Malmö","Lund University","Entrance 78, 3rd floor, UMAS","Malmö","SE-20502","Sweden","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM497nnn/GSM497690/GSM497690.gpr.gz","19889"
"GSM497691","UC_0009_1_RAP_27k_h1","GSM497691","Public on Jun 14 2010","Jan 15 2010","Jan 19 2010","RNA","2","Urinary bladder tumor UC_0009_1","Homo sapiens","sample histology: Urothelial carcinoma","tumor stage: Ta","tumor grade: G2","dead of disease: NO","follow up time (months): 63.9","tat1 progress^to minv/cystectomy/dead: NO","","","total RNA","Tissue homogenization and RNA recovery using TRIzol reagent (Invitrogen), followed by purification of total RNA using RNeasy kit (Qiagen).","Cy3","1.5 microrgram of sample and reference aRNA, amplified using the MessageAmp aRNA Kit (Ambion), were labeled using the CyScribe Post-Labeling Kit (Amersham Biosciences) followed by purification using the Cyscribe GFX Purification Kit (Amersham)","9606","Stratagene Universal Human Reference","Homo sapiens","reference: RNA pooled from ten human cell lines","total RNA","Tissue homogenization and RNA recovery using TRIzol reagent (Invitrogen), followed by purification of total RNA using RNeasy kit (Qiagen).","Cy5","1.5 microrgram of sample and reference aRNA, amplified using the MessageAmp aRNA Kit (Ambion), were labeled using the CyScribe Post-Labeling Kit (Amersham Biosciences) followed by purification using the Cyscribe GFX Purification Kit (Amersham)","9606","Samples were dissolved in 42 mul of Universal Hybridization Solution (Corning, Acton, MA, USA) and hybridizations were carried out in a CMT-Hybridization Chamber (Corning) for 18 h at 42°C. Pre-hybridization of slides and post-hybridization washes were performed as described in the Universal Hybridization Kit (Corning)","Fluorescence was recorded using an Agilent G2565AA microarray scanner (Agilent Technologies). Image analysis on scanned arrays was performed with GenePix 4.0 (Axon Instruments)","UC_0009_1_RAP_27k_h1","","Data was processed in the BioArray Software Environment (BASE). For each channel, the Mean FG - Median BG intensity value was used. Features flagged bad, missing or saturated during image analysis were removed. Poorly measured features with ch1 or ch2 intensities <15 were removed. Data was normalized using pin-based LOWESS algorithm.","GPL3883","David,,Lindgren","david.lindgren@med.lu.se","Molecular Pathology","Dep of Laboratory Medicine. Malmö","Lund University","Entrance 78, 3rd floor, UMAS","Malmö","SE-20502","Sweden","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM497nnn/GSM497691/GSM497691.gpr.gz","19889"
"GSM497692","UC_0010_1_RAP_27k_h1","GSM497692","Public on Jun 14 2010","Jan 15 2010","Jan 19 2010","RNA","2","Urinary bladder tumor UC_0010_1","Homo sapiens","sample histology: Urothelial carcinoma","tumor stage: T1","tumor grade: G2","dead of disease: NO","follow up time (months): 42.5","tat1 progress^to minv/cystectomy/dead: NO","","","total RNA","Tissue homogenization and RNA recovery using TRIzol reagent (Invitrogen), followed by purification of total RNA using RNeasy kit (Qiagen).","Cy3","1.5 microrgram of sample and reference aRNA, amplified using the MessageAmp aRNA Kit (Ambion), were labeled using the CyScribe Post-Labeling Kit (Amersham Biosciences) followed by purification using the Cyscribe GFX Purification Kit (Amersham)","9606","Stratagene Universal Human Reference","Homo sapiens","reference: RNA pooled from ten human cell lines","total RNA","Tissue homogenization and RNA recovery using TRIzol reagent (Invitrogen), followed by purification of total RNA using RNeasy kit (Qiagen).","Cy5","1.5 microrgram of sample and reference aRNA, amplified using the MessageAmp aRNA Kit (Ambion), were labeled using the CyScribe Post-Labeling Kit (Amersham Biosciences) followed by purification using the Cyscribe GFX Purification Kit (Amersham)","9606","Samples were dissolved in 42 mul of Universal Hybridization Solution (Corning, Acton, MA, USA) and hybridizations were carried out in a CMT-Hybridization Chamber (Corning) for 18 h at 42°C. Pre-hybridization of slides and post-hybridization washes were performed as described in the Universal Hybridization Kit (Corning)","Fluorescence was recorded using an Agilent G2565AA microarray scanner (Agilent Technologies). Image analysis on scanned arrays was performed with GenePix 4.0 (Axon Instruments)","UC_0010_1_RAP_27k_h1","","Data was processed in the BioArray Software Environment (BASE). For each channel, the Mean FG - Median BG intensity value was used. Features flagged bad, missing or saturated during image analysis were removed. Poorly measured features with ch1 or ch2 intensities <15 were removed. Data was normalized using pin-based LOWESS algorithm.","GPL3883","David,,Lindgren","david.lindgren@med.lu.se","Molecular Pathology","Dep of Laboratory Medicine. Malmö","Lund University","Entrance 78, 3rd floor, UMAS","Malmö","SE-20502","Sweden","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM497nnn/GSM497692/GSM497692.gpr.gz","19889"
"GSM497693","UC_0011_3_RAP_27k_h1","GSM497693","Public on Jun 14 2010","Jan 15 2010","Jan 19 2010","RNA","2","Urinary bladder tumor UC_0011_3","Homo sapiens","sample histology: Urothelial carcinoma","tumor stage: Ta","tumor grade: G2","dead of disease: NO","follow up time (months): 56.4","tat1 progress^to minv/cystectomy/dead: NO","","","total RNA","Tissue homogenization and RNA recovery using TRIzol reagent (Invitrogen), followed by purification of total RNA using RNeasy kit (Qiagen).","Cy3","1.5 microrgram of sample and reference aRNA, amplified using the MessageAmp aRNA Kit (Ambion), were labeled using the CyScribe Post-Labeling Kit (Amersham Biosciences) followed by purification using the Cyscribe GFX Purification Kit (Amersham)","9606","Stratagene Universal Human Reference","Homo sapiens","reference: RNA pooled from ten human cell lines","total RNA","Tissue homogenization and RNA recovery using TRIzol reagent (Invitrogen), followed by purification of total RNA using RNeasy kit (Qiagen).","Cy5","1.5 microrgram of sample and reference aRNA, amplified using the MessageAmp aRNA Kit (Ambion), were labeled using the CyScribe Post-Labeling Kit (Amersham Biosciences) followed by purification using the Cyscribe GFX Purification Kit (Amersham)","9606","Samples were dissolved in 42 mul of Universal Hybridization Solution (Corning, Acton, MA, USA) and hybridizations were carried out in a CMT-Hybridization Chamber (Corning) for 18 h at 42°C. Pre-hybridization of slides and post-hybridization washes were performed as described in the Universal Hybridization Kit (Corning)","Fluorescence was recorded using an Agilent G2565AA microarray scanner (Agilent Technologies). Image analysis on scanned arrays was performed with GenePix 4.0 (Axon Instruments)","UC_0011_3_RAP_27k_h1","","Data was processed in the BioArray Software Environment (BASE). For each channel, the Mean FG - Median BG intensity value was used. Features flagged bad, missing or saturated during image analysis were removed. Poorly measured features with ch1 or ch2 intensities <15 were removed. Data was normalized using pin-based LOWESS algorithm.","GPL3883","David,,Lindgren","david.lindgren@med.lu.se","Molecular Pathology","Dep of Laboratory Medicine. Malmö","Lund University","Entrance 78, 3rd floor, UMAS","Malmö","SE-20502","Sweden","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM497nnn/GSM497693/GSM497693.gpr.gz","19889"
"GSM497694","UC_0012_1_RAP_27k_h4","GSM497694","Public on Jun 14 2010","Jan 15 2010","Jan 19 2010","RNA","2","Urinary bladder tumor UC_0012_1","Homo sapiens","sample histology: Urothelial carcinoma","tumor stage: Ta","tumor grade: G1","dead of disease: NO","follow up time (months): 49.5","tat1 progress^to minv/cystectomy/dead: NO","","","total RNA","Tissue homogenization and RNA recovery using TRIzol reagent (Invitrogen), followed by purification of total RNA using RNeasy kit (Qiagen).","Cy3","1.5 microrgram of sample and reference aRNA, amplified using the MessageAmp aRNA Kit (Ambion), were labeled using the CyScribe Post-Labeling Kit (Amersham Biosciences) followed by purification using the Cyscribe GFX Purification Kit (Amersham)","9606","Stratagene Universal Human Reference","Homo sapiens","reference: RNA pooled from ten human cell lines","total RNA","Tissue homogenization and RNA recovery using TRIzol reagent (Invitrogen), followed by purification of total RNA using RNeasy kit (Qiagen).","Cy5","1.5 microrgram of sample and reference aRNA, amplified using the MessageAmp aRNA Kit (Ambion), were labeled using the CyScribe Post-Labeling Kit (Amersham Biosciences) followed by purification using the Cyscribe GFX Purification Kit (Amersham)","9606","Samples were dissolved in 42 mul of Universal Hybridization Solution (Corning, Acton, MA, USA) and hybridizations were carried out in a CMT-Hybridization Chamber (Corning) for 18 h at 42°C. Pre-hybridization of slides and post-hybridization washes were performed as described in the Universal Hybridization Kit (Corning)","Fluorescence was recorded using an Agilent G2565AA microarray scanner (Agilent Technologies). Image analysis on scanned arrays was performed with GenePix 4.0 (Axon Instruments)","UC_0012_1_RAP_27k_h4","","Data was processed in the BioArray Software Environment (BASE). For each channel, the Mean FG - Median BG intensity value was used. Features flagged bad, missing or saturated during image analysis were removed. Poorly measured features with ch1 or ch2 intensities <15 were removed. Data was normalized using pin-based LOWESS algorithm.","GPL3883","David,,Lindgren","david.lindgren@med.lu.se","Molecular Pathology","Dep of Laboratory Medicine. Malmö","Lund University","Entrance 78, 3rd floor, UMAS","Malmö","SE-20502","Sweden","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM497nnn/GSM497694/GSM497694.gpr.gz","19889"
"GSM497695","UC_0015_1_RAP_27k_h1","GSM497695","Public on Jun 14 2010","Jan 15 2010","Jan 19 2010","RNA","2","Urinary bladder tumor UC_0015_1","Homo sapiens","sample histology: Urothelial carcinoma","tumor stage: Ta","tumor grade: G1","dead of disease: NO","follow up time (months): 77.8","tat1 progress^to minv/cystectomy/dead: NO","","","total RNA","Tissue homogenization and RNA recovery using TRIzol reagent (Invitrogen), followed by purification of total RNA using RNeasy kit (Qiagen).","Cy3","1.5 microrgram of sample and reference aRNA, amplified using the MessageAmp aRNA Kit (Ambion), were labeled using the CyScribe Post-Labeling Kit (Amersham Biosciences) followed by purification using the Cyscribe GFX Purification Kit (Amersham)","9606","Stratagene Universal Human Reference","Homo sapiens","reference: RNA pooled from ten human cell lines","total RNA","Tissue homogenization and RNA recovery using TRIzol reagent (Invitrogen), followed by purification of total RNA using RNeasy kit (Qiagen).","Cy5","1.5 microrgram of sample and reference aRNA, amplified using the MessageAmp aRNA Kit (Ambion), were labeled using the CyScribe Post-Labeling Kit (Amersham Biosciences) followed by purification using the Cyscribe GFX Purification Kit (Amersham)","9606","Samples were dissolved in 42 mul of Universal Hybridization Solution (Corning, Acton, MA, USA) and hybridizations were carried out in a CMT-Hybridization Chamber (Corning) for 18 h at 42°C. Pre-hybridization of slides and post-hybridization washes were performed as described in the Universal Hybridization Kit (Corning)","Fluorescence was recorded using an Agilent G2565AA microarray scanner (Agilent Technologies). Image analysis on scanned arrays was performed with GenePix 4.0 (Axon Instruments)","UC_0015_1_RAP_27k_h1","","Data was processed in the BioArray Software Environment (BASE). For each channel, the Mean FG - Median BG intensity value was used. Features flagged bad, missing or saturated during image analysis were removed. Poorly measured features with ch1 or ch2 intensities <15 were removed. Data was normalized using pin-based LOWESS algorithm.","GPL3883","David,,Lindgren","david.lindgren@med.lu.se","Molecular Pathology","Dep of Laboratory Medicine. Malmö","Lund University","Entrance 78, 3rd floor, UMAS","Malmö","SE-20502","Sweden","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM497nnn/GSM497695/GSM497695.gpr.gz","19889"
"GSM497696","UC_0017_1_RAP_27k_h1","GSM497696","Public on Jun 14 2010","Jan 15 2010","Jan 19 2010","RNA","2","Urinary bladder tumor UC_0017_1","Homo sapiens","sample histology: Urothelial carcinoma","tumor stage: Ta","tumor grade: G2","dead of disease: NO","follow up time (months): 13.2","tat1 progress^to minv/cystectomy/dead: NO","","","total RNA","Tissue homogenization and RNA recovery using TRIzol reagent (Invitrogen), followed by purification of total RNA using RNeasy kit (Qiagen).","Cy3","1.5 microrgram of sample and reference aRNA, amplified using the MessageAmp aRNA Kit (Ambion), were labeled using the CyScribe Post-Labeling Kit (Amersham Biosciences) followed by purification using the Cyscribe GFX Purification Kit (Amersham)","9606","Stratagene Universal Human Reference","Homo sapiens","reference: RNA pooled from ten human cell lines","total RNA","Tissue homogenization and RNA recovery using TRIzol reagent (Invitrogen), followed by purification of total RNA using RNeasy kit (Qiagen).","Cy5","1.5 microrgram of sample and reference aRNA, amplified using the MessageAmp aRNA Kit (Ambion), were labeled using the CyScribe Post-Labeling Kit (Amersham Biosciences) followed by purification using the Cyscribe GFX Purification Kit (Amersham)","9606","Samples were dissolved in 42 mul of Universal Hybridization Solution (Corning, Acton, MA, USA) and hybridizations were carried out in a CMT-Hybridization Chamber (Corning) for 18 h at 42°C. Pre-hybridization of slides and post-hybridization washes were performed as described in the Universal Hybridization Kit (Corning)","Fluorescence was recorded using an Agilent G2565AA microarray scanner (Agilent Technologies). Image analysis on scanned arrays was performed with GenePix 4.0 (Axon Instruments)","UC_0017_1_RAP_27k_h1","","Data was processed in the BioArray Software Environment (BASE). For each channel, the Mean FG - Median BG intensity value was used. Features flagged bad, missing or saturated during image analysis were removed. Poorly measured features with ch1 or ch2 intensities <15 were removed. Data was normalized using pin-based LOWESS algorithm.","GPL3883","David,,Lindgren","david.lindgren@med.lu.se","Molecular Pathology","Dep of Laboratory Medicine. Malmö","Lund University","Entrance 78, 3rd floor, UMAS","Malmö","SE-20502","Sweden","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM497nnn/GSM497696/GSM497696.gpr.gz","19889"
"GSM497697","UC_0019_1_RAP_27k_h1","GSM497697","Public on Jun 14 2010","Jan 15 2010","Jan 19 2010","RNA","2","Urinary bladder tumor UC_0019_1","Homo sapiens","sample histology: Urothelial carcinoma","tumor stage: Ta","tumor grade: G2","dead of disease: NO","follow up time (months): 71.1","tat1 progress^to minv/cystectomy/dead: NO","","","total RNA","Tissue homogenization and RNA recovery using TRIzol reagent (Invitrogen), followed by purification of total RNA using RNeasy kit (Qiagen).","Cy3","1.5 microrgram of sample and reference aRNA, amplified using the MessageAmp aRNA Kit (Ambion), were labeled using the CyScribe Post-Labeling Kit (Amersham Biosciences) followed by purification using the Cyscribe GFX Purification Kit (Amersham)","9606","Stratagene Universal Human Reference","Homo sapiens","reference: RNA pooled from ten human cell lines","total RNA","Tissue homogenization and RNA recovery using TRIzol reagent (Invitrogen), followed by purification of total RNA using RNeasy kit (Qiagen).","Cy5","1.5 microrgram of sample and reference aRNA, amplified using the MessageAmp aRNA Kit (Ambion), were labeled using the CyScribe Post-Labeling Kit (Amersham Biosciences) followed by purification using the Cyscribe GFX Purification Kit (Amersham)","9606","Samples were dissolved in 42 mul of Universal Hybridization Solution (Corning, Acton, MA, USA) and hybridizations were carried out in a CMT-Hybridization Chamber (Corning) for 18 h at 42°C. Pre-hybridization of slides and post-hybridization washes were performed as described in the Universal Hybridization Kit (Corning)","Fluorescence was recorded using an Agilent G2565AA microarray scanner (Agilent Technologies). Image analysis on scanned arrays was performed with GenePix 4.0 (Axon Instruments)","UC_0019_1_RAP_27k_h1","","Data was processed in the BioArray Software Environment (BASE). For each channel, the Mean FG - Median BG intensity value was used. Features flagged bad, missing or saturated during image analysis were removed. Poorly measured features with ch1 or ch2 intensities <15 were removed. Data was normalized using pin-based LOWESS algorithm.","GPL3883","David,,Lindgren","david.lindgren@med.lu.se","Molecular Pathology","Dep of Laboratory Medicine. Malmö","Lund University","Entrance 78, 3rd floor, UMAS","Malmö","SE-20502","Sweden","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM497nnn/GSM497697/GSM497697.gpr.gz","19889"
"GSM497698","UC_0021_1_RAP_27k_h1","GSM497698","Public on Jun 14 2010","Jan 15 2010","Jan 19 2010","RNA","2","Urinary bladder tumor UC_0021_1","Homo sapiens","sample histology: Urothelial carcinoma","tumor stage: Ta","tumor grade: G1","dead of disease: NO","follow up time (months): 72.9","tat1 progress^to minv/cystectomy/dead: NO","","","total RNA","Tissue homogenization and RNA recovery using TRIzol reagent (Invitrogen), followed by purification of total RNA using RNeasy kit (Qiagen).","Cy3","1.5 microrgram of sample and reference aRNA, amplified using the MessageAmp aRNA Kit (Ambion), were labeled using the CyScribe Post-Labeling Kit (Amersham Biosciences) followed by purification using the Cyscribe GFX Purification Kit (Amersham)","9606","Stratagene Universal Human Reference","Homo sapiens","reference: RNA pooled from ten human cell lines","total RNA","Tissue homogenization and RNA recovery using TRIzol reagent (Invitrogen), followed by purification of total RNA using RNeasy kit (Qiagen).","Cy5","1.5 microrgram of sample and reference aRNA, amplified using the MessageAmp aRNA Kit (Ambion), were labeled using the CyScribe Post-Labeling Kit (Amersham Biosciences) followed by purification using the Cyscribe GFX Purification Kit (Amersham)","9606","Samples were dissolved in 42 mul of Universal Hybridization Solution (Corning, Acton, MA, USA) and hybridizations were carried out in a CMT-Hybridization Chamber (Corning) for 18 h at 42°C. Pre-hybridization of slides and post-hybridization washes were performed as described in the Universal Hybridization Kit (Corning)","Fluorescence was recorded using an Agilent G2565AA microarray scanner (Agilent Technologies). Image analysis on scanned arrays was performed with GenePix 4.0 (Axon Instruments)","UC_0021_1_RAP_27k_h1","","Data was processed in the BioArray Software Environment (BASE). For each channel, the Mean FG - Median BG intensity value was used. Features flagged bad, missing or saturated during image analysis were removed. Poorly measured features with ch1 or ch2 intensities <15 were removed. Data was normalized using pin-based LOWESS algorithm.","GPL3883","David,,Lindgren","david.lindgren@med.lu.se","Molecular Pathology","Dep of Laboratory Medicine. Malmö","Lund University","Entrance 78, 3rd floor, UMAS","Malmö","SE-20502","Sweden","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM497nnn/GSM497698/GSM497698.gpr.gz","19889"
"GSM497699","UC_0023_1_RAP_27k_h1","GSM497699","Public on Jun 14 2010","Jan 15 2010","Jan 19 2010","RNA","2","Urinary bladder tumor UC_0023_1","Homo sapiens","sample histology: Urothelial carcinoma","tumor stage: T3","tumor grade: G3","dead of disease: NO","follow up time (months): 75.9","cystectomy: YES","","","total RNA","Tissue homogenization and RNA recovery using TRIzol reagent (Invitrogen), followed by purification of total RNA using RNeasy kit (Qiagen).","Cy3","1.5 microrgram of sample and reference aRNA, amplified using the MessageAmp aRNA Kit (Ambion), were labeled using the CyScribe Post-Labeling Kit (Amersham Biosciences) followed by purification using the Cyscribe GFX Purification Kit (Amersham)","9606","Stratagene Universal Human Reference","Homo sapiens","reference: RNA pooled from ten human cell lines","total RNA","Tissue homogenization and RNA recovery using TRIzol reagent (Invitrogen), followed by purification of total RNA using RNeasy kit (Qiagen).","Cy5","1.5 microrgram of sample and reference aRNA, amplified using the MessageAmp aRNA Kit (Ambion), were labeled using the CyScribe Post-Labeling Kit (Amersham Biosciences) followed by purification using the Cyscribe GFX Purification Kit (Amersham)","9606","Samples were dissolved in 42 mul of Universal Hybridization Solution (Corning, Acton, MA, USA) and hybridizations were carried out in a CMT-Hybridization Chamber (Corning) for 18 h at 42°C. Pre-hybridization of slides and post-hybridization washes were performed as described in the Universal Hybridization Kit (Corning)","Fluorescence was recorded using an Agilent G2565AA microarray scanner (Agilent Technologies). Image analysis on scanned arrays was performed with GenePix 4.0 (Axon Instruments)","UC_0023_1_RAP_27k_h1","","Data was processed in the BioArray Software Environment (BASE). For each channel, the Mean FG - Median BG intensity value was used. Features flagged bad, missing or saturated during image analysis were removed. Poorly measured features with ch1 or ch2 intensities <15 were removed. Data was normalized using pin-based LOWESS algorithm.","GPL3883","David,,Lindgren","david.lindgren@med.lu.se","Molecular Pathology","Dep of Laboratory Medicine. Malmö","Lund University","Entrance 78, 3rd floor, UMAS","Malmö","SE-20502","Sweden","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM497nnn/GSM497699/GSM497699.gpr.gz","19889"
"GSM497700","UC_0025_1_RAP_27k_h1","GSM497700","Public on Jun 14 2010","Jan 15 2010","Jan 19 2010","RNA","2","Urinary bladder tumor UC_0025_1","Homo sapiens","sample histology: Urothelial carcinoma","tumor stage: Ta","tumor grade: G2","dead of disease: NO","follow up time (months): 66.2","tat1 progress^to minv/cystectomy/dead: NO","","","total RNA","Tissue homogenization and RNA recovery using TRIzol reagent (Invitrogen), followed by purification of total RNA using RNeasy kit (Qiagen).","Cy3","1.5 microrgram of sample and reference aRNA, amplified using the MessageAmp aRNA Kit (Ambion), were labeled using the CyScribe Post-Labeling Kit (Amersham Biosciences) followed by purification using the Cyscribe GFX Purification Kit (Amersham)","9606","Stratagene Universal Human Reference","Homo sapiens","reference: RNA pooled from ten human cell lines","total RNA","Tissue homogenization and RNA recovery using TRIzol reagent (Invitrogen), followed by purification of total RNA using RNeasy kit (Qiagen).","Cy5","1.5 microrgram of sample and reference aRNA, amplified using the MessageAmp aRNA Kit (Ambion), were labeled using the CyScribe Post-Labeling Kit (Amersham Biosciences) followed by purification using the Cyscribe GFX Purification Kit (Amersham)","9606","Samples were dissolved in 42 mul of Universal Hybridization Solution (Corning, Acton, MA, USA) and hybridizations were carried out in a CMT-Hybridization Chamber (Corning) for 18 h at 42°C. Pre-hybridization of slides and post-hybridization washes were performed as described in the Universal Hybridization Kit (Corning)","Fluorescence was recorded using an Agilent G2565AA microarray scanner (Agilent Technologies). Image analysis on scanned arrays was performed with GenePix 4.0 (Axon Instruments)","UC_0025_1_RAP_27k_h1","","Data was processed in the BioArray Software Environment (BASE). For each channel, the Mean FG - Median BG intensity value was used. Features flagged bad, missing or saturated during image analysis were removed. Poorly measured features with ch1 or ch2 intensities <15 were removed. Data was normalized using pin-based LOWESS algorithm.","GPL3883","David,,Lindgren","david.lindgren@med.lu.se","Molecular Pathology","Dep of Laboratory Medicine. Malmö","Lund University","Entrance 78, 3rd floor, UMAS","Malmö","SE-20502","Sweden","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM497nnn/GSM497700/GSM497700.gpr.gz","19889"
"GSM497701","UC_0026_1_RAP_27k_h1","GSM497701","Public on Jun 14 2010","Jan 15 2010","Jan 19 2010","RNA","2","Urinary bladder tumor UC_0026_1","Homo sapiens","sample histology: Urothelial carcinoma","tumor stage: Ta","tumor grade: G2","dead of disease: NO","follow up time (months): 74.7","tat1 progress^to minv/cystectomy/dead: NO","","","total RNA","Tissue homogenization and RNA recovery using TRIzol reagent (Invitrogen), followed by purification of total RNA using RNeasy kit (Qiagen).","Cy3","1.5 microrgram of sample and reference aRNA, amplified using the MessageAmp aRNA Kit (Ambion), were labeled using the CyScribe Post-Labeling Kit (Amersham Biosciences) followed by purification using the Cyscribe GFX Purification Kit (Amersham)","9606","Stratagene Universal Human Reference","Homo sapiens","reference: RNA pooled from ten human cell lines","total RNA","Tissue homogenization and RNA recovery using TRIzol reagent (Invitrogen), followed by purification of total RNA using RNeasy kit (Qiagen).","Cy5","1.5 microrgram of sample and reference aRNA, amplified using the MessageAmp aRNA Kit (Ambion), were labeled using the CyScribe Post-Labeling Kit (Amersham Biosciences) followed by purification using the Cyscribe GFX Purification Kit (Amersham)","9606","Samples were dissolved in 42 mul of Universal Hybridization Solution (Corning, Acton, MA, USA) and hybridizations were carried out in a CMT-Hybridization Chamber (Corning) for 18 h at 42°C. Pre-hybridization of slides and post-hybridization washes were performed as described in the Universal Hybridization Kit (Corning)","Fluorescence was recorded using an Agilent G2565AA microarray scanner (Agilent Technologies). Image analysis on scanned arrays was performed with GenePix 4.0 (Axon Instruments)","UC_0026_1_RAP_27k_h1","","Data was processed in the BioArray Software Environment (BASE). For each channel, the Mean FG - Median BG intensity value was used. Features flagged bad, missing or saturated during image analysis were removed. Poorly measured features with ch1 or ch2 intensities <15 were removed. Data was normalized using pin-based LOWESS algorithm.","GPL3883","David,,Lindgren","david.lindgren@med.lu.se","Molecular Pathology","Dep of Laboratory Medicine. Malmö","Lund University","Entrance 78, 3rd floor, UMAS","Malmö","SE-20502","Sweden","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM497nnn/GSM497701/GSM497701.gpr.gz","19889"
"GSM497702","UC_0029_1_RAP_27k_h1","GSM497702","Public on Jun 14 2010","Jan 15 2010","Jan 19 2010","RNA","2","Urinary bladder tumor UC_0029_1","Homo sapiens","sample histology: Urothelial carcinoma","tumor stage: Ta","tumor grade: G2","dead of disease: NO","follow up time (months): 34.7","tat1 progress^to minv/cystectomy/dead: NO","","","total RNA","Tissue homogenization and RNA recovery using TRIzol reagent (Invitrogen), followed by purification of total RNA using RNeasy kit (Qiagen).","Cy3","1.5 microrgram of sample and reference aRNA, amplified using the MessageAmp aRNA Kit (Ambion), were labeled using the CyScribe Post-Labeling Kit (Amersham Biosciences) followed by purification using the Cyscribe GFX Purification Kit (Amersham)","9606","Stratagene Universal Human Reference","Homo sapiens","reference: RNA pooled from ten human cell lines","total RNA","Tissue homogenization and RNA recovery using TRIzol reagent (Invitrogen), followed by purification of total RNA using RNeasy kit (Qiagen).","Cy5","1.5 microrgram of sample and reference aRNA, amplified using the MessageAmp aRNA Kit (Ambion), were labeled using the CyScribe Post-Labeling Kit (Amersham Biosciences) followed by purification using the Cyscribe GFX Purification Kit (Amersham)","9606","Samples were dissolved in 42 mul of Universal Hybridization Solution (Corning, Acton, MA, USA) and hybridizations were carried out in a CMT-Hybridization Chamber (Corning) for 18 h at 42°C. Pre-hybridization of slides and post-hybridization washes were performed as described in the Universal Hybridization Kit (Corning)","Fluorescence was recorded using an Agilent G2565AA microarray scanner (Agilent Technologies). Image analysis on scanned arrays was performed with GenePix 4.0 (Axon Instruments)","UC_0029_1_RAP_27k_h1","","Data was processed in the BioArray Software Environment (BASE). For each channel, the Mean FG - Median BG intensity value was used. Features flagged bad, missing or saturated during image analysis were removed. Poorly measured features with ch1 or ch2 intensities <15 were removed. Data was normalized using pin-based LOWESS algorithm.","GPL3883","David,,Lindgren","david.lindgren@med.lu.se","Molecular Pathology","Dep of Laboratory Medicine. Malmö","Lund University","Entrance 78, 3rd floor, UMAS","Malmö","SE-20502","Sweden","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM497nnn/GSM497702/GSM497702.gpr.gz","19889"
"GSM497703","UC_0032_1_RAP_27k_h1","GSM497703","Public on Jun 14 2010","Jan 15 2010","Jan 19 2010","RNA","2","Urinary bladder tumor UC_0032_1","Homo sapiens","sample histology: Urothelial carcinoma","tumor stage: Ta","tumor grade: G1","dead of disease: NO","follow up time (months): 72.0","tat1 progress^to minv/cystectomy/dead: NO","","","total RNA","Tissue homogenization and RNA recovery using TRIzol reagent (Invitrogen), followed by purification of total RNA using RNeasy kit (Qiagen).","Cy3","1.5 microrgram of sample and reference aRNA, amplified using the MessageAmp aRNA Kit (Ambion), were labeled using the CyScribe Post-Labeling Kit (Amersham Biosciences) followed by purification using the Cyscribe GFX Purification Kit (Amersham)","9606","Stratagene Universal Human Reference","Homo sapiens","reference: RNA pooled from ten human cell lines","total RNA","Tissue homogenization and RNA recovery using TRIzol reagent (Invitrogen), followed by purification of total RNA using RNeasy kit (Qiagen).","Cy5","1.5 microrgram of sample and reference aRNA, amplified using the MessageAmp aRNA Kit (Ambion), were labeled using the CyScribe Post-Labeling Kit (Amersham Biosciences) followed by purification using the Cyscribe GFX Purification Kit (Amersham)","9606","Samples were dissolved in 42 mul of Universal Hybridization Solution (Corning, Acton, MA, USA) and hybridizations were carried out in a CMT-Hybridization Chamber (Corning) for 18 h at 42°C. Pre-hybridization of slides and post-hybridization washes were performed as described in the Universal Hybridization Kit (Corning)","Fluorescence was recorded using an Agilent G2565AA microarray scanner (Agilent Technologies). Image analysis on scanned arrays was performed with GenePix 4.0 (Axon Instruments)","UC_0032_1_RAP_27k_h1","","Data was processed in the BioArray Software Environment (BASE). For each channel, the Mean FG - Median BG intensity value was used. Features flagged bad, missing or saturated during image analysis were removed. Poorly measured features with ch1 or ch2 intensities <15 were removed. Data was normalized using pin-based LOWESS algorithm.","GPL3883","David,,Lindgren","david.lindgren@med.lu.se","Molecular Pathology","Dep of Laboratory Medicine. Malmö","Lund University","Entrance 78, 3rd floor, UMAS","Malmö","SE-20502","Sweden","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM497nnn/GSM497703/GSM497703.gpr.gz","19889"
"GSM497704","UC_0033_1_RAP_27k_h1","GSM497704","Public on Jun 14 2010","Jan 15 2010","Jan 19 2010","RNA","2","Urinary bladder tumor UC_0033_1","Homo sapiens","sample histology: Urothelial carcinoma","tumor stage: Ta","tumor grade: G2","dead of disease: NO","follow up time (months): 66.5","tat1 progress^to minv/cystectomy/dead: NO","","","total RNA","Tissue homogenization and RNA recovery using TRIzol reagent (Invitrogen), followed by purification of total RNA using RNeasy kit (Qiagen).","Cy3","1.5 microrgram of sample and reference aRNA, amplified using the MessageAmp aRNA Kit (Ambion), were labeled using the CyScribe Post-Labeling Kit (Amersham Biosciences) followed by purification using the Cyscribe GFX Purification Kit (Amersham)","9606","Stratagene Universal Human Reference","Homo sapiens","reference: RNA pooled from ten human cell lines","total RNA","Tissue homogenization and RNA recovery using TRIzol reagent (Invitrogen), followed by purification of total RNA using RNeasy kit (Qiagen).","Cy5","1.5 microrgram of sample and reference aRNA, amplified using the MessageAmp aRNA Kit (Ambion), were labeled using the CyScribe Post-Labeling Kit (Amersham Biosciences) followed by purification using the Cyscribe GFX Purification Kit (Amersham)","9606","Samples were dissolved in 42 mul of Universal Hybridization Solution (Corning, Acton, MA, USA) and hybridizations were carried out in a CMT-Hybridization Chamber (Corning) for 18 h at 42°C. Pre-hybridization of slides and post-hybridization washes were performed as described in the Universal Hybridization Kit (Corning)","Fluorescence was recorded using an Agilent G2565AA microarray scanner (Agilent Technologies). Image analysis on scanned arrays was performed with GenePix 4.0 (Axon Instruments)","UC_0033_1_RAP_27k_h1","","Data was processed in the BioArray Software Environment (BASE). For each channel, the Mean FG - Median BG intensity value was used. Features flagged bad, missing or saturated during image analysis were removed. Poorly measured features with ch1 or ch2 intensities <15 were removed. Data was normalized using pin-based LOWESS algorithm.","GPL3883","David,,Lindgren","david.lindgren@med.lu.se","Molecular Pathology","Dep of Laboratory Medicine. Malmö","Lund University","Entrance 78, 3rd floor, UMAS","Malmö","SE-20502","Sweden","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM497nnn/GSM497704/GSM497704.gpr.gz","19889"
"GSM497705","UC_0035_1_RAP_27k_h1","GSM497705","Public on Jun 14 2010","Jan 15 2010","Jan 19 2010","RNA","2","Urinary bladder tumor UC_0035_1","Homo sapiens","sample histology: Urothelial carcinoma","tumor stage: Tx","tumor grade: Gx","","","","","","total RNA","Tissue homogenization and RNA recovery using TRIzol reagent (Invitrogen), followed by purification of total RNA using RNeasy kit (Qiagen).","Cy3","1.5 microrgram of sample and reference aRNA, amplified using the MessageAmp aRNA Kit (Ambion), were labeled using the CyScribe Post-Labeling Kit (Amersham Biosciences) followed by purification using the Cyscribe GFX Purification Kit (Amersham)","9606","Stratagene Universal Human Reference","Homo sapiens","reference: RNA pooled from ten human cell lines","total RNA","Tissue homogenization and RNA recovery using TRIzol reagent (Invitrogen), followed by purification of total RNA using RNeasy kit (Qiagen).","Cy5","1.5 microrgram of sample and reference aRNA, amplified using the MessageAmp aRNA Kit (Ambion), were labeled using the CyScribe Post-Labeling Kit (Amersham Biosciences) followed by purification using the Cyscribe GFX Purification Kit (Amersham)","9606","Samples were dissolved in 42 mul of Universal Hybridization Solution (Corning, Acton, MA, USA) and hybridizations were carried out in a CMT-Hybridization Chamber (Corning) for 18 h at 42°C. Pre-hybridization of slides and post-hybridization washes were performed as described in the Universal Hybridization Kit (Corning)","Fluorescence was recorded using an Agilent G2565AA microarray scanner (Agilent Technologies). Image analysis on scanned arrays was performed with GenePix 4.0 (Axon Instruments)","UC_0035_1_RAP_27k_h1","This is one of two samples that were hybridized to both 27k and 35k platforms. They were only used for merging of the two expression datasets.","Data was processed in the BioArray Software Environment (BASE). For each channel, the Mean FG - Median BG intensity value was used. Features flagged bad, missing or saturated during image analysis were removed. Poorly measured features with ch1 or ch2 intensities <15 were removed. Data was normalized using pin-based LOWESS algorithm.","GPL3883","David,,Lindgren","david.lindgren@med.lu.se","Molecular Pathology","Dep of Laboratory Medicine. Malmö","Lund University","Entrance 78, 3rd floor, UMAS","Malmö","SE-20502","Sweden","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM497nnn/GSM497705/GSM497705.gpr.gz","19889"
"GSM497706","UC_0037_1_RAP_27k_h1","GSM497706","Public on Jun 14 2010","Jan 15 2010","Jan 19 2010","RNA","2","Urinary bladder tumor UC_0037_1","Homo sapiens","sample histology: Urothelial carcinoma","tumor stage: T1","tumor grade: G2","dead of disease: NO","follow up time (months): 66.9","tat1 progress^to minv/cystectomy/dead: NO","","","total RNA","Tissue homogenization and RNA recovery using TRIzol reagent (Invitrogen), followed by purification of total RNA using RNeasy kit (Qiagen).","Cy3","1.5 microrgram of sample and reference aRNA, amplified using the MessageAmp aRNA Kit (Ambion), were labeled using the CyScribe Post-Labeling Kit (Amersham Biosciences) followed by purification using the Cyscribe GFX Purification Kit (Amersham)","9606","Stratagene Universal Human Reference","Homo sapiens","reference: RNA pooled from ten human cell lines","total RNA","Tissue homogenization and RNA recovery using TRIzol reagent (Invitrogen), followed by purification of total RNA using RNeasy kit (Qiagen).","Cy5","1.5 microrgram of sample and reference aRNA, amplified using the MessageAmp aRNA Kit (Ambion), were labeled using the CyScribe Post-Labeling Kit (Amersham Biosciences) followed by purification using the Cyscribe GFX Purification Kit (Amersham)","9606","Samples were dissolved in 42 mul of Universal Hybridization Solution (Corning, Acton, MA, USA) and hybridizations were carried out in a CMT-Hybridization Chamber (Corning) for 18 h at 42°C. Pre-hybridization of slides and post-hybridization washes were performed as described in the Universal Hybridization Kit (Corning)","Fluorescence was recorded using an Agilent G2565AA microarray scanner (Agilent Technologies). Image analysis on scanned arrays was performed with GenePix 4.0 (Axon Instruments)","UC_0037_1_RAP_27k_h1","","Data was processed in the BioArray Software Environment (BASE). For each channel, the Mean FG - Median BG intensity value was used. Features flagged bad, missing or saturated during image analysis were removed. Poorly measured features with ch1 or ch2 intensities <15 were removed. Data was normalized using pin-based LOWESS algorithm.","GPL3883","David,,Lindgren","david.lindgren@med.lu.se","Molecular Pathology","Dep of Laboratory Medicine. Malmö","Lund University","Entrance 78, 3rd floor, UMAS","Malmö","SE-20502","Sweden","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM497nnn/GSM497706/GSM497706.gpr.gz","19889"
"GSM497707","UC_0040_1_RAP_27k_h1","GSM497707","Public on Jun 14 2010","Jan 15 2010","Jan 19 2010","RNA","2","Urinary bladder tumor UC_0040_1","Homo sapiens","sample histology: Urothelial carcinoma","tumor stage: T1","tumor grade: G3","dead of disease: NO","follow up time (months): 1.2","tat1 progress^to minv/cystectomy/dead: NO","","","total RNA","Tissue homogenization and RNA recovery using TRIzol reagent (Invitrogen), followed by purification of total RNA using RNeasy kit (Qiagen).","Cy3","1.5 microrgram of sample and reference aRNA, amplified using the MessageAmp aRNA Kit (Ambion), were labeled using the CyScribe Post-Labeling Kit (Amersham Biosciences) followed by purification using the Cyscribe GFX Purification Kit (Amersham)","9606","Stratagene Universal Human Reference","Homo sapiens","reference: RNA pooled from ten human cell lines","total RNA","Tissue homogenization and RNA recovery using TRIzol reagent (Invitrogen), followed by purification of total RNA using RNeasy kit (Qiagen).","Cy5","1.5 microrgram of sample and reference aRNA, amplified using the MessageAmp aRNA Kit (Ambion), were labeled using the CyScribe Post-Labeling Kit (Amersham Biosciences) followed by purification using the Cyscribe GFX Purification Kit (Amersham)","9606","Samples were dissolved in 42 mul of Universal Hybridization Solution (Corning, Acton, MA, USA) and hybridizations were carried out in a CMT-Hybridization Chamber (Corning) for 18 h at 42°C. Pre-hybridization of slides and post-hybridization washes were performed as described in the Universal Hybridization Kit (Corning)","Fluorescence was recorded using an Agilent G2565AA microarray scanner (Agilent Technologies). Image analysis on scanned arrays was performed with GenePix 4.0 (Axon Instruments)","UC_0040_1_RAP_27k_h1","","Data was processed in the BioArray Software Environment (BASE). For each channel, the Mean FG - Median BG intensity value was used. Features flagged bad, missing or saturated during image analysis were removed. Poorly measured features with ch1 or ch2 intensities <15 were removed. Data was normalized using pin-based LOWESS algorithm.","GPL3883","David,,Lindgren","david.lindgren@med.lu.se","Molecular Pathology","Dep of Laboratory Medicine. Malmö","Lund University","Entrance 78, 3rd floor, UMAS","Malmö","SE-20502","Sweden","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM497nnn/GSM497707/GSM497707.gpr.gz","19889"
"GSM497708","UC_0042_1_RAP_27k_h1","GSM497708","Public on Jun 14 2010","Jan 15 2010","Jan 19 2010","RNA","2","Urinary bladder tumor UC_0042_1","Homo sapiens","sample histology: Urothelial carcinoma","tumor stage: Ta","tumor grade: G2","dead of disease: NO","follow up time (months): 68.8","tat1 progress^to minv/cystectomy/dead: NO","","","total RNA","Tissue homogenization and RNA recovery using TRIzol reagent (Invitrogen), followed by purification of total RNA using RNeasy kit (Qiagen).","Cy3","1.5 microrgram of sample and reference aRNA, amplified using the MessageAmp aRNA Kit (Ambion), were labeled using the CyScribe Post-Labeling Kit (Amersham Biosciences) followed by purification using the Cyscribe GFX Purification Kit (Amersham)","9606","Stratagene Universal Human Reference","Homo sapiens","reference: RNA pooled from ten human cell lines","total RNA","Tissue homogenization and RNA recovery using TRIzol reagent (Invitrogen), followed by purification of total RNA using RNeasy kit (Qiagen).","Cy5","1.5 microrgram of sample and reference aRNA, amplified using the MessageAmp aRNA Kit (Ambion), were labeled using the CyScribe Post-Labeling Kit (Amersham Biosciences) followed by purification using the Cyscribe GFX Purification Kit (Amersham)","9606","Samples were dissolved in 42 mul of Universal Hybridization Solution (Corning, Acton, MA, USA) and hybridizations were carried out in a CMT-Hybridization Chamber (Corning) for 18 h at 42°C. Pre-hybridization of slides and post-hybridization washes were performed as described in the Universal Hybridization Kit (Corning)","Fluorescence was recorded using an Agilent G2565AA microarray scanner (Agilent Technologies). Image analysis on scanned arrays was performed with GenePix 4.0 (Axon Instruments)","UC_0042_1_RAP_27k_h1","","Data was processed in the BioArray Software Environment (BASE). For each channel, the Mean FG - Median BG intensity value was used. Features flagged bad, missing or saturated during image analysis were removed. Poorly measured features with ch1 or ch2 intensities <15 were removed. Data was normalized using pin-based LOWESS algorithm.","GPL3883","David,,Lindgren","david.lindgren@med.lu.se","Molecular Pathology","Dep of Laboratory Medicine. Malmö","Lund University","Entrance 78, 3rd floor, UMAS","Malmö","SE-20502","Sweden","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM497nnn/GSM497708/GSM497708.gpr.gz","19889"
"GSM497709","UC_0043_1_RAP_27k_h1","GSM497709","Public on Jun 14 2010","Jan 15 2010","Jan 19 2010","RNA","2","Urinary bladder tumor UC_0043_1","Homo sapiens","sample histology: Urothelial carcinoma","tumor stage: T1","tumor grade: G2","dead of disease: NO","follow up time (months): 37.9","tat1 progress^to minv/cystectomy/dead: NO","","","total RNA","Tissue homogenization and RNA recovery using TRIzol reagent (Invitrogen), followed by purification of total RNA using RNeasy kit (Qiagen).","Cy3","1.5 microrgram of sample and reference aRNA, amplified using the MessageAmp aRNA Kit (Ambion), were labeled using the CyScribe Post-Labeling Kit (Amersham Biosciences) followed by purification using the Cyscribe GFX Purification Kit (Amersham)","9606","Stratagene Universal Human Reference","Homo sapiens","reference: RNA pooled from ten human cell lines","total RNA","Tissue homogenization and RNA recovery using TRIzol reagent (Invitrogen), followed by purification of total RNA using RNeasy kit (Qiagen).","Cy5","1.5 microrgram of sample and reference aRNA, amplified using the MessageAmp aRNA Kit (Ambion), were labeled using the CyScribe Post-Labeling Kit (Amersham Biosciences) followed by purification using the Cyscribe GFX Purification Kit (Amersham)","9606","Samples were dissolved in 42 mul of Universal Hybridization Solution (Corning, Acton, MA, USA) and hybridizations were carried out in a CMT-Hybridization Chamber (Corning) for 18 h at 42°C. Pre-hybridization of slides and post-hybridization washes were performed as described in the Universal Hybridization Kit (Corning)","Fluorescence was recorded using an Agilent G2565AA microarray scanner (Agilent Technologies). Image analysis on scanned arrays was performed with GenePix 4.0 (Axon Instruments)","UC_0043_1_RAP_27k_h1","","Data was processed in the BioArray Software Environment (BASE). For each channel, the Mean FG - Median BG intensity value was used. Features flagged bad, missing or saturated during image analysis were removed. Poorly measured features with ch1 or ch2 intensities <15 were removed. Data was normalized using pin-based LOWESS algorithm.","GPL3883","David,,Lindgren","david.lindgren@med.lu.se","Molecular Pathology","Dep of Laboratory Medicine. Malmö","Lund University","Entrance 78, 3rd floor, UMAS","Malmö","SE-20502","Sweden","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM497nnn/GSM497709/GSM497709.gpr.gz","19889"
"GSM497710","UC_0047_1_RAP_27k_h1","GSM497710","Public on Jun 14 2010","Jan 15 2010","Jan 19 2010","RNA","2","Urinary bladder tumor UC_0047_1","Homo sapiens","sample histology: Urothelial carcinoma","tumor stage: Ta","tumor grade: G1","dead of disease: NO","follow up time (months): 9.6","tat1 progress^to minv/cystectomy/dead: NO","","","total RNA","Tissue homogenization and RNA recovery using TRIzol reagent (Invitrogen), followed by purification of total RNA using RNeasy kit (Qiagen).","Cy3","1.5 microrgram of sample and reference aRNA, amplified using the MessageAmp aRNA Kit (Ambion), were labeled using the CyScribe Post-Labeling Kit (Amersham Biosciences) followed by purification using the Cyscribe GFX Purification Kit (Amersham)","9606","Stratagene Universal Human Reference","Homo sapiens","reference: RNA pooled from ten human cell lines","total RNA","Tissue homogenization and RNA recovery using TRIzol reagent (Invitrogen), followed by purification of total RNA using RNeasy kit (Qiagen).","Cy5","1.5 microrgram of sample and reference aRNA, amplified using the MessageAmp aRNA Kit (Ambion), were labeled using the CyScribe Post-Labeling Kit (Amersham Biosciences) followed by purification using the Cyscribe GFX Purification Kit (Amersham)","9606","Samples were dissolved in 42 mul of Universal Hybridization Solution (Corning, Acton, MA, USA) and hybridizations were carried out in a CMT-Hybridization Chamber (Corning) for 18 h at 42°C. Pre-hybridization of slides and post-hybridization washes were performed as described in the Universal Hybridization Kit (Corning)","Fluorescence was recorded using an Agilent G2565AA microarray scanner (Agilent Technologies). Image analysis on scanned arrays was performed with GenePix 4.0 (Axon Instruments)","UC_0047_1_RAP_27k_h1","","Data was processed in the BioArray Software Environment (BASE). For each channel, the Mean FG - Median BG intensity value was used. Features flagged bad, missing or saturated during image analysis were removed. Poorly measured features with ch1 or ch2 intensities <15 were removed. Data was normalized using pin-based LOWESS algorithm.","GPL3883","David,,Lindgren","david.lindgren@med.lu.se","Molecular Pathology","Dep of Laboratory Medicine. Malmö","Lund University","Entrance 78, 3rd floor, UMAS","Malmö","SE-20502","Sweden","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM497nnn/GSM497710/GSM497710.gpr.gz","19889"
"GSM497711","UC_0049_2_RAP_27k_h1","GSM497711","Public on Jun 14 2010","Jan 15 2010","Jan 19 2010","RNA","2","Urinary bladder tumor UC_0049_2","Homo sapiens","sample histology: Urothelial carcinoma","tumor stage: T1","tumor grade: G3","dead of disease: NO","follow up time (months): 61.1","tat1 progress^to minv/cystectomy/dead: NO","","","total RNA","Tissue homogenization and RNA recovery using TRIzol reagent (Invitrogen), followed by purification of total RNA using RNeasy kit (Qiagen).","Cy3","1.5 microrgram of sample and reference aRNA, amplified using the MessageAmp aRNA Kit (Ambion), were labeled using the CyScribe Post-Labeling Kit (Amersham Biosciences) followed by purification using the Cyscribe GFX Purification Kit (Amersham)","9606","Stratagene Universal Human Reference","Homo sapiens","reference: RNA pooled from ten human cell lines","total RNA","Tissue homogenization and RNA recovery using TRIzol reagent (Invitrogen), followed by purification of total RNA using RNeasy kit (Qiagen).","Cy5","1.5 microrgram of sample and reference aRNA, amplified using the MessageAmp aRNA Kit (Ambion), were labeled using the CyScribe Post-Labeling Kit (Amersham Biosciences) followed by purification using the Cyscribe GFX Purification Kit (Amersham)","9606","Samples were dissolved in 42 mul of Universal Hybridization Solution (Corning, Acton, MA, USA) and hybridizations were carried out in a CMT-Hybridization Chamber (Corning) for 18 h at 42°C. Pre-hybridization of slides and post-hybridization washes were performed as described in the Universal Hybridization Kit (Corning)","Fluorescence was recorded using an Agilent G2565AA microarray scanner (Agilent Technologies). Image analysis on scanned arrays was performed with GenePix 4.0 (Axon Instruments)","UC_0049_2_RAP_27k_h1","","Data was processed in the BioArray Software Environment (BASE). For each channel, the Mean FG - Median BG intensity value was used. Features flagged bad, missing or saturated during image analysis were removed. Poorly measured features with ch1 or ch2 intensities <15 were removed. Data was normalized using pin-based LOWESS algorithm.","GPL3883","David,,Lindgren","david.lindgren@med.lu.se","Molecular Pathology","Dep of Laboratory Medicine. Malmö","Lund University","Entrance 78, 3rd floor, UMAS","Malmö","SE-20502","Sweden","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM497nnn/GSM497711/GSM497711.gpr.gz","19889"
"GSM497712","UC_0051_1_RAP_27k_h1","GSM497712","Public on Jun 14 2010","Jan 15 2010","Jan 19 2010","RNA","2","Urinary bladder tumor UC_0051_1","Homo sapiens","sample histology: Urothelial carcinoma","tumor stage: Ta","tumor grade: G2","dead of disease: NO","follow up time (months): 0.0","tat1 progress^to minv/cystectomy/dead: NO","","","total RNA","Tissue homogenization and RNA recovery using TRIzol reagent (Invitrogen), followed by purification of total RNA using RNeasy kit (Qiagen).","Cy3","1.5 microrgram of sample and reference aRNA, amplified using the MessageAmp aRNA Kit (Ambion), were labeled using the CyScribe Post-Labeling Kit (Amersham Biosciences) followed by purification using the Cyscribe GFX Purification Kit (Amersham)","9606","Stratagene Universal Human Reference","Homo sapiens","reference: RNA pooled from ten human cell lines","total RNA","Tissue homogenization and RNA recovery using TRIzol reagent (Invitrogen), followed by purification of total RNA using RNeasy kit (Qiagen).","Cy5","1.5 microrgram of sample and reference aRNA, amplified using the MessageAmp aRNA Kit (Ambion), were labeled using the CyScribe Post-Labeling Kit (Amersham Biosciences) followed by purification using the Cyscribe GFX Purification Kit (Amersham)","9606","Samples were dissolved in 42 mul of Universal Hybridization Solution (Corning, Acton, MA, USA) and hybridizations were carried out in a CMT-Hybridization Chamber (Corning) for 18 h at 42°C. Pre-hybridization of slides and post-hybridization washes were performed as described in the Universal Hybridization Kit (Corning)","Fluorescence was recorded using an Agilent G2565AA microarray scanner (Agilent Technologies). Image analysis on scanned arrays was performed with GenePix 4.0 (Axon Instruments)","UC_0051_1_RAP_27k_h1","","Data was processed in the BioArray Software Environment (BASE). For each channel, the Mean FG - Median BG intensity value was used. Features flagged bad, missing or saturated during image analysis were removed. Poorly measured features with ch1 or ch2 intensities <15 were removed. Data was normalized using pin-based LOWESS algorithm.","GPL3883","David,,Lindgren","david.lindgren@med.lu.se","Molecular Pathology","Dep of Laboratory Medicine. Malmö","Lund University","Entrance 78, 3rd floor, UMAS","Malmö","SE-20502","Sweden","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM497nnn/GSM497712/GSM497712.gpr.gz","19889"
"GSM497713","UC_0052_1_RAP_27k_h1","GSM497713","Public on Jun 14 2010","Jan 15 2010","Jan 19 2010","RNA","2","Urinary bladder tumor UC_0052_1","Homo sapiens","sample histology: Urothelial carcinoma","tumor stage: Ta","tumor grade: G1","dead of disease: NO","follow up time (months): 41.4","tat1 progress^to minv/cystectomy/dead: NO","","","total RNA","Tissue homogenization and RNA recovery using TRIzol reagent (Invitrogen), followed by purification of total RNA using RNeasy kit (Qiagen).","Cy3","1.5 microrgram of sample and reference aRNA, amplified using the MessageAmp aRNA Kit (Ambion), were labeled using the CyScribe Post-Labeling Kit (Amersham Biosciences) followed by purification using the Cyscribe GFX Purification Kit (Amersham)","9606","Stratagene Universal Human Reference","Homo sapiens","reference: RNA pooled from ten human cell lines","total RNA","Tissue homogenization and RNA recovery using TRIzol reagent (Invitrogen), followed by purification of total RNA using RNeasy kit (Qiagen).","Cy5","1.5 microrgram of sample and reference aRNA, amplified using the MessageAmp aRNA Kit (Ambion), were labeled using the CyScribe Post-Labeling Kit (Amersham Biosciences) followed by purification using the Cyscribe GFX Purification Kit (Amersham)","9606","Samples were dissolved in 42 mul of Universal Hybridization Solution (Corning, Acton, MA, USA) and hybridizations were carried out in a CMT-Hybridization Chamber (Corning) for 18 h at 42°C. Pre-hybridization of slides and post-hybridization washes were performed as described in the Universal Hybridization Kit (Corning)","Fluorescence was recorded using an Agilent G2565AA microarray scanner (Agilent Technologies). Image analysis on scanned arrays was performed with GenePix 4.0 (Axon Instruments)","UC_0052_1_RAP_27k_h1","","Data was processed in the BioArray Software Environment (BASE). For each channel, the Mean FG - Median BG intensity value was used. Features flagged bad, missing or saturated during image analysis were removed. Poorly measured features with ch1 or ch2 intensities <15 were removed. Data was normalized using pin-based LOWESS algorithm.","GPL3883","David,,Lindgren","david.lindgren@med.lu.se","Molecular Pathology","Dep of Laboratory Medicine. Malmö","Lund University","Entrance 78, 3rd floor, UMAS","Malmö","SE-20502","Sweden","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM497nnn/GSM497713/GSM497713.gpr.gz","19889"
"GSM497714","UC_0053_1_RAP_27k_h1","GSM497714","Public on Jun 14 2010","Jan 15 2010","Jan 19 2010","RNA","2","Urinary bladder tumor UC_0053_1","Homo sapiens","sample histology: Urothelial carcinoma","tumor stage: T1","tumor grade: G3","dead of disease: NO","follow up time (months): 66.1","tat1 progress^to minv/cystectomy/dead: YES^cystectomy+met","cystectomy: YES","distant metastasis: M+","total RNA","Tissue homogenization and RNA recovery using TRIzol reagent (Invitrogen), followed by purification of total RNA using RNeasy kit (Qiagen).","Cy3","1.5 microrgram of sample and reference aRNA, amplified using the MessageAmp aRNA Kit (Ambion), were labeled using the CyScribe Post-Labeling Kit (Amersham Biosciences) followed by purification using the Cyscribe GFX Purification Kit (Amersham)","9606","Stratagene Universal Human Reference","Homo sapiens","reference: RNA pooled from ten human cell lines","total RNA","Tissue homogenization and RNA recovery using TRIzol reagent (Invitrogen), followed by purification of total RNA using RNeasy kit (Qiagen).","Cy5","1.5 microrgram of sample and reference aRNA, amplified using the MessageAmp aRNA Kit (Ambion), were labeled using the CyScribe Post-Labeling Kit (Amersham Biosciences) followed by purification using the Cyscribe GFX Purification Kit (Amersham)","9606","Samples were dissolved in 42 mul of Universal Hybridization Solution (Corning, Acton, MA, USA) and hybridizations were carried out in a CMT-Hybridization Chamber (Corning) for 18 h at 42°C. Pre-hybridization of slides and post-hybridization washes were performed as described in the Universal Hybridization Kit (Corning)","Fluorescence was recorded using an Agilent G2565AA microarray scanner (Agilent Technologies). Image analysis on scanned arrays was performed with GenePix 4.0 (Axon Instruments)","UC_0053_1_RAP_27k_h1","","Data was processed in the BioArray Software Environment (BASE). For each channel, the Mean FG - Median BG intensity value was used. Features flagged bad, missing or saturated during image analysis were removed. Poorly measured features with ch1 or ch2 intensities <15 were removed. Data was normalized using pin-based LOWESS algorithm.","GPL3883","David,,Lindgren","david.lindgren@med.lu.se","Molecular Pathology","Dep of Laboratory Medicine. Malmö","Lund University","Entrance 78, 3rd floor, UMAS","Malmö","SE-20502","Sweden","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM497nnn/GSM497714/GSM497714.gpr.gz","19889"
"GSM497715","UC_0056_1_RAP_27k_h1","GSM497715","Public on Jun 14 2010","Jan 15 2010","Jan 19 2010","RNA","2","Urinary bladder tumor UC_0056_1","Homo sapiens","sample histology: Urothelial carcinoma","tumor stage: Ta","tumor grade: G1","dead of disease: NO","follow up time (months): 51.0","tat1 progress^to minv/cystectomy/dead: NO","","","total RNA","Tissue homogenization and RNA recovery using TRIzol reagent (Invitrogen), followed by purification of total RNA using RNeasy kit (Qiagen).","Cy3","1.5 microrgram of sample and reference aRNA, amplified using the MessageAmp aRNA Kit (Ambion), were labeled using the CyScribe Post-Labeling Kit (Amersham Biosciences) followed by purification using the Cyscribe GFX Purification Kit (Amersham)","9606","Stratagene Universal Human Reference","Homo sapiens","reference: RNA pooled from ten human cell lines","total RNA","Tissue homogenization and RNA recovery using TRIzol reagent (Invitrogen), followed by purification of total RNA using RNeasy kit (Qiagen).","Cy5","1.5 microrgram of sample and reference aRNA, amplified using the MessageAmp aRNA Kit (Ambion), were labeled using the CyScribe Post-Labeling Kit (Amersham Biosciences) followed by purification using the Cyscribe GFX Purification Kit (Amersham)","9606","Samples were dissolved in 42 mul of Universal Hybridization Solution (Corning, Acton, MA, USA) and hybridizations were carried out in a CMT-Hybridization Chamber (Corning) for 18 h at 42°C. Pre-hybridization of slides and post-hybridization washes were performed as described in the Universal Hybridization Kit (Corning)","Fluorescence was recorded using an Agilent G2565AA microarray scanner (Agilent Technologies). Image analysis on scanned arrays was performed with GenePix 4.0 (Axon Instruments)","UC_0056_1_RAP_27k_h1","","Data was processed in the BioArray Software Environment (BASE). For each channel, the Mean FG - Median BG intensity value was used. Features flagged bad, missing or saturated during image analysis were removed. Poorly measured features with ch1 or ch2 intensities <15 were removed. Data was normalized using pin-based LOWESS algorithm.","GPL3883","David,,Lindgren","david.lindgren@med.lu.se","Molecular Pathology","Dep of Laboratory Medicine. Malmö","Lund University","Entrance 78, 3rd floor, UMAS","Malmö","SE-20502","Sweden","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM497nnn/GSM497715/GSM497715.gpr.gz","19889"
"GSM497716","UC_0057_1_RAP_27k_h1","GSM497716","Public on Jun 14 2010","Jan 15 2010","Jan 19 2010","RNA","2","Urinary bladder tumor UC_0057_1","Homo sapiens","sample histology: Urothelial carcinoma","tumor stage: Ta","tumor grade: G3","dead of disease: NO","follow up time (months): 62.6","tat1 progress^to minv/cystectomy/dead: NO","","","total RNA","Tissue homogenization and RNA recovery using TRIzol reagent (Invitrogen), followed by purification of total RNA using RNeasy kit (Qiagen).","Cy3","1.5 microrgram of sample and reference aRNA, amplified using the MessageAmp aRNA Kit (Ambion), were labeled using the CyScribe Post-Labeling Kit (Amersham Biosciences) followed by purification using the Cyscribe GFX Purification Kit (Amersham)","9606","Stratagene Universal Human Reference","Homo sapiens","reference: RNA pooled from ten human cell lines","total RNA","Tissue homogenization and RNA recovery using TRIzol reagent (Invitrogen), followed by purification of total RNA using RNeasy kit (Qiagen).","Cy5","1.5 microrgram of sample and reference aRNA, amplified using the MessageAmp aRNA Kit (Ambion), were labeled using the CyScribe Post-Labeling Kit (Amersham Biosciences) followed by purification using the Cyscribe GFX Purification Kit (Amersham)","9606","Samples were dissolved in 42 mul of Universal Hybridization Solution (Corning, Acton, MA, USA) and hybridizations were carried out in a CMT-Hybridization Chamber (Corning) for 18 h at 42°C. Pre-hybridization of slides and post-hybridization washes were performed as described in the Universal Hybridization Kit (Corning)","Fluorescence was recorded using an Agilent G2565AA microarray scanner (Agilent Technologies). Image analysis on scanned arrays was performed with GenePix 4.0 (Axon Instruments)","UC_0057_1_RAP_27k_h1","","Data was processed in the BioArray Software Environment (BASE). For each channel, the Mean FG - Median BG intensity value was used. Features flagged bad, missing or saturated during image analysis were removed. Poorly measured features with ch1 or ch2 intensities <15 were removed. Data was normalized using pin-based LOWESS algorithm.","GPL3883","David,,Lindgren","david.lindgren@med.lu.se","Molecular Pathology","Dep of Laboratory Medicine. Malmö","Lund University","Entrance 78, 3rd floor, UMAS","Malmö","SE-20502","Sweden","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM497nnn/GSM497716/GSM497716.gpr.gz","19889"
"GSM497717","UC_0060_1_RAP_27k_h1","GSM497717","Public on Jun 14 2010","Jan 15 2010","Jan 19 2010","RNA","2","Urinary bladder tumor UC_0060_1","Homo sapiens","sample histology: Urothelial carcinoma","tumor stage: Ta","tumor grade: G2","dead of disease: YES","follow up time (months): 32.3","tat1 progress^to minv/cystectomy/dead: YES","cystectomy: YES","distant metastasis: M+","total RNA","Tissue homogenization and RNA recovery using TRIzol reagent (Invitrogen), followed by purification of total RNA using RNeasy kit (Qiagen).","Cy3","1.5 microrgram of sample and reference aRNA, amplified using the MessageAmp aRNA Kit (Ambion), were labeled using the CyScribe Post-Labeling Kit (Amersham Biosciences) followed by purification using the Cyscribe GFX Purification Kit (Amersham)","9606","Stratagene Universal Human Reference","Homo sapiens","reference: RNA pooled from ten human cell lines","total RNA","Tissue homogenization and RNA recovery using TRIzol reagent (Invitrogen), followed by purification of total RNA using RNeasy kit (Qiagen).","Cy5","1.5 microrgram of sample and reference aRNA, amplified using the MessageAmp aRNA Kit (Ambion), were labeled using the CyScribe Post-Labeling Kit (Amersham Biosciences) followed by purification using the Cyscribe GFX Purification Kit (Amersham)","9606","Samples were dissolved in 42 mul of Universal Hybridization Solution (Corning, Acton, MA, USA) and hybridizations were carried out in a CMT-Hybridization Chamber (Corning) for 18 h at 42°C. Pre-hybridization of slides and post-hybridization washes were performed as described in the Universal Hybridization Kit (Corning)","Fluorescence was recorded using an Agilent G2565AA microarray scanner (Agilent Technologies). Image analysis on scanned arrays was performed with GenePix 4.0 (Axon Instruments)","UC_0060_1_RAP_27k_h1","","Data was processed in the BioArray Software Environment (BASE). For each channel, the Mean FG - Median BG intensity value was used. Features flagged bad, missing or saturated during image analysis were removed. Poorly measured features with ch1 or ch2 intensities <15 were removed. Data was normalized using pin-based LOWESS algorithm.","GPL3883","David,,Lindgren","david.lindgren@med.lu.se","Molecular Pathology","Dep of Laboratory Medicine. Malmö","Lund University","Entrance 78, 3rd floor, UMAS","Malmö","SE-20502","Sweden","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM497nnn/GSM497717/GSM497717.gpr.gz","19889"
"GSM497718","UC_0061_1_RAP_27k_h1","GSM497718","Public on Jun 14 2010","Jan 15 2010","Jan 19 2010","RNA","2","Urinary bladder tumor UC_0061_1","Homo sapiens","sample histology: Urothelial carcinoma","tumor stage: Ta","tumor grade: G2","dead of disease: NO","follow up time (months): 43.5","tat1 progress^to minv/cystectomy/dead: NO","","","total RNA","Tissue homogenization and RNA recovery using TRIzol reagent (Invitrogen), followed by purification of total RNA using RNeasy kit (Qiagen).","Cy3","1.5 microrgram of sample and reference aRNA, amplified using the MessageAmp aRNA Kit (Ambion), were labeled using the CyScribe Post-Labeling Kit (Amersham Biosciences) followed by purification using the Cyscribe GFX Purification Kit (Amersham)","9606","Stratagene Universal Human Reference","Homo sapiens","reference: RNA pooled from ten human cell lines","total RNA","Tissue homogenization and RNA recovery using TRIzol reagent (Invitrogen), followed by purification of total RNA using RNeasy kit (Qiagen).","Cy5","1.5 microrgram of sample and reference aRNA, amplified using the MessageAmp aRNA Kit (Ambion), were labeled using the CyScribe Post-Labeling Kit (Amersham Biosciences) followed by purification using the Cyscribe GFX Purification Kit (Amersham)","9606","Samples were dissolved in 42 mul of Universal Hybridization Solution (Corning, Acton, MA, USA) and hybridizations were carried out in a CMT-Hybridization Chamber (Corning) for 18 h at 42°C. Pre-hybridization of slides and post-hybridization washes were performed as described in the Universal Hybridization Kit (Corning)","Fluorescence was recorded using an Agilent G2565AA microarray scanner (Agilent Technologies). Image analysis on scanned arrays was performed with GenePix 4.0 (Axon Instruments)","UC_0061_1_RAP_27k_h1","","Data was processed in the BioArray Software Environment (BASE). For each channel, the Mean FG - Median BG intensity value was used. Features flagged bad, missing or saturated during image analysis were removed. Poorly measured features with ch1 or ch2 intensities <15 were removed. Data was normalized using pin-based LOWESS algorithm.","GPL3883","David,,Lindgren","david.lindgren@med.lu.se","Molecular Pathology","Dep of Laboratory Medicine. Malmö","Lund University","Entrance 78, 3rd floor, UMAS","Malmö","SE-20502","Sweden","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM497nnn/GSM497718/GSM497718.gpr.gz","19889"
"GSM497719","UC_0064_1_RAP_27k_h1","GSM497719","Public on Jun 14 2010","Jan 15 2010","Jan 19 2010","RNA","2","Urinary bladder tumor UC_0064_1","Homo sapiens","sample histology: Urothelial carcinoma","tumor stage: Ta","tumor grade: G2","dead of disease: NO","follow up time (months): 61.1","tat1 progress^to minv/cystectomy/dead: NO","","","total RNA","Tissue homogenization and RNA recovery using TRIzol reagent (Invitrogen), followed by purification of total RNA using RNeasy kit (Qiagen).","Cy3","1.5 microrgram of sample and reference aRNA, amplified using the MessageAmp aRNA Kit (Ambion), were labeled using the CyScribe Post-Labeling Kit (Amersham Biosciences) followed by purification using the Cyscribe GFX Purification Kit (Amersham)","9606","Stratagene Universal Human Reference","Homo sapiens","reference: RNA pooled from ten human cell lines","total RNA","Tissue homogenization and RNA recovery using TRIzol reagent (Invitrogen), followed by purification of total RNA using RNeasy kit (Qiagen).","Cy5","1.5 microrgram of sample and reference aRNA, amplified using the MessageAmp aRNA Kit (Ambion), were labeled using the CyScribe Post-Labeling Kit (Amersham Biosciences) followed by purification using the Cyscribe GFX Purification Kit (Amersham)","9606","Samples were dissolved in 42 mul of Universal Hybridization Solution (Corning, Acton, MA, USA) and hybridizations were carried out in a CMT-Hybridization Chamber (Corning) for 18 h at 42°C. Pre-hybridization of slides and post-hybridization washes were performed as described in the Universal Hybridization Kit (Corning)","Fluorescence was recorded using an Agilent G2565AA microarray scanner (Agilent Technologies). Image analysis on scanned arrays was performed with GenePix 4.0 (Axon Instruments)","UC_0064_1_RAP_27k_h1","","Data was processed in the BioArray Software Environment (BASE). For each channel, the Mean FG - Median BG intensity value was used. Features flagged bad, missing or saturated during image analysis were removed. Poorly measured features with ch1 or ch2 intensities <15 were removed. Data was normalized using pin-based LOWESS algorithm.","GPL3883","David,,Lindgren","david.lindgren@med.lu.se","Molecular Pathology","Dep of Laboratory Medicine. Malmö","Lund University","Entrance 78, 3rd floor, UMAS","Malmö","SE-20502","Sweden","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM497nnn/GSM497719/GSM497719.gpr.gz","19889"
"GSM497720","UC_0066_1_RAP_27k_h1","GSM497720","Public on Jun 14 2010","Jan 15 2010","Jan 19 2010","RNA","2","Urinary bladder tumor UC_0066_1","Homo sapiens","sample histology: Urothelial carcinoma","tumor stage: Ta","tumor grade: G2","dead of disease: NO","follow up time (months): 68.8","tat1 progress^to minv/cystectomy/dead: YES","cystectomy: YES","","total RNA","Tissue homogenization and RNA recovery using TRIzol reagent (Invitrogen), followed by purification of total RNA using RNeasy kit (Qiagen).","Cy3","1.5 microrgram of sample and reference aRNA, amplified using the MessageAmp aRNA Kit (Ambion), were labeled using the CyScribe Post-Labeling Kit (Amersham Biosciences) followed by purification using the Cyscribe GFX Purification Kit (Amersham)","9606","Stratagene Universal Human Reference","Homo sapiens","reference: RNA pooled from ten human cell lines","total RNA","Tissue homogenization and RNA recovery using TRIzol reagent (Invitrogen), followed by purification of total RNA using RNeasy kit (Qiagen).","Cy5","1.5 microrgram of sample and reference aRNA, amplified using the MessageAmp aRNA Kit (Ambion), were labeled using the CyScribe Post-Labeling Kit (Amersham Biosciences) followed by purification using the Cyscribe GFX Purification Kit (Amersham)","9606","Samples were dissolved in 42 mul of Universal Hybridization Solution (Corning, Acton, MA, USA) and hybridizations were carried out in a CMT-Hybridization Chamber (Corning) for 18 h at 42°C. Pre-hybridization of slides and post-hybridization washes were performed as described in the Universal Hybridization Kit (Corning)","Fluorescence was recorded using an Agilent G2565AA microarray scanner (Agilent Technologies). Image analysis on scanned arrays was performed with GenePix 4.0 (Axon Instruments)","UC_0066_1_RAP_27k_h1","","Data was processed in the BioArray Software Environment (BASE). For each channel, the Mean FG - Median BG intensity value was used. Features flagged bad, missing or saturated during image analysis were removed. Poorly measured features with ch1 or ch2 intensities <15 were removed. Data was normalized using pin-based LOWESS algorithm.","GPL3883","David,,Lindgren","david.lindgren@med.lu.se","Molecular Pathology","Dep of Laboratory Medicine. Malmö","Lund University","Entrance 78, 3rd floor, UMAS","Malmö","SE-20502","Sweden","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM497nnn/GSM497720/GSM497720.gpr.gz","19889"
"GSM497721","UC_0070_1_RAP_27k_h1","GSM497721","Public on Jun 14 2010","Jan 15 2010","Jan 19 2010","RNA","2","Urinary bladder tumor UC_0070_1","Homo sapiens","sample histology: Urothelial carcinoma","tumor stage: Ta","tumor grade: G2","dead of disease: NO","follow up time (months): 68.5","tat1 progress^to minv/cystectomy/dead: NO","","","total RNA","Tissue homogenization and RNA recovery using TRIzol reagent (Invitrogen), followed by purification of total RNA using RNeasy kit (Qiagen).","Cy3","1.5 microrgram of sample and reference aRNA, amplified using the MessageAmp aRNA Kit (Ambion), were labeled using the CyScribe Post-Labeling Kit (Amersham Biosciences) followed by purification using the Cyscribe GFX Purification Kit (Amersham)","9606","Stratagene Universal Human Reference","Homo sapiens","reference: RNA pooled from ten human cell lines","total RNA","Tissue homogenization and RNA recovery using TRIzol reagent (Invitrogen), followed by purification of total RNA using RNeasy kit (Qiagen).","Cy5","1.5 microrgram of sample and reference aRNA, amplified using the MessageAmp aRNA Kit (Ambion), were labeled using the CyScribe Post-Labeling Kit (Amersham Biosciences) followed by purification using the Cyscribe GFX Purification Kit (Amersham)","9606","Samples were dissolved in 42 mul of Universal Hybridization Solution (Corning, Acton, MA, USA) and hybridizations were carried out in a CMT-Hybridization Chamber (Corning) for 18 h at 42°C. Pre-hybridization of slides and post-hybridization washes were performed as described in the Universal Hybridization Kit (Corning)","Fluorescence was recorded using an Agilent G2565AA microarray scanner (Agilent Technologies). Image analysis on scanned arrays was performed with GenePix 4.0 (Axon Instruments)","UC_0070_1_RAP_27k_h1","","Data was processed in the BioArray Software Environment (BASE). For each channel, the Mean FG - Median BG intensity value was used. Features flagged bad, missing or saturated during image analysis were removed. Poorly measured features with ch1 or ch2 intensities <15 were removed. Data was normalized using pin-based LOWESS algorithm.","GPL3883","David,,Lindgren","david.lindgren@med.lu.se","Molecular Pathology","Dep of Laboratory Medicine. Malmö","Lund University","Entrance 78, 3rd floor, UMAS","Malmö","SE-20502","Sweden","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM497nnn/GSM497721/GSM497721.gpr.gz","19889"
"GSM497722","UC_0073_1_RAP_27k_h1","GSM497722","Public on Jun 14 2010","Jan 15 2010","Jan 19 2010","RNA","2","Urinary bladder tumor UC_0073_1","Homo sapiens","sample histology: Urothelial carcinoma","tumor stage: Ta","tumor grade: G3","dead of disease: NO","follow up time (months): 28.5","tat1 progress^to minv/cystectomy/dead: NO","","","total RNA","Tissue homogenization and RNA recovery using TRIzol reagent (Invitrogen), followed by purification of total RNA using RNeasy kit (Qiagen).","Cy3","1.5 microrgram of sample and reference aRNA, amplified using the MessageAmp aRNA Kit (Ambion), were labeled using the CyScribe Post-Labeling Kit (Amersham Biosciences) followed by purification using the Cyscribe GFX Purification Kit (Amersham)","9606","Stratagene Universal Human Reference","Homo sapiens","reference: RNA pooled from ten human cell lines","total RNA","Tissue homogenization and RNA recovery using TRIzol reagent (Invitrogen), followed by purification of total RNA using RNeasy kit (Qiagen).","Cy5","1.5 microrgram of sample and reference aRNA, amplified using the MessageAmp aRNA Kit (Ambion), were labeled using the CyScribe Post-Labeling Kit (Amersham Biosciences) followed by purification using the Cyscribe GFX Purification Kit (Amersham)","9606","Samples were dissolved in 42 mul of Universal Hybridization Solution (Corning, Acton, MA, USA) and hybridizations were carried out in a CMT-Hybridization Chamber (Corning) for 18 h at 42°C. Pre-hybridization of slides and post-hybridization washes were performed as described in the Universal Hybridization Kit (Corning)","Fluorescence was recorded using an Agilent G2565AA microarray scanner (Agilent Technologies). Image analysis on scanned arrays was performed with GenePix 4.0 (Axon Instruments)","UC_0073_1_RAP_27k_h1","","Data was processed in the BioArray Software Environment (BASE). For each channel, the Mean FG - Median BG intensity value was used. Features flagged bad, missing or saturated during image analysis were removed. Poorly measured features with ch1 or ch2 intensities <15 were removed. Data was normalized using pin-based LOWESS algorithm.","GPL3883","David,,Lindgren","david.lindgren@med.lu.se","Molecular Pathology","Dep of Laboratory Medicine. Malmö","Lund University","Entrance 78, 3rd floor, UMAS","Malmö","SE-20502","Sweden","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM497nnn/GSM497722/GSM497722.gpr.gz","19889"
"GSM497723","UC_0075_1_RAP_27k_h1","GSM497723","Public on Jun 14 2010","Jan 15 2010","Jan 19 2010","RNA","2","Urinary bladder tumor UC_0075_1","Homo sapiens","sample histology: Urothelial carcinoma","tumor stage: Ta","tumor grade: G1","dead of disease: NO","follow up time (months): 39.7","tat1 progress^to minv/cystectomy/dead: YES","cystectomy: YES","","total RNA","Tissue homogenization and RNA recovery using TRIzol reagent (Invitrogen), followed by purification of total RNA using RNeasy kit (Qiagen).","Cy3","1.5 microrgram of sample and reference aRNA, amplified using the MessageAmp aRNA Kit (Ambion), were labeled using the CyScribe Post-Labeling Kit (Amersham Biosciences) followed by purification using the Cyscribe GFX Purification Kit (Amersham)","9606","Stratagene Universal Human Reference","Homo sapiens","reference: RNA pooled from ten human cell lines","total RNA","Tissue homogenization and RNA recovery using TRIzol reagent (Invitrogen), followed by purification of total RNA using RNeasy kit (Qiagen).","Cy5","1.5 microrgram of sample and reference aRNA, amplified using the MessageAmp aRNA Kit (Ambion), were labeled using the CyScribe Post-Labeling Kit (Amersham Biosciences) followed by purification using the Cyscribe GFX Purification Kit (Amersham)","9606","Samples were dissolved in 42 mul of Universal Hybridization Solution (Corning, Acton, MA, USA) and hybridizations were carried out in a CMT-Hybridization Chamber (Corning) for 18 h at 42°C. Pre-hybridization of slides and post-hybridization washes were performed as described in the Universal Hybridization Kit (Corning)","Fluorescence was recorded using an Agilent G2565AA microarray scanner (Agilent Technologies). Image analysis on scanned arrays was performed with GenePix 4.0 (Axon Instruments)","UC_0075_1_RAP_27k_h1","","Data was processed in the BioArray Software Environment (BASE). For each channel, the Mean FG - Median BG intensity value was used. Features flagged bad, missing or saturated during image analysis were removed. Poorly measured features with ch1 or ch2 intensities <15 were removed. Data was normalized using pin-based LOWESS algorithm.","GPL3883","David,,Lindgren","david.lindgren@med.lu.se","Molecular Pathology","Dep of Laboratory Medicine. Malmö","Lund University","Entrance 78, 3rd floor, UMAS","Malmö","SE-20502","Sweden","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM497nnn/GSM497723/GSM497723.gpr.gz","19889"
"GSM497724","UC_0076_1_RAP_27k_h1","GSM497724","Public on Jun 14 2010","Jan 15 2010","Jan 19 2010","RNA","2","Urinary bladder tumor UC_0076_1","Homo sapiens","sample histology: Urothelial carcinoma","tumor stage: Ta","tumor grade: G2","dead of disease: NO","follow up time (months): 67.4","tat1 progress^to minv/cystectomy/dead: NO","","","total RNA","Tissue homogenization and RNA recovery using TRIzol reagent (Invitrogen), followed by purification of total RNA using RNeasy kit (Qiagen).","Cy3","1.5 microrgram of sample and reference aRNA, amplified using the MessageAmp aRNA Kit (Ambion), were labeled using the CyScribe Post-Labeling Kit (Amersham Biosciences) followed by purification using the Cyscribe GFX Purification Kit (Amersham)","9606","Stratagene Universal Human Reference","Homo sapiens","reference: RNA pooled from ten human cell lines","total RNA","Tissue homogenization and RNA recovery using TRIzol reagent (Invitrogen), followed by purification of total RNA using RNeasy kit (Qiagen).","Cy5","1.5 microrgram of sample and reference aRNA, amplified using the MessageAmp aRNA Kit (Ambion), were labeled using the CyScribe Post-Labeling Kit (Amersham Biosciences) followed by purification using the Cyscribe GFX Purification Kit (Amersham)","9606","Samples were dissolved in 42 mul of Universal Hybridization Solution (Corning, Acton, MA, USA) and hybridizations were carried out in a CMT-Hybridization Chamber (Corning) for 18 h at 42°C. Pre-hybridization of slides and post-hybridization washes were performed as described in the Universal Hybridization Kit (Corning)","Fluorescence was recorded using an Agilent G2565AA microarray scanner (Agilent Technologies). Image analysis on scanned arrays was performed with GenePix 4.0 (Axon Instruments)","UC_0076_1_RAP_27k_h1","","Data was processed in the BioArray Software Environment (BASE). For each channel, the Mean FG - Median BG intensity value was used. Features flagged bad, missing or saturated during image analysis were removed. Poorly measured features with ch1 or ch2 intensities <15 were removed. Data was normalized using pin-based LOWESS algorithm.","GPL3883","David,,Lindgren","david.lindgren@med.lu.se","Molecular Pathology","Dep of Laboratory Medicine. Malmö","Lund University","Entrance 78, 3rd floor, UMAS","Malmö","SE-20502","Sweden","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM497nnn/GSM497724/GSM497724.gpr.gz","19889"
"GSM497725","UC_0077_1_RAP_27k_h1","GSM497725","Public on Jun 14 2010","Jan 15 2010","Jan 19 2010","RNA","2","Urinary bladder tumor UC_0077_1","Homo sapiens","sample histology: Urothelial carcinoma","tumor stage: T1","tumor grade: G3","dead of disease: YES","follow up time (months): 32.9","tat1 progress^to minv/cystectomy/dead: YES","","","total RNA","Tissue homogenization and RNA recovery using TRIzol reagent (Invitrogen), followed by purification of total RNA using RNeasy kit (Qiagen).","Cy3","1.5 microrgram of sample and reference aRNA, amplified using the MessageAmp aRNA Kit (Ambion), were labeled using the CyScribe Post-Labeling Kit (Amersham Biosciences) followed by purification using the Cyscribe GFX Purification Kit (Amersham)","9606","Stratagene Universal Human Reference","Homo sapiens","reference: RNA pooled from ten human cell lines","total RNA","Tissue homogenization and RNA recovery using TRIzol reagent (Invitrogen), followed by purification of total RNA using RNeasy kit (Qiagen).","Cy5","1.5 microrgram of sample and reference aRNA, amplified using the MessageAmp aRNA Kit (Ambion), were labeled using the CyScribe Post-Labeling Kit (Amersham Biosciences) followed by purification using the Cyscribe GFX Purification Kit (Amersham)","9606","Samples were dissolved in 42 mul of Universal Hybridization Solution (Corning, Acton, MA, USA) and hybridizations were carried out in a CMT-Hybridization Chamber (Corning) for 18 h at 42°C. Pre-hybridization of slides and post-hybridization washes were performed as described in the Universal Hybridization Kit (Corning)","Fluorescence was recorded using an Agilent G2565AA microarray scanner (Agilent Technologies). Image analysis on scanned arrays was performed with GenePix 4.0 (Axon Instruments)","UC_0077_1_RAP_27k_h1","","Data was processed in the BioArray Software Environment (BASE). For each channel, the Mean FG - Median BG intensity value was used. Features flagged bad, missing or saturated during image analysis were removed. Poorly measured features with ch1 or ch2 intensities <15 were removed. Data was normalized using pin-based LOWESS algorithm.","GPL3883","David,,Lindgren","david.lindgren@med.lu.se","Molecular Pathology","Dep of Laboratory Medicine. Malmö","Lund University","Entrance 78, 3rd floor, UMAS","Malmö","SE-20502","Sweden","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM497nnn/GSM497725/GSM497725.gpr.gz","19889"
"GSM497726","UC_0078_1_RAP_27k_h1","GSM497726","Public on Jun 14 2010","Jan 15 2010","Jan 19 2010","RNA","2","Urinary bladder tumor UC_0078_1","Homo sapiens","sample histology: Urothelial carcinoma","tumor stage: Ta","tumor grade: G1","dead of disease: NO","follow up time (months): 63.4","tat1 progress^to minv/cystectomy/dead: NO","","","total RNA","Tissue homogenization and RNA recovery using TRIzol reagent (Invitrogen), followed by purification of total RNA using RNeasy kit (Qiagen).","Cy3","1.5 microrgram of sample and reference aRNA, amplified using the MessageAmp aRNA Kit (Ambion), were labeled using the CyScribe Post-Labeling Kit (Amersham Biosciences) followed by purification using the Cyscribe GFX Purification Kit (Amersham)","9606","Stratagene Universal Human Reference","Homo sapiens","reference: RNA pooled from ten human cell lines","total RNA","Tissue homogenization and RNA recovery using TRIzol reagent (Invitrogen), followed by purification of total RNA using RNeasy kit (Qiagen).","Cy5","1.5 microrgram of sample and reference aRNA, amplified using the MessageAmp aRNA Kit (Ambion), were labeled using the CyScribe Post-Labeling Kit (Amersham Biosciences) followed by purification using the Cyscribe GFX Purification Kit (Amersham)","9606","Samples were dissolved in 42 mul of Universal Hybridization Solution (Corning, Acton, MA, USA) and hybridizations were carried out in a CMT-Hybridization Chamber (Corning) for 18 h at 42°C. Pre-hybridization of slides and post-hybridization washes were performed as described in the Universal Hybridization Kit (Corning)","Fluorescence was recorded using an Agilent G2565AA microarray scanner (Agilent Technologies). Image analysis on scanned arrays was performed with GenePix 4.0 (Axon Instruments)","UC_0078_1_RAP_27k_h1","","Data was processed in the BioArray Software Environment (BASE). For each channel, the Mean FG - Median BG intensity value was used. Features flagged bad, missing or saturated during image analysis were removed. Poorly measured features with ch1 or ch2 intensities <15 were removed. Data was normalized using pin-based LOWESS algorithm.","GPL3883","David,,Lindgren","david.lindgren@med.lu.se","Molecular Pathology","Dep of Laboratory Medicine. Malmö","Lund University","Entrance 78, 3rd floor, UMAS","Malmö","SE-20502","Sweden","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM497nnn/GSM497726/GSM497726.gpr.gz","19889"
"GSM497727","UC_0089_1_RAP_27k_h1","GSM497727","Public on Jun 14 2010","Jan 15 2010","Jan 19 2010","RNA","2","Urinary bladder tumor UC_0089_1","Homo sapiens","sample histology: Urothelial carcinoma","tumor stage: Ta","tumor grade: G2","dead of disease: NO","follow up time (months): 40.1","tat1 progress^to minv/cystectomy/dead: NO","","","total RNA","Tissue homogenization and RNA recovery using TRIzol reagent (Invitrogen), followed by purification of total RNA using RNeasy kit (Qiagen).","Cy3","1.5 microrgram of sample and reference aRNA, amplified using the MessageAmp aRNA Kit (Ambion), were labeled using the CyScribe Post-Labeling Kit (Amersham Biosciences) followed by purification using the Cyscribe GFX Purification Kit (Amersham)","9606","Stratagene Universal Human Reference","Homo sapiens","reference: RNA pooled from ten human cell lines","total RNA","Tissue homogenization and RNA recovery using TRIzol reagent (Invitrogen), followed by purification of total RNA using RNeasy kit (Qiagen).","Cy5","1.5 microrgram of sample and reference aRNA, amplified using the MessageAmp aRNA Kit (Ambion), were labeled using the CyScribe Post-Labeling Kit (Amersham Biosciences) followed by purification using the Cyscribe GFX Purification Kit (Amersham)","9606","Samples were dissolved in 42 mul of Universal Hybridization Solution (Corning, Acton, MA, USA) and hybridizations were carried out in a CMT-Hybridization Chamber (Corning) for 18 h at 42°C. Pre-hybridization of slides and post-hybridization washes were performed as described in the Universal Hybridization Kit (Corning)","Fluorescence was recorded using an Agilent G2565AA microarray scanner (Agilent Technologies). Image analysis on scanned arrays was performed with GenePix 4.0 (Axon Instruments)","UC_0089_1_RAP_27k_h1","","Data was processed in the BioArray Software Environment (BASE). For each channel, the Mean FG - Median BG intensity value was used. Features flagged bad, missing or saturated during image analysis were removed. Poorly measured features with ch1 or ch2 intensities <15 were removed. Data was normalized using pin-based LOWESS algorithm.","GPL3883","David,,Lindgren","david.lindgren@med.lu.se","Molecular Pathology","Dep of Laboratory Medicine. Malmö","Lund University","Entrance 78, 3rd floor, UMAS","Malmö","SE-20502","Sweden","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM497nnn/GSM497727/GSM497727.gpr.gz","19889"
"GSM497728","UC_0095_1_RAP_27k_h1","GSM497728","Public on Jun 14 2010","Jan 15 2010","Jan 19 2010","RNA","2","Urinary bladder tumor UC_0095_1","Homo sapiens","sample histology: Urothelial carcinoma","tumor stage: T3","tumor grade: G3","dead of disease: YES","follow up time (months): 29.4","cystectomy: YES","distant metastasis: M+","","total RNA","Tissue homogenization and RNA recovery using TRIzol reagent (Invitrogen), followed by purification of total RNA using RNeasy kit (Qiagen).","Cy3","1.5 microrgram of sample and reference aRNA, amplified using the MessageAmp aRNA Kit (Ambion), were labeled using the CyScribe Post-Labeling Kit (Amersham Biosciences) followed by purification using the Cyscribe GFX Purification Kit (Amersham)","9606","Stratagene Universal Human Reference","Homo sapiens","reference: RNA pooled from ten human cell lines","total RNA","Tissue homogenization and RNA recovery using TRIzol reagent (Invitrogen), followed by purification of total RNA using RNeasy kit (Qiagen).","Cy5","1.5 microrgram of sample and reference aRNA, amplified using the MessageAmp aRNA Kit (Ambion), were labeled using the CyScribe Post-Labeling Kit (Amersham Biosciences) followed by purification using the Cyscribe GFX Purification Kit (Amersham)","9606","Samples were dissolved in 42 mul of Universal Hybridization Solution (Corning, Acton, MA, USA) and hybridizations were carried out in a CMT-Hybridization Chamber (Corning) for 18 h at 42°C. Pre-hybridization of slides and post-hybridization washes were performed as described in the Universal Hybridization Kit (Corning)","Fluorescence was recorded using an Agilent G2565AA microarray scanner (Agilent Technologies). Image analysis on scanned arrays was performed with GenePix 4.0 (Axon Instruments)","UC_0095_1_RAP_27k_h1","","Data was processed in the BioArray Software Environment (BASE). For each channel, the Mean FG - Median BG intensity value was used. Features flagged bad, missing or saturated during image analysis were removed. Poorly measured features with ch1 or ch2 intensities <15 were removed. Data was normalized using pin-based LOWESS algorithm.","GPL3883","David,,Lindgren","david.lindgren@med.lu.se","Molecular Pathology","Dep of Laboratory Medicine. Malmö","Lund University","Entrance 78, 3rd floor, UMAS","Malmö","SE-20502","Sweden","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM497nnn/GSM497728/GSM497728.gpr.gz","19889"
"GSM497729","UC_0096_1_RAP_27k_h1","GSM497729","Public on Jun 14 2010","Jan 15 2010","Jan 19 2010","RNA","2","Urinary bladder tumor UC_0096_1","Homo sapiens","sample histology: Urothelial carcinoma","tumor stage: Ta","tumor grade: G2","dead of disease: NO","follow up time (months): 57.6","tat1 progress^to minv/cystectomy/dead: NO","","","total RNA","Tissue homogenization and RNA recovery using TRIzol reagent (Invitrogen), followed by purification of total RNA using RNeasy kit (Qiagen).","Cy3","1.5 microrgram of sample and reference aRNA, amplified using the MessageAmp aRNA Kit (Ambion), were labeled using the CyScribe Post-Labeling Kit (Amersham Biosciences) followed by purification using the Cyscribe GFX Purification Kit (Amersham)","9606","Stratagene Universal Human Reference","Homo sapiens","reference: RNA pooled from ten human cell lines","total RNA","Tissue homogenization and RNA recovery using TRIzol reagent (Invitrogen), followed by purification of total RNA using RNeasy kit (Qiagen).","Cy5","1.5 microrgram of sample and reference aRNA, amplified using the MessageAmp aRNA Kit (Ambion), were labeled using the CyScribe Post-Labeling Kit (Amersham Biosciences) followed by purification using the Cyscribe GFX Purification Kit (Amersham)","9606","Samples were dissolved in 42 mul of Universal Hybridization Solution (Corning, Acton, MA, USA) and hybridizations were carried out in a CMT-Hybridization Chamber (Corning) for 18 h at 42°C. Pre-hybridization of slides and post-hybridization washes were performed as described in the Universal Hybridization Kit (Corning)","Fluorescence was recorded using an Agilent G2565AA microarray scanner (Agilent Technologies). Image analysis on scanned arrays was performed with GenePix 4.0 (Axon Instruments)","UC_0096_1_RAP_27k_h1","","Data was processed in the BioArray Software Environment (BASE). For each channel, the Mean FG - Median BG intensity value was used. Features flagged bad, missing or saturated during image analysis were removed. Poorly measured features with ch1 or ch2 intensities <15 were removed. Data was normalized using pin-based LOWESS algorithm.","GPL3883","David,,Lindgren","david.lindgren@med.lu.se","Molecular Pathology","Dep of Laboratory Medicine. Malmö","Lund University","Entrance 78, 3rd floor, UMAS","Malmö","SE-20502","Sweden","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM497nnn/GSM497729/GSM497729.gpr.gz","19889"
"GSM497730","UC_0097_1_RAP_27k_h1","GSM497730","Public on Jun 14 2010","Jan 15 2010","Jan 19 2010","RNA","2","Urinary bladder tumor UC_0097_1","Homo sapiens","sample histology: Urothelial carcinoma","tumor stage: Ta","tumor grade: G3","dead of disease: NO","follow up time (months): 38.4","tat1 progress^to minv/cystectomy/dead: NO","","","total RNA","Tissue homogenization and RNA recovery using TRIzol reagent (Invitrogen), followed by purification of total RNA using RNeasy kit (Qiagen).","Cy3","1.5 microrgram of sample and reference aRNA, amplified using the MessageAmp aRNA Kit (Ambion), were labeled using the CyScribe Post-Labeling Kit (Amersham Biosciences) followed by purification using the Cyscribe GFX Purification Kit (Amersham)","9606","Stratagene Universal Human Reference","Homo sapiens","reference: RNA pooled from ten human cell lines","total RNA","Tissue homogenization and RNA recovery using TRIzol reagent (Invitrogen), followed by purification of total RNA using RNeasy kit (Qiagen).","Cy5","1.5 microrgram of sample and reference aRNA, amplified using the MessageAmp aRNA Kit (Ambion), were labeled using the CyScribe Post-Labeling Kit (Amersham Biosciences) followed by purification using the Cyscribe GFX Purification Kit (Amersham)","9606","Samples were dissolved in 42 mul of Universal Hybridization Solution (Corning, Acton, MA, USA) and hybridizations were carried out in a CMT-Hybridization Chamber (Corning) for 18 h at 42°C. Pre-hybridization of slides and post-hybridization washes were performed as described in the Universal Hybridization Kit (Corning)","Fluorescence was recorded using an Agilent G2565AA microarray scanner (Agilent Technologies). Image analysis on scanned arrays was performed with GenePix 4.0 (Axon Instruments)","UC_0097_1_RAP_27k_h1","","Data was processed in the BioArray Software Environment (BASE). For each channel, the Mean FG - Median BG intensity value was used. Features flagged bad, missing or saturated during image analysis were removed. Poorly measured features with ch1 or ch2 intensities <15 were removed. Data was normalized using pin-based LOWESS algorithm.","GPL3883","David,,Lindgren","david.lindgren@med.lu.se","Molecular Pathology","Dep of Laboratory Medicine. Malmö","Lund University","Entrance 78, 3rd floor, UMAS","Malmö","SE-20502","Sweden","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM497nnn/GSM497730/GSM497730.gpr.gz","19889"
"GSM497731","UC_0098_1_RAP_27k_h1","GSM497731","Public on Jun 14 2010","Jan 15 2010","Jan 19 2010","RNA","2","Urinary bladder tumor UC_0098_1","Homo sapiens","sample histology: Urothelial carcinoma","tumor stage: Ta","tumor grade: G1","dead of disease: NO","follow up time (months): 59.3","tat1 progress^to minv/cystectomy/dead: NO","","","total RNA","Tissue homogenization and RNA recovery using TRIzol reagent (Invitrogen), followed by purification of total RNA using RNeasy kit (Qiagen).","Cy3","1.5 microrgram of sample and reference aRNA, amplified using the MessageAmp aRNA Kit (Ambion), were labeled using the CyScribe Post-Labeling Kit (Amersham Biosciences) followed by purification using the Cyscribe GFX Purification Kit (Amersham)","9606","Stratagene Universal Human Reference","Homo sapiens","reference: RNA pooled from ten human cell lines","total RNA","Tissue homogenization and RNA recovery using TRIzol reagent (Invitrogen), followed by purification of total RNA using RNeasy kit (Qiagen).","Cy5","1.5 microrgram of sample and reference aRNA, amplified using the MessageAmp aRNA Kit (Ambion), were labeled using the CyScribe Post-Labeling Kit (Amersham Biosciences) followed by purification using the Cyscribe GFX Purification Kit (Amersham)","9606","Samples were dissolved in 42 mul of Universal Hybridization Solution (Corning, Acton, MA, USA) and hybridizations were carried out in a CMT-Hybridization Chamber (Corning) for 18 h at 42°C. Pre-hybridization of slides and post-hybridization washes were performed as described in the Universal Hybridization Kit (Corning)","Fluorescence was recorded using an Agilent G2565AA microarray scanner (Agilent Technologies). Image analysis on scanned arrays was performed with GenePix 4.0 (Axon Instruments)","UC_0098_1_RAP_27k_h1","","Data was processed in the BioArray Software Environment (BASE). For each channel, the Mean FG - Median BG intensity value was used. Features flagged bad, missing or saturated during image analysis were removed. Poorly measured features with ch1 or ch2 intensities <15 were removed. Data was normalized using pin-based LOWESS algorithm.","GPL3883","David,,Lindgren","david.lindgren@med.lu.se","Molecular Pathology","Dep of Laboratory Medicine. Malmö","Lund University","Entrance 78, 3rd floor, UMAS","Malmö","SE-20502","Sweden","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM497nnn/GSM497731/GSM497731.gpr.gz","19889"
"GSM497732","UC_0099_1_RAP_27k_h1","GSM497732","Public on Jun 14 2010","Jan 15 2010","Jan 19 2010","RNA","2","Urinary bladder tumor UC_0099_1","Homo sapiens","sample histology: Urothelial carcinoma","tumor stage: Ta","tumor grade: G1","dead of disease: NO","follow up time (months): 63.7","tat1 progress^to minv/cystectomy/dead: NO","","","total RNA","Tissue homogenization and RNA recovery using TRIzol reagent (Invitrogen), followed by purification of total RNA using RNeasy kit (Qiagen).","Cy3","1.5 microrgram of sample and reference aRNA, amplified using the MessageAmp aRNA Kit (Ambion), were labeled using the CyScribe Post-Labeling Kit (Amersham Biosciences) followed by purification using the Cyscribe GFX Purification Kit (Amersham)","9606","Stratagene Universal Human Reference","Homo sapiens","reference: RNA pooled from ten human cell lines","total RNA","Tissue homogenization and RNA recovery using TRIzol reagent (Invitrogen), followed by purification of total RNA using RNeasy kit (Qiagen).","Cy5","1.5 microrgram of sample and reference aRNA, amplified using the MessageAmp aRNA Kit (Ambion), were labeled using the CyScribe Post-Labeling Kit (Amersham Biosciences) followed by purification using the Cyscribe GFX Purification Kit (Amersham)","9606","Samples were dissolved in 42 mul of Universal Hybridization Solution (Corning, Acton, MA, USA) and hybridizations were carried out in a CMT-Hybridization Chamber (Corning) for 18 h at 42°C. Pre-hybridization of slides and post-hybridization washes were performed as described in the Universal Hybridization Kit (Corning)","Fluorescence was recorded using an Agilent G2565AA microarray scanner (Agilent Technologies). Image analysis on scanned arrays was performed with GenePix 4.0 (Axon Instruments)","UC_0099_1_RAP_27k_h1","","Data was processed in the BioArray Software Environment (BASE). For each channel, the Mean FG - Median BG intensity value was used. Features flagged bad, missing or saturated during image analysis were removed. Poorly measured features with ch1 or ch2 intensities <15 were removed. Data was normalized using pin-based LOWESS algorithm.","GPL3883","David,,Lindgren","david.lindgren@med.lu.se","Molecular Pathology","Dep of Laboratory Medicine. Malmö","Lund University","Entrance 78, 3rd floor, UMAS","Malmö","SE-20502","Sweden","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM497nnn/GSM497732/GSM497732.gpr.gz","19889"
"GSM497733","UC_0101_1_RAP_27k_h1","GSM497733","Public on Jun 14 2010","Jan 15 2010","Jan 19 2010","RNA","2","Urinary bladder tumor UC_0101_1","Homo sapiens","sample histology: Urothelial carcinoma","tumor stage: T1","tumor grade: G2","dead of disease: NO","follow up time (months): 27.8","tat1 progress^to minv/cystectomy/dead: NO","","","total RNA","Tissue homogenization and RNA recovery using TRIzol reagent (Invitrogen), followed by purification of total RNA using RNeasy kit (Qiagen).","Cy3","1.5 microrgram of sample and reference aRNA, amplified using the MessageAmp aRNA Kit (Ambion), were labeled using the CyScribe Post-Labeling Kit (Amersham Biosciences) followed by purification using the Cyscribe GFX Purification Kit (Amersham)","9606","Stratagene Universal Human Reference","Homo sapiens","reference: RNA pooled from ten human cell lines","total RNA","Tissue homogenization and RNA recovery using TRIzol reagent (Invitrogen), followed by purification of total RNA using RNeasy kit (Qiagen).","Cy5","1.5 microrgram of sample and reference aRNA, amplified using the MessageAmp aRNA Kit (Ambion), were labeled using the CyScribe Post-Labeling Kit (Amersham Biosciences) followed by purification using the Cyscribe GFX Purification Kit (Amersham)","9606","Samples were dissolved in 42 mul of Universal Hybridization Solution (Corning, Acton, MA, USA) and hybridizations were carried out in a CMT-Hybridization Chamber (Corning) for 18 h at 42°C. Pre-hybridization of slides and post-hybridization washes were performed as described in the Universal Hybridization Kit (Corning)","Fluorescence was recorded using an Agilent G2565AA microarray scanner (Agilent Technologies). Image analysis on scanned arrays was performed with GenePix 4.0 (Axon Instruments)","UC_0101_1_RAP_27k_h1","","Data was processed in the BioArray Software Environment (BASE). For each channel, the Mean FG - Median BG intensity value was used. Features flagged bad, missing or saturated during image analysis were removed. Poorly measured features with ch1 or ch2 intensities <15 were removed. Data was normalized using pin-based LOWESS algorithm.","GPL3883","David,,Lindgren","david.lindgren@med.lu.se","Molecular Pathology","Dep of Laboratory Medicine. Malmö","Lund University","Entrance 78, 3rd floor, UMAS","Malmö","SE-20502","Sweden","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM497nnn/GSM497733/GSM497733.gpr.gz","19889"
"GSM497734","UC_0104_1_RAP_27k_h2","GSM497734","Public on Jun 14 2010","Jan 15 2010","Jan 19 2010","RNA","2","Urinary bladder tumor UC_0104_1","Homo sapiens","sample histology: Urothelial carcinoma","tumor stage: Ta","tumor grade: G2","dead of disease: NO","follow up time (months): 63.2","tat1 progress^to minv/cystectomy/dead: NO","","","total RNA","Tissue homogenization and RNA recovery using TRIzol reagent (Invitrogen), followed by purification of total RNA using RNeasy kit (Qiagen).","Cy3","1.5 microrgram of sample and reference aRNA, amplified using the MessageAmp aRNA Kit (Ambion), were labeled using the CyScribe Post-Labeling Kit (Amersham Biosciences) followed by purification using the Cyscribe GFX Purification Kit (Amersham)","9606","Stratagene Universal Human Reference","Homo sapiens","reference: RNA pooled from ten human cell lines","total RNA","Tissue homogenization and RNA recovery using TRIzol reagent (Invitrogen), followed by purification of total RNA using RNeasy kit (Qiagen).","Cy5","1.5 microrgram of sample and reference aRNA, amplified using the MessageAmp aRNA Kit (Ambion), were labeled using the CyScribe Post-Labeling Kit (Amersham Biosciences) followed by purification using the Cyscribe GFX Purification Kit (Amersham)","9606","Samples were dissolved in 42 mul of Universal Hybridization Solution (Corning, Acton, MA, USA) and hybridizations were carried out in a CMT-Hybridization Chamber (Corning) for 18 h at 42°C. Pre-hybridization of slides and post-hybridization washes were performed as described in the Universal Hybridization Kit (Corning)","Fluorescence was recorded using an Agilent G2565AA microarray scanner (Agilent Technologies). Image analysis on scanned arrays was performed with GenePix 4.0 (Axon Instruments)","UC_0104_1_RAP_27k_h2","","Data was processed in the BioArray Software Environment (BASE). For each channel, the Mean FG - Median BG intensity value was used. Features flagged bad, missing or saturated during image analysis were removed. Poorly measured features with ch1 or ch2 intensities <15 were removed. Data was normalized using pin-based LOWESS algorithm.","GPL3883","David,,Lindgren","david.lindgren@med.lu.se","Molecular Pathology","Dep of Laboratory Medicine. Malmö","Lund University","Entrance 78, 3rd floor, UMAS","Malmö","SE-20502","Sweden","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM497nnn/GSM497734/GSM497734.gpr.gz","19889"
"GSM497735","UC_0106_1_RAP_27k_h2","GSM497735","Public on Jun 14 2010","Jan 15 2010","Jan 19 2010","RNA","2","Urinary bladder tumor UC_0106_1","Homo sapiens","sample histology: Urothelial carcinoma","tumor stage: Ta","tumor grade: G1","dead of disease: NO","follow up time (months): 62.1","tat1 progress^to minv/cystectomy/dead: NO","","","total RNA","Tissue homogenization and RNA recovery using TRIzol reagent (Invitrogen), followed by purification of total RNA using RNeasy kit (Qiagen).","Cy3","1.5 microrgram of sample and reference aRNA, amplified using the MessageAmp aRNA Kit (Ambion), were labeled using the CyScribe Post-Labeling Kit (Amersham Biosciences) followed by purification using the Cyscribe GFX Purification Kit (Amersham)","9606","Stratagene Universal Human Reference","Homo sapiens","reference: RNA pooled from ten human cell lines","total RNA","Tissue homogenization and RNA recovery using TRIzol reagent (Invitrogen), followed by purification of total RNA using RNeasy kit (Qiagen).","Cy5","1.5 microrgram of sample and reference aRNA, amplified using the MessageAmp aRNA Kit (Ambion), were labeled using the CyScribe Post-Labeling Kit (Amersham Biosciences) followed by purification using the Cyscribe GFX Purification Kit (Amersham)","9606","Samples were dissolved in 42 mul of Universal Hybridization Solution (Corning, Acton, MA, USA) and hybridizations were carried out in a CMT-Hybridization Chamber (Corning) for 18 h at 42°C. Pre-hybridization of slides and post-hybridization washes were performed as described in the Universal Hybridization Kit (Corning)","Fluorescence was recorded using an Agilent G2565AA microarray scanner (Agilent Technologies). Image analysis on scanned arrays was performed with GenePix 4.0 (Axon Instruments)","UC_0106_1_RAP_27k_h2","","Data was processed in the BioArray Software Environment (BASE). For each channel, the Mean FG - Median BG intensity value was used. Features flagged bad, missing or saturated during image analysis were removed. Poorly measured features with ch1 or ch2 intensities <15 were removed. Data was normalized using pin-based LOWESS algorithm.","GPL3883","David,,Lindgren","david.lindgren@med.lu.se","Molecular Pathology","Dep of Laboratory Medicine. Malmö","Lund University","Entrance 78, 3rd floor, UMAS","Malmö","SE-20502","Sweden","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM497nnn/GSM497735/GSM497735.gpr.gz","19889"
"GSM497736","UC_0110_1_RAP_27k_h1","GSM497736","Public on Jun 14 2010","Jan 15 2010","Jan 19 2010","RNA","2","Urinary bladder tumor UC_0110_1","Homo sapiens","sample histology: Urothelial carcinoma","tumor stage: Ta","tumor grade: G2","dead of disease: NO","follow up time (months): 56.2","tat1 progress^to minv/cystectomy/dead: NO","","","total RNA","Tissue homogenization and RNA recovery using TRIzol reagent (Invitrogen), followed by purification of total RNA using RNeasy kit (Qiagen).","Cy3","1.5 microrgram of sample and reference aRNA, amplified using the MessageAmp aRNA Kit (Ambion), were labeled using the CyScribe Post-Labeling Kit (Amersham Biosciences) followed by purification using the Cyscribe GFX Purification Kit (Amersham)","9606","Stratagene Universal Human Reference","Homo sapiens","reference: RNA pooled from ten human cell lines","total RNA","Tissue homogenization and RNA recovery using TRIzol reagent (Invitrogen), followed by purification of total RNA using RNeasy kit (Qiagen).","Cy5","1.5 microrgram of sample and reference aRNA, amplified using the MessageAmp aRNA Kit (Ambion), were labeled using the CyScribe Post-Labeling Kit (Amersham Biosciences) followed by purification using the Cyscribe GFX Purification Kit (Amersham)","9606","Samples were dissolved in 42 mul of Universal Hybridization Solution (Corning, Acton, MA, USA) and hybridizations were carried out in a CMT-Hybridization Chamber (Corning) for 18 h at 42°C. Pre-hybridization of slides and post-hybridization washes were performed as described in the Universal Hybridization Kit (Corning)","Fluorescence was recorded using an Agilent G2565AA microarray scanner (Agilent Technologies). Image analysis on scanned arrays was performed with GenePix 4.0 (Axon Instruments)","UC_0110_1_RAP_27k_h1","","Data was processed in the BioArray Software Environment (BASE). For each channel, the Mean FG - Median BG intensity value was used. Features flagged bad, missing or saturated during image analysis were removed. Poorly measured features with ch1 or ch2 intensities <15 were removed. Data was normalized using pin-based LOWESS algorithm.","GPL3883","David,,Lindgren","david.lindgren@med.lu.se","Molecular Pathology","Dep of Laboratory Medicine. Malmö","Lund University","Entrance 78, 3rd floor, UMAS","Malmö","SE-20502","Sweden","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM497nnn/GSM497736/GSM497736.gpr.gz","19889"
"GSM497737","UC_0111_1_RAP_27k_h1","GSM497737","Public on Jun 14 2010","Jan 15 2010","Jan 19 2010","RNA","2","Urinary bladder tumor UC_0111_1","Homo sapiens","sample histology: Urothelial carcinoma","tumor stage: T1","tumor grade: G2","dead of disease: YES","follow up time (months): 10.3","tat1 progress^to minv/cystectomy/dead: YES","distant metastasis: M+","","total RNA","Tissue homogenization and RNA recovery using TRIzol reagent (Invitrogen), followed by purification of total RNA using RNeasy kit (Qiagen).","Cy3","1.5 microrgram of sample and reference aRNA, amplified using the MessageAmp aRNA Kit (Ambion), were labeled using the CyScribe Post-Labeling Kit (Amersham Biosciences) followed by purification using the Cyscribe GFX Purification Kit (Amersham)","9606","Stratagene Universal Human Reference","Homo sapiens","reference: RNA pooled from ten human cell lines","total RNA","Tissue homogenization and RNA recovery using TRIzol reagent (Invitrogen), followed by purification of total RNA using RNeasy kit (Qiagen).","Cy5","1.5 microrgram of sample and reference aRNA, amplified using the MessageAmp aRNA Kit (Ambion), were labeled using the CyScribe Post-Labeling Kit (Amersham Biosciences) followed by purification using the Cyscribe GFX Purification Kit (Amersham)","9606","Samples were dissolved in 42 mul of Universal Hybridization Solution (Corning, Acton, MA, USA) and hybridizations were carried out in a CMT-Hybridization Chamber (Corning) for 18 h at 42°C. Pre-hybridization of slides and post-hybridization washes were performed as described in the Universal Hybridization Kit (Corning)","Fluorescence was recorded using an Agilent G2565AA microarray scanner (Agilent Technologies). Image analysis on scanned arrays was performed with GenePix 4.0 (Axon Instruments)","UC_0111_1_RAP_27k_h1","","Data was processed in the BioArray Software Environment (BASE). For each channel, the Mean FG - Median BG intensity value was used. Features flagged bad, missing or saturated during image analysis were removed. Poorly measured features with ch1 or ch2 intensities <15 were removed. Data was normalized using pin-based LOWESS algorithm.","GPL3883","David,,Lindgren","david.lindgren@med.lu.se","Molecular Pathology","Dep of Laboratory Medicine. Malmö","Lund University","Entrance 78, 3rd floor, UMAS","Malmö","SE-20502","Sweden","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM497nnn/GSM497737/GSM497737.gpr.gz","19889"
"GSM497738","UC_0112_1_RAP_27k_h1","GSM497738","Public on Jun 14 2010","Jan 15 2010","Jan 19 2010","RNA","2","Urinary bladder tumor UC_0112_1","Homo sapiens","sample histology: Urothelial carcinoma","tumor stage: Ta","tumor grade: G2","dead of disease: NO","follow up time (months): 62.9","tat1 progress^to minv/cystectomy/dead: NO","","","total RNA","Tissue homogenization and RNA recovery using TRIzol reagent (Invitrogen), followed by purification of total RNA using RNeasy kit (Qiagen).","Cy3","1.5 microrgram of sample and reference aRNA, amplified using the MessageAmp aRNA Kit (Ambion), were labeled using the CyScribe Post-Labeling Kit (Amersham Biosciences) followed by purification using the Cyscribe GFX Purification Kit (Amersham)","9606","Stratagene Universal Human Reference","Homo sapiens","reference: RNA pooled from ten human cell lines","total RNA","Tissue homogenization and RNA recovery using TRIzol reagent (Invitrogen), followed by purification of total RNA using RNeasy kit (Qiagen).","Cy5","1.5 microrgram of sample and reference aRNA, amplified using the MessageAmp aRNA Kit (Ambion), were labeled using the CyScribe Post-Labeling Kit (Amersham Biosciences) followed by purification using the Cyscribe GFX Purification Kit (Amersham)","9606","Samples were dissolved in 42 mul of Universal Hybridization Solution (Corning, Acton, MA, USA) and hybridizations were carried out in a CMT-Hybridization Chamber (Corning) for 18 h at 42°C. Pre-hybridization of slides and post-hybridization washes were performed as described in the Universal Hybridization Kit (Corning)","Fluorescence was recorded using an Agilent G2565AA microarray scanner (Agilent Technologies). Image analysis on scanned arrays was performed with GenePix 4.0 (Axon Instruments)","UC_0112_1_RAP_27k_h1","","Data was processed in the BioArray Software Environment (BASE). For each channel, the Mean FG - Median BG intensity value was used. Features flagged bad, missing or saturated during image analysis were removed. Poorly measured features with ch1 or ch2 intensities <15 were removed. Data was normalized using pin-based LOWESS algorithm.","GPL3883","David,,Lindgren","david.lindgren@med.lu.se","Molecular Pathology","Dep of Laboratory Medicine. Malmö","Lund University","Entrance 78, 3rd floor, UMAS","Malmö","SE-20502","Sweden","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM497nnn/GSM497738/GSM497738.gpr.gz","19889"
"GSM497739","UC_0114_1_RAP_27k_h2","GSM497739","Public on Jun 14 2010","Jan 15 2010","Jan 19 2010","RNA","2","Urinary bladder tumor UC_0114_1","Homo sapiens","sample histology: Urothelial carcinoma","tumor stage: Ta","tumor grade: G2","dead of disease: NO","follow up time (months): 61.7","tat1 progress^to minv/cystectomy/dead: NO","","","total RNA","Tissue homogenization and RNA recovery using TRIzol reagent (Invitrogen), followed by purification of total RNA using RNeasy kit (Qiagen).","Cy3","1.5 microrgram of sample and reference aRNA, amplified using the MessageAmp aRNA Kit (Ambion), were labeled using the CyScribe Post-Labeling Kit (Amersham Biosciences) followed by purification using the Cyscribe GFX Purification Kit (Amersham)","9606","Stratagene Universal Human Reference","Homo sapiens","reference: RNA pooled from ten human cell lines","total RNA","Tissue homogenization and RNA recovery using TRIzol reagent (Invitrogen), followed by purification of total RNA using RNeasy kit (Qiagen).","Cy5","1.5 microrgram of sample and reference aRNA, amplified using the MessageAmp aRNA Kit (Ambion), were labeled using the CyScribe Post-Labeling Kit (Amersham Biosciences) followed by purification using the Cyscribe GFX Purification Kit (Amersham)","9606","Samples were dissolved in 42 mul of Universal Hybridization Solution (Corning, Acton, MA, USA) and hybridizations were carried out in a CMT-Hybridization Chamber (Corning) for 18 h at 42°C. Pre-hybridization of slides and post-hybridization washes were performed as described in the Universal Hybridization Kit (Corning)","Fluorescence was recorded using an Agilent G2565AA microarray scanner (Agilent Technologies). Image analysis on scanned arrays was performed with GenePix 4.0 (Axon Instruments)","UC_0114_1_RAP_27k_h2","","Data was processed in the BioArray Software Environment (BASE). For each channel, the Mean FG - Median BG intensity value was used. Features flagged bad, missing or saturated during image analysis were removed. Poorly measured features with ch1 or ch2 intensities <15 were removed. Data was normalized using pin-based LOWESS algorithm.","GPL3883","David,,Lindgren","david.lindgren@med.lu.se","Molecular Pathology","Dep of Laboratory Medicine. Malmö","Lund University","Entrance 78, 3rd floor, UMAS","Malmö","SE-20502","Sweden","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM497nnn/GSM497739/GSM497739.gpr.gz","19889"
"GSM497740","UC_0115_1_RAP_27k_h1","GSM497740","Public on Jun 14 2010","Jan 15 2010","Jan 19 2010","RNA","2","Urinary bladder tumor UC_0115_1","Homo sapiens","sample histology: Urothelial carcinoma","tumor stage: T1","tumor grade: G2","dead of disease: NO","follow up time (months): 32.8","tat1 progress^to minv/cystectomy/dead: NO","","","total RNA","Tissue homogenization and RNA recovery using TRIzol reagent (Invitrogen), followed by purification of total RNA using RNeasy kit (Qiagen).","Cy3","1.5 microrgram of sample and reference aRNA, amplified using the MessageAmp aRNA Kit (Ambion), were labeled using the CyScribe Post-Labeling Kit (Amersham Biosciences) followed by purification using the Cyscribe GFX Purification Kit (Amersham)","9606","Stratagene Universal Human Reference","Homo sapiens","reference: RNA pooled from ten human cell lines","total RNA","Tissue homogenization and RNA recovery using TRIzol reagent (Invitrogen), followed by purification of total RNA using RNeasy kit (Qiagen).","Cy5","1.5 microrgram of sample and reference aRNA, amplified using the MessageAmp aRNA Kit (Ambion), were labeled using the CyScribe Post-Labeling Kit (Amersham Biosciences) followed by purification using the Cyscribe GFX Purification Kit (Amersham)","9606","Samples were dissolved in 42 mul of Universal Hybridization Solution (Corning, Acton, MA, USA) and hybridizations were carried out in a CMT-Hybridization Chamber (Corning) for 18 h at 42°C. Pre-hybridization of slides and post-hybridization washes were performed as described in the Universal Hybridization Kit (Corning)","Fluorescence was recorded using an Agilent G2565AA microarray scanner (Agilent Technologies). Image analysis on scanned arrays was performed with GenePix 4.0 (Axon Instruments)","UC_0115_1_RAP_27k_h1","","Data was processed in the BioArray Software Environment (BASE). For each channel, the Mean FG - Median BG intensity value was used. Features flagged bad, missing or saturated during image analysis were removed. Poorly measured features with ch1 or ch2 intensities <15 were removed. Data was normalized using pin-based LOWESS algorithm.","GPL3883","David,,Lindgren","david.lindgren@med.lu.se","Molecular Pathology","Dep of Laboratory Medicine. Malmö","Lund University","Entrance 78, 3rd floor, UMAS","Malmö","SE-20502","Sweden","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM497nnn/GSM497740/GSM497740.gpr.gz","19889"
"GSM497741","UC_0120_1_RAP_27k_h1","GSM497741","Public on Jun 14 2010","Jan 15 2010","Jan 19 2010","RNA","2","Urinary bladder tumor UC_0120_1","Homo sapiens","sample histology: Urothelial carcinoma","tumor stage: T1","tumor grade: G3","dead of disease: NO","follow up time (months): 42.8","tat1 progress^to minv/cystectomy/dead: NO","","","total RNA","Tissue homogenization and RNA recovery using TRIzol reagent (Invitrogen), followed by purification of total RNA using RNeasy kit (Qiagen).","Cy3","1.5 microrgram of sample and reference aRNA, amplified using the MessageAmp aRNA Kit (Ambion), were labeled using the CyScribe Post-Labeling Kit (Amersham Biosciences) followed by purification using the Cyscribe GFX Purification Kit (Amersham)","9606","Stratagene Universal Human Reference","Homo sapiens","reference: RNA pooled from ten human cell lines","total RNA","Tissue homogenization and RNA recovery using TRIzol reagent (Invitrogen), followed by purification of total RNA using RNeasy kit (Qiagen).","Cy5","1.5 microrgram of sample and reference aRNA, amplified using the MessageAmp aRNA Kit (Ambion), were labeled using the CyScribe Post-Labeling Kit (Amersham Biosciences) followed by purification using the Cyscribe GFX Purification Kit (Amersham)","9606","Samples were dissolved in 42 mul of Universal Hybridization Solution (Corning, Acton, MA, USA) and hybridizations were carried out in a CMT-Hybridization Chamber (Corning) for 18 h at 42°C. Pre-hybridization of slides and post-hybridization washes were performed as described in the Universal Hybridization Kit (Corning)","Fluorescence was recorded using an Agilent G2565AA microarray scanner (Agilent Technologies). Image analysis on scanned arrays was performed with GenePix 4.0 (Axon Instruments)","UC_0120_1_RAP_27k_h1","","Data was processed in the BioArray Software Environment (BASE). For each channel, the Mean FG - Median BG intensity value was used. Features flagged bad, missing or saturated during image analysis were removed. Poorly measured features with ch1 or ch2 intensities <15 were removed. Data was normalized using pin-based LOWESS algorithm.","GPL3883","David,,Lindgren","david.lindgren@med.lu.se","Molecular Pathology","Dep of Laboratory Medicine. Malmö","Lund University","Entrance 78, 3rd floor, UMAS","Malmö","SE-20502","Sweden","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM497nnn/GSM497741/GSM497741.gpr.gz","19889"
"GSM497742","UC_0122_1_RAP_27k_h1","GSM497742","Public on Jun 14 2010","Jan 15 2010","Jan 19 2010","RNA","2","Urinary bladder tumor UC_0122_1","Homo sapiens","sample histology: Urothelial carcinoma","tumor stage: T1","tumor grade: G3","dead of disease: NO","follow up time (months): 59.7","tat1 progress^to minv/cystectomy/dead: NO","","","total RNA","Tissue homogenization and RNA recovery using TRIzol reagent (Invitrogen), followed by purification of total RNA using RNeasy kit (Qiagen).","Cy3","1.5 microrgram of sample and reference aRNA, amplified using the MessageAmp aRNA Kit (Ambion), were labeled using the CyScribe Post-Labeling Kit (Amersham Biosciences) followed by purification using the Cyscribe GFX Purification Kit (Amersham)","9606","Stratagene Universal Human Reference","Homo sapiens","reference: RNA pooled from ten human cell lines","total RNA","Tissue homogenization and RNA recovery using TRIzol reagent (Invitrogen), followed by purification of total RNA using RNeasy kit (Qiagen).","Cy5","1.5 microrgram of sample and reference aRNA, amplified using the MessageAmp aRNA Kit (Ambion), were labeled using the CyScribe Post-Labeling Kit (Amersham Biosciences) followed by purification using the Cyscribe GFX Purification Kit (Amersham)","9606","Samples were dissolved in 42 mul of Universal Hybridization Solution (Corning, Acton, MA, USA) and hybridizations were carried out in a CMT-Hybridization Chamber (Corning) for 18 h at 42°C. Pre-hybridization of slides and post-hybridization washes were performed as described in the Universal Hybridization Kit (Corning)","Fluorescence was recorded using an Agilent G2565AA microarray scanner (Agilent Technologies). Image analysis on scanned arrays was performed with GenePix 4.0 (Axon Instruments)","UC_0122_1_RAP_27k_h1","","Data was processed in the BioArray Software Environment (BASE). For each channel, the Mean FG - Median BG intensity value was used. Features flagged bad, missing or saturated during image analysis were removed. Poorly measured features with ch1 or ch2 intensities <15 were removed. Data was normalized using pin-based LOWESS algorithm.","GPL3883","David,,Lindgren","david.lindgren@med.lu.se","Molecular Pathology","Dep of Laboratory Medicine. Malmö","Lund University","Entrance 78, 3rd floor, UMAS","Malmö","SE-20502","Sweden","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM497nnn/GSM497742/GSM497742.gpr.gz","19889"
"GSM497743","UC_0129_1_RAP_27k_h1","GSM497743","Public on Jun 14 2010","Jan 15 2010","Jan 19 2010","RNA","2","Urinary bladder tumor UC_0129_1","Homo sapiens","sample histology: Urothelial carcinoma","tumor stage: Ta","tumor grade: G1","dead of disease: NO","follow up time (months): 43.7","tat1 progress^to minv/cystectomy/dead: NO","","","total RNA","Tissue homogenization and RNA recovery using TRIzol reagent (Invitrogen), followed by purification of total RNA using RNeasy kit (Qiagen).","Cy3","1.5 microrgram of sample and reference aRNA, amplified using the MessageAmp aRNA Kit (Ambion), were labeled using the CyScribe Post-Labeling Kit (Amersham Biosciences) followed by purification using the Cyscribe GFX Purification Kit (Amersham)","9606","Stratagene Universal Human Reference","Homo sapiens","reference: RNA pooled from ten human cell lines","total RNA","Tissue homogenization and RNA recovery using TRIzol reagent (Invitrogen), followed by purification of total RNA using RNeasy kit (Qiagen).","Cy5","1.5 microrgram of sample and reference aRNA, amplified using the MessageAmp aRNA Kit (Ambion), were labeled using the CyScribe Post-Labeling Kit (Amersham Biosciences) followed by purification using the Cyscribe GFX Purification Kit (Amersham)","9606","Samples were dissolved in 42 mul of Universal Hybridization Solution (Corning, Acton, MA, USA) and hybridizations were carried out in a CMT-Hybridization Chamber (Corning) for 18 h at 42°C. Pre-hybridization of slides and post-hybridization washes were performed as described in the Universal Hybridization Kit (Corning)","Fluorescence was recorded using an Agilent G2565AA microarray scanner (Agilent Technologies). Image analysis on scanned arrays was performed with GenePix 4.0 (Axon Instruments)","UC_0129_1_RAP_27k_h1","","Data was processed in the BioArray Software Environment (BASE). For each channel, the Mean FG - Median BG intensity value was used. Features flagged bad, missing or saturated during image analysis were removed. Poorly measured features with ch1 or ch2 intensities <15 were removed. Data was normalized using pin-based LOWESS algorithm.","GPL3883","David,,Lindgren","david.lindgren@med.lu.se","Molecular Pathology","Dep of Laboratory Medicine. Malmö","Lund University","Entrance 78, 3rd floor, UMAS","Malmö","SE-20502","Sweden","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM497nnn/GSM497743/GSM497743.gpr.gz","19889"
"GSM497744","UC_0130_1_RAP_27k_h1","GSM497744","Public on Jun 14 2010","Jan 15 2010","Jan 19 2010","RNA","2","Urinary bladder tumor UC_0130_1","Homo sapiens","sample histology: Urothelial carcinoma","tumor stage: Ta","tumor grade: G1","dead of disease: NO","follow up time (months): 56.6","tat1 progress^to minv/cystectomy/dead: NO","","","total RNA","Tissue homogenization and RNA recovery using TRIzol reagent (Invitrogen), followed by purification of total RNA using RNeasy kit (Qiagen).","Cy3","1.5 microrgram of sample and reference aRNA, amplified using the MessageAmp aRNA Kit (Ambion), were labeled using the CyScribe Post-Labeling Kit (Amersham Biosciences) followed by purification using the Cyscribe GFX Purification Kit (Amersham)","9606","Stratagene Universal Human Reference","Homo sapiens","reference: RNA pooled from ten human cell lines","total RNA","Tissue homogenization and RNA recovery using TRIzol reagent (Invitrogen), followed by purification of total RNA using RNeasy kit (Qiagen).","Cy5","1.5 microrgram of sample and reference aRNA, amplified using the MessageAmp aRNA Kit (Ambion), were labeled using the CyScribe Post-Labeling Kit (Amersham Biosciences) followed by purification using the Cyscribe GFX Purification Kit (Amersham)","9606","Samples were dissolved in 42 mul of Universal Hybridization Solution (Corning, Acton, MA, USA) and hybridizations were carried out in a CMT-Hybridization Chamber (Corning) for 18 h at 42°C. Pre-hybridization of slides and post-hybridization washes were performed as described in the Universal Hybridization Kit (Corning)","Fluorescence was recorded using an Agilent G2565AA microarray scanner (Agilent Technologies). Image analysis on scanned arrays was performed with GenePix 4.0 (Axon Instruments)","UC_0130_1_RAP_27k_h1","","Data was processed in the BioArray Software Environment (BASE). For each channel, the Mean FG - Median BG intensity value was used. Features flagged bad, missing or saturated during image analysis were removed. Poorly measured features with ch1 or ch2 intensities <15 were removed. Data was normalized using pin-based LOWESS algorithm.","GPL3883","David,,Lindgren","david.lindgren@med.lu.se","Molecular Pathology","Dep of Laboratory Medicine. Malmö","Lund University","Entrance 78, 3rd floor, UMAS","Malmö","SE-20502","Sweden","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM497nnn/GSM497744/GSM497744.gpr.gz","19889"
"GSM497745","UC_0131_1_RAP_27k_h2","GSM497745","Public on Jun 14 2010","Jan 15 2010","Jan 19 2010","RNA","2","Urinary bladder tumor UC_0131_1","Homo sapiens","sample histology: Urothelial carcinoma","tumor stage: Ta","tumor grade: G1","dead of disease: NO","follow up time (months): 59.0","tat1 progress^to minv/cystectomy/dead: NO","","","total RNA","Tissue homogenization and RNA recovery using TRIzol reagent (Invitrogen), followed by purification of total RNA using RNeasy kit (Qiagen).","Cy3","1.5 microrgram of sample and reference aRNA, amplified using the MessageAmp aRNA Kit (Ambion), were labeled using the CyScribe Post-Labeling Kit (Amersham Biosciences) followed by purification using the Cyscribe GFX Purification Kit (Amersham)","9606","Stratagene Universal Human Reference","Homo sapiens","reference: RNA pooled from ten human cell lines","total RNA","Tissue homogenization and RNA recovery using TRIzol reagent (Invitrogen), followed by purification of total RNA using RNeasy kit (Qiagen).","Cy5","1.5 microrgram of sample and reference aRNA, amplified using the MessageAmp aRNA Kit (Ambion), were labeled using the CyScribe Post-Labeling Kit (Amersham Biosciences) followed by purification using the Cyscribe GFX Purification Kit (Amersham)","9606","Samples were dissolved in 42 mul of Universal Hybridization Solution (Corning, Acton, MA, USA) and hybridizations were carried out in a CMT-Hybridization Chamber (Corning) for 18 h at 42°C. Pre-hybridization of slides and post-hybridization washes were performed as described in the Universal Hybridization Kit (Corning)","Fluorescence was recorded using an Agilent G2565AA microarray scanner (Agilent Technologies). Image analysis on scanned arrays was performed with GenePix 4.0 (Axon Instruments)","UC_0131_1_RAP_27k_h2","","Data was processed in the BioArray Software Environment (BASE). For each channel, the Mean FG - Median BG intensity value was used. Features flagged bad, missing or saturated during image analysis were removed. Poorly measured features with ch1 or ch2 intensities <15 were removed. Data was normalized using pin-based LOWESS algorithm.","GPL3883","David,,Lindgren","david.lindgren@med.lu.se","Molecular Pathology","Dep of Laboratory Medicine. Malmö","Lund University","Entrance 78, 3rd floor, UMAS","Malmö","SE-20502","Sweden","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM497nnn/GSM497745/GSM497745.gpr.gz","19889"
"GSM497746","UC_0132_1_RAP_27k_h1","GSM497746","Public on Jun 14 2010","Jan 15 2010","Jan 19 2010","RNA","2","Urinary bladder tumor UC_0132_1","Homo sapiens","sample histology: Urothelial carcinoma","tumor stage: T1","tumor grade: G3","dead of disease: NO","follow up time (months): 52.4","tat1 progress^to minv/cystectomy/dead: YES^cystect","cystectomy: YES","","total RNA","Tissue homogenization and RNA recovery using TRIzol reagent (Invitrogen), followed by purification of total RNA using RNeasy kit (Qiagen).","Cy3","1.5 microrgram of sample and reference aRNA, amplified using the MessageAmp aRNA Kit (Ambion), were labeled using the CyScribe Post-Labeling Kit (Amersham Biosciences) followed by purification using the Cyscribe GFX Purification Kit (Amersham)","9606","Stratagene Universal Human Reference","Homo sapiens","reference: RNA pooled from ten human cell lines","total RNA","Tissue homogenization and RNA recovery using TRIzol reagent (Invitrogen), followed by purification of total RNA using RNeasy kit (Qiagen).","Cy5","1.5 microrgram of sample and reference aRNA, amplified using the MessageAmp aRNA Kit (Ambion), were labeled using the CyScribe Post-Labeling Kit (Amersham Biosciences) followed by purification using the Cyscribe GFX Purification Kit (Amersham)","9606","Samples were dissolved in 42 mul of Universal Hybridization Solution (Corning, Acton, MA, USA) and hybridizations were carried out in a CMT-Hybridization Chamber (Corning) for 18 h at 42°C. Pre-hybridization of slides and post-hybridization washes were performed as described in the Universal Hybridization Kit (Corning)","Fluorescence was recorded using an Agilent G2565AA microarray scanner (Agilent Technologies). Image analysis on scanned arrays was performed with GenePix 4.0 (Axon Instruments)","UC_0132_1_RAP_27k_h1","","Data was processed in the BioArray Software Environment (BASE). For each channel, the Mean FG - Median BG intensity value was used. Features flagged bad, missing or saturated during image analysis were removed. Poorly measured features with ch1 or ch2 intensities <15 were removed. Data was normalized using pin-based LOWESS algorithm.","GPL3883","David,,Lindgren","david.lindgren@med.lu.se","Molecular Pathology","Dep of Laboratory Medicine. Malmö","Lund University","Entrance 78, 3rd floor, UMAS","Malmö","SE-20502","Sweden","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM497nnn/GSM497746/GSM497746.gpr.gz","19889"
"GSM497747","UC_0135_1_RAP_27k_h1","GSM497747","Public on Jun 14 2010","Jan 15 2010","Jan 19 2010","RNA","2","Urinary bladder tumor UC_0135_1","Homo sapiens","sample histology: Urothelial carcinoma","tumor stage: Ta","tumor grade: G2","dead of disease: NO","follow up time (months): 25.0","tat1 progress^to minv/cystectomy/dead: NO","","","total RNA","Tissue homogenization and RNA recovery using TRIzol reagent (Invitrogen), followed by purification of total RNA using RNeasy kit (Qiagen).","Cy3","1.5 microrgram of sample and reference aRNA, amplified using the MessageAmp aRNA Kit (Ambion), were labeled using the CyScribe Post-Labeling Kit (Amersham Biosciences) followed by purification using the Cyscribe GFX Purification Kit (Amersham)","9606","Stratagene Universal Human Reference","Homo sapiens","reference: RNA pooled from ten human cell lines","total RNA","Tissue homogenization and RNA recovery using TRIzol reagent (Invitrogen), followed by purification of total RNA using RNeasy kit (Qiagen).","Cy5","1.5 microrgram of sample and reference aRNA, amplified using the MessageAmp aRNA Kit (Ambion), were labeled using the CyScribe Post-Labeling Kit (Amersham Biosciences) followed by purification using the Cyscribe GFX Purification Kit (Amersham)","9606","Samples were dissolved in 42 mul of Universal Hybridization Solution (Corning, Acton, MA, USA) and hybridizations were carried out in a CMT-Hybridization Chamber (Corning) for 18 h at 42°C. Pre-hybridization of slides and post-hybridization washes were performed as described in the Universal Hybridization Kit (Corning)","Fluorescence was recorded using an Agilent G2565AA microarray scanner (Agilent Technologies). Image analysis on scanned arrays was performed with GenePix 4.0 (Axon Instruments)","UC_0135_1_RAP_27k_h1","","Data was processed in the BioArray Software Environment (BASE). For each channel, the Mean FG - Median BG intensity value was used. Features flagged bad, missing or saturated during image analysis were removed. Poorly measured features with ch1 or ch2 intensities <15 were removed. Data was normalized using pin-based LOWESS algorithm.","GPL3883","David,,Lindgren","david.lindgren@med.lu.se","Molecular Pathology","Dep of Laboratory Medicine. Malmö","Lund University","Entrance 78, 3rd floor, UMAS","Malmö","SE-20502","Sweden","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM497nnn/GSM497747/GSM497747.gpr.gz","19889"
"GSM497748","UC_0137_1_RAP_27k_h1","GSM497748","Public on Jun 14 2010","Jan 15 2010","Jan 19 2010","RNA","2","Urinary bladder tumor UC_0137_1","Homo sapiens","sample histology: Urothelial carcinoma","tumor stage: Ta","tumor grade: G1","dead of disease: NO","follow up time (months): 60.8","tat1 progress^to minv/cystectomy/dead: NO","","","total RNA","Tissue homogenization and RNA recovery using TRIzol reagent (Invitrogen), followed by purification of total RNA using RNeasy kit (Qiagen).","Cy3","1.5 microrgram of sample and reference aRNA, amplified using the MessageAmp aRNA Kit (Ambion), were labeled using the CyScribe Post-Labeling Kit (Amersham Biosciences) followed by purification using the Cyscribe GFX Purification Kit (Amersham)","9606","Stratagene Universal Human Reference","Homo sapiens","reference: RNA pooled from ten human cell lines","total RNA","Tissue homogenization and RNA recovery using TRIzol reagent (Invitrogen), followed by purification of total RNA using RNeasy kit (Qiagen).","Cy5","1.5 microrgram of sample and reference aRNA, amplified using the MessageAmp aRNA Kit (Ambion), were labeled using the CyScribe Post-Labeling Kit (Amersham Biosciences) followed by purification using the Cyscribe GFX Purification Kit (Amersham)","9606","Samples were dissolved in 42 mul of Universal Hybridization Solution (Corning, Acton, MA, USA) and hybridizations were carried out in a CMT-Hybridization Chamber (Corning) for 18 h at 42°C. Pre-hybridization of slides and post-hybridization washes were performed as described in the Universal Hybridization Kit (Corning)","Fluorescence was recorded using an Agilent G2565AA microarray scanner (Agilent Technologies). Image analysis on scanned arrays was performed with GenePix 4.0 (Axon Instruments)","UC_0137_1_RAP_27k_h1","","Data was processed in the BioArray Software Environment (BASE). For each channel, the Mean FG - Median BG intensity value was used. Features flagged bad, missing or saturated during image analysis were removed. Poorly measured features with ch1 or ch2 intensities <15 were removed. Data was normalized using pin-based LOWESS algorithm.","GPL3883","David,,Lindgren","david.lindgren@med.lu.se","Molecular Pathology","Dep of Laboratory Medicine. Malmö","Lund University","Entrance 78, 3rd floor, UMAS","Malmö","SE-20502","Sweden","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM497nnn/GSM497748/GSM497748.gpr.gz","19889"
"GSM497749","UC_0140_1_RAP_27k_h1","GSM497749","Public on Jun 14 2010","Jan 15 2010","Jan 19 2010","RNA","2","Urinary bladder tumor UC_0140_1","Homo sapiens","sample histology: Urothelial carcinoma","tumor stage: Ta","tumor grade: G1","dead of disease: NO","follow up time (months): 49.2","tat1 progress^to minv/cystectomy/dead: NO","","","total RNA","Tissue homogenization and RNA recovery using TRIzol reagent (Invitrogen), followed by purification of total RNA using RNeasy kit (Qiagen).","Cy3","1.5 microrgram of sample and reference aRNA, amplified using the MessageAmp aRNA Kit (Ambion), were labeled using the CyScribe Post-Labeling Kit (Amersham Biosciences) followed by purification using the Cyscribe GFX Purification Kit (Amersham)","9606","Stratagene Universal Human Reference","Homo sapiens","reference: RNA pooled from ten human cell lines","total RNA","Tissue homogenization and RNA recovery using TRIzol reagent (Invitrogen), followed by purification of total RNA using RNeasy kit (Qiagen).","Cy5","1.5 microrgram of sample and reference aRNA, amplified using the MessageAmp aRNA Kit (Ambion), were labeled using the CyScribe Post-Labeling Kit (Amersham Biosciences) followed by purification using the Cyscribe GFX Purification Kit (Amersham)","9606","Samples were dissolved in 42 mul of Universal Hybridization Solution (Corning, Acton, MA, USA) and hybridizations were carried out in a CMT-Hybridization Chamber (Corning) for 18 h at 42°C. Pre-hybridization of slides and post-hybridization washes were performed as described in the Universal Hybridization Kit (Corning)","Fluorescence was recorded using an Agilent G2565AA microarray scanner (Agilent Technologies). Image analysis on scanned arrays was performed with GenePix 4.0 (Axon Instruments)","UC_0140_1_RAP_27k_h1","","Data was processed in the BioArray Software Environment (BASE). For each channel, the Mean FG - Median BG intensity value was used. Features flagged bad, missing or saturated during image analysis were removed. Poorly measured features with ch1 or ch2 intensities <15 were removed. Data was normalized using pin-based LOWESS algorithm.","GPL3883","David,,Lindgren","david.lindgren@med.lu.se","Molecular Pathology","Dep of Laboratory Medicine. Malmö","Lund University","Entrance 78, 3rd floor, UMAS","Malmö","SE-20502","Sweden","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM497nnn/GSM497749/GSM497749.gpr.gz","19889"
"GSM497750","UC_0145_1_RAP_27k_h2","GSM497750","Public on Jun 14 2010","Jan 15 2010","Jan 19 2010","RNA","2","Urinary bladder tumor UC_0145_1","Homo sapiens","sample histology: Urothelial carcinoma","tumor stage: Ta","tumor grade: G2","dead of disease: NO","follow up time (months): 52.4","tat1 progress^to minv/cystectomy/dead: NO","","","total RNA","Tissue homogenization and RNA recovery using TRIzol reagent (Invitrogen), followed by purification of total RNA using RNeasy kit (Qiagen).","Cy3","1.5 microrgram of sample and reference aRNA, amplified using the MessageAmp aRNA Kit (Ambion), were labeled using the CyScribe Post-Labeling Kit (Amersham Biosciences) followed by purification using the Cyscribe GFX Purification Kit (Amersham)","9606","Stratagene Universal Human Reference","Homo sapiens","reference: RNA pooled from ten human cell lines","total RNA","Tissue homogenization and RNA recovery using TRIzol reagent (Invitrogen), followed by purification of total RNA using RNeasy kit (Qiagen).","Cy5","1.5 microrgram of sample and reference aRNA, amplified using the MessageAmp aRNA Kit (Ambion), were labeled using the CyScribe Post-Labeling Kit (Amersham Biosciences) followed by purification using the Cyscribe GFX Purification Kit (Amersham)","9606","Samples were dissolved in 42 mul of Universal Hybridization Solution (Corning, Acton, MA, USA) and hybridizations were carried out in a CMT-Hybridization Chamber (Corning) for 18 h at 42°C. Pre-hybridization of slides and post-hybridization washes were performed as described in the Universal Hybridization Kit (Corning)","Fluorescence was recorded using an Agilent G2565AA microarray scanner (Agilent Technologies). Image analysis on scanned arrays was performed with GenePix 4.0 (Axon Instruments)","UC_0145_1_RAP_27k_h2","","Data was processed in the BioArray Software Environment (BASE). For each channel, the Mean FG - Median BG intensity value was used. Features flagged bad, missing or saturated during image analysis were removed. Poorly measured features with ch1 or ch2 intensities <15 were removed. Data was normalized using pin-based LOWESS algorithm.","GPL3883","David,,Lindgren","david.lindgren@med.lu.se","Molecular Pathology","Dep of Laboratory Medicine. Malmö","Lund University","Entrance 78, 3rd floor, UMAS","Malmö","SE-20502","Sweden","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM497nnn/GSM497750/GSM497750.gpr.gz","19889"
"GSM497751","UC_0147_1_RAP_27k_h2","GSM497751","Public on Jun 14 2010","Jan 15 2010","Jan 19 2010","RNA","2","Urinary bladder tumor UC_0147_1","Homo sapiens","sample histology: Urothelial carcinoma","tumor stage: Ta","tumor grade: G1","dead of disease: NO","follow up time (months): 59.4","tat1 progress^to minv/cystectomy/dead: NO","","","total RNA","Tissue homogenization and RNA recovery using TRIzol reagent (Invitrogen), followed by purification of total RNA using RNeasy kit (Qiagen).","Cy3","1.5 microrgram of sample and reference aRNA, amplified using the MessageAmp aRNA Kit (Ambion), were labeled using the CyScribe Post-Labeling Kit (Amersham Biosciences) followed by purification using the Cyscribe GFX Purification Kit (Amersham)","9606","Stratagene Universal Human Reference","Homo sapiens","reference: RNA pooled from ten human cell lines","total RNA","Tissue homogenization and RNA recovery using TRIzol reagent (Invitrogen), followed by purification of total RNA using RNeasy kit (Qiagen).","Cy5","1.5 microrgram of sample and reference aRNA, amplified using the MessageAmp aRNA Kit (Ambion), were labeled using the CyScribe Post-Labeling Kit (Amersham Biosciences) followed by purification using the Cyscribe GFX Purification Kit (Amersham)","9606","Samples were dissolved in 42 mul of Universal Hybridization Solution (Corning, Acton, MA, USA) and hybridizations were carried out in a CMT-Hybridization Chamber (Corning) for 18 h at 42°C. Pre-hybridization of slides and post-hybridization washes were performed as described in the Universal Hybridization Kit (Corning)","Fluorescence was recorded using an Agilent G2565AA microarray scanner (Agilent Technologies). Image analysis on scanned arrays was performed with GenePix 4.0 (Axon Instruments)","UC_0147_1_RAP_27k_h2","","Data was processed in the BioArray Software Environment (BASE). For each channel, the Mean FG - Median BG intensity value was used. Features flagged bad, missing or saturated during image analysis were removed. Poorly measured features with ch1 or ch2 intensities <15 were removed. Data was normalized using pin-based LOWESS algorithm.","GPL3883","David,,Lindgren","david.lindgren@med.lu.se","Molecular Pathology","Dep of Laboratory Medicine. Malmö","Lund University","Entrance 78, 3rd floor, UMAS","Malmö","SE-20502","Sweden","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM497nnn/GSM497751/GSM497751.gpr.gz","19889"
"GSM497752","UC_0149_1_RAP_27k_h1","GSM497752","Public on Jun 14 2010","Jan 15 2010","Jan 19 2010","RNA","2","Urinary bladder tumor UC_0149_1","Homo sapiens","sample histology: Urothelial carcinoma","tumor stage: Ta","tumor grade: G1","dead of disease: NO","follow up time (months): 54.5","tat1 progress^to minv/cystectomy/dead: NO","","","total RNA","Tissue homogenization and RNA recovery using TRIzol reagent (Invitrogen), followed by purification of total RNA using RNeasy kit (Qiagen).","Cy3","1.5 microrgram of sample and reference aRNA, amplified using the MessageAmp aRNA Kit (Ambion), were labeled using the CyScribe Post-Labeling Kit (Amersham Biosciences) followed by purification using the Cyscribe GFX Purification Kit (Amersham)","9606","Stratagene Universal Human Reference","Homo sapiens","reference: RNA pooled from ten human cell lines","total RNA","Tissue homogenization and RNA recovery using TRIzol reagent (Invitrogen), followed by purification of total RNA using RNeasy kit (Qiagen).","Cy5","1.5 microrgram of sample and reference aRNA, amplified using the MessageAmp aRNA Kit (Ambion), were labeled using the CyScribe Post-Labeling Kit (Amersham Biosciences) followed by purification using the Cyscribe GFX Purification Kit (Amersham)","9606","Samples were dissolved in 42 mul of Universal Hybridization Solution (Corning, Acton, MA, USA) and hybridizations were carried out in a CMT-Hybridization Chamber (Corning) for 18 h at 42°C. Pre-hybridization of slides and post-hybridization washes were performed as described in the Universal Hybridization Kit (Corning)","Fluorescence was recorded using an Agilent G2565AA microarray scanner (Agilent Technologies). Image analysis on scanned arrays was performed with GenePix 4.0 (Axon Instruments)","UC_0149_1_RAP_27k_h1","","Data was processed in the BioArray Software Environment (BASE). For each channel, the Mean FG - Median BG intensity value was used. Features flagged bad, missing or saturated during image analysis were removed. Poorly measured features with ch1 or ch2 intensities <15 were removed. Data was normalized using pin-based LOWESS algorithm.","GPL3883","David,,Lindgren","david.lindgren@med.lu.se","Molecular Pathology","Dep of Laboratory Medicine. Malmö","Lund University","Entrance 78, 3rd floor, UMAS","Malmö","SE-20502","Sweden","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM497nnn/GSM497752/GSM497752.gpr.gz","19889"
"GSM497753","UC_0159_1_RAP_27k_h1","GSM497753","Public on Jun 14 2010","Jan 15 2010","Jan 19 2010","RNA","2","Urinary bladder tumor UC_0159_1","Homo sapiens","sample histology: Urothelial carcinoma","tumor stage: T1","tumor grade: G2","dead of disease: NO","follow up time (months): 51.0","tat1 progress^to minv/cystectomy/dead: NO","","","total RNA","Tissue homogenization and RNA recovery using TRIzol reagent (Invitrogen), followed by purification of total RNA using RNeasy kit (Qiagen).","Cy3","1.5 microrgram of sample and reference aRNA, amplified using the MessageAmp aRNA Kit (Ambion), were labeled using the CyScribe Post-Labeling Kit (Amersham Biosciences) followed by purification using the Cyscribe GFX Purification Kit (Amersham)","9606","Stratagene Universal Human Reference","Homo sapiens","reference: RNA pooled from ten human cell lines","total RNA","Tissue homogenization and RNA recovery using TRIzol reagent (Invitrogen), followed by purification of total RNA using RNeasy kit (Qiagen).","Cy5","1.5 microrgram of sample and reference aRNA, amplified using the MessageAmp aRNA Kit (Ambion), were labeled using the CyScribe Post-Labeling Kit (Amersham Biosciences) followed by purification using the Cyscribe GFX Purification Kit (Amersham)","9606","Samples were dissolved in 42 mul of Universal Hybridization Solution (Corning, Acton, MA, USA) and hybridizations were carried out in a CMT-Hybridization Chamber (Corning) for 18 h at 42°C. Pre-hybridization of slides and post-hybridization washes were performed as described in the Universal Hybridization Kit (Corning)","Fluorescence was recorded using an Agilent G2565AA microarray scanner (Agilent Technologies). Image analysis on scanned arrays was performed with GenePix 4.0 (Axon Instruments)","UC_0159_1_RAP_27k_h1","","Data was processed in the BioArray Software Environment (BASE). For each channel, the Mean FG - Median BG intensity value was used. Features flagged bad, missing or saturated during image analysis were removed. Poorly measured features with ch1 or ch2 intensities <15 were removed. Data was normalized using pin-based LOWESS algorithm.","GPL3883","David,,Lindgren","david.lindgren@med.lu.se","Molecular Pathology","Dep of Laboratory Medicine. Malmö","Lund University","Entrance 78, 3rd floor, UMAS","Malmö","SE-20502","Sweden","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM497nnn/GSM497753/GSM497753.gpr.gz","19889"
"GSM497754","UC_0161_1_RAP_27k_h1","GSM497754","Public on Jun 14 2010","Jan 15 2010","Jan 19 2010","RNA","2","Urinary bladder tumor UC_0161_1","Homo sapiens","sample histology: Urothelial carcinoma","tumor stage: Ta","tumor grade: G1","dead of disease: NO","follow up time (months): 47.9","tat1 progress^to minv/cystectomy/dead: NO","","","total RNA","Tissue homogenization and RNA recovery using TRIzol reagent (Invitrogen), followed by purification of total RNA using RNeasy kit (Qiagen).","Cy3","1.5 microrgram of sample and reference aRNA, amplified using the MessageAmp aRNA Kit (Ambion), were labeled using the CyScribe Post-Labeling Kit (Amersham Biosciences) followed by purification using the Cyscribe GFX Purification Kit (Amersham)","9606","Stratagene Universal Human Reference","Homo sapiens","reference: RNA pooled from ten human cell lines","total RNA","Tissue homogenization and RNA recovery using TRIzol reagent (Invitrogen), followed by purification of total RNA using RNeasy kit (Qiagen).","Cy5","1.5 microrgram of sample and reference aRNA, amplified using the MessageAmp aRNA Kit (Ambion), were labeled using the CyScribe Post-Labeling Kit (Amersham Biosciences) followed by purification using the Cyscribe GFX Purification Kit (Amersham)","9606","Samples were dissolved in 42 mul of Universal Hybridization Solution (Corning, Acton, MA, USA) and hybridizations were carried out in a CMT-Hybridization Chamber (Corning) for 18 h at 42°C. Pre-hybridization of slides and post-hybridization washes were performed as described in the Universal Hybridization Kit (Corning)","Fluorescence was recorded using an Agilent G2565AA microarray scanner (Agilent Technologies). Image analysis on scanned arrays was performed with GenePix 4.0 (Axon Instruments)","UC_0161_1_RAP_27k_h1","","Data was processed in the BioArray Software Environment (BASE). For each channel, the Mean FG - Median BG intensity value was used. Features flagged bad, missing or saturated during image analysis were removed. Poorly measured features with ch1 or ch2 intensities <15 were removed. Data was normalized using pin-based LOWESS algorithm.","GPL3883","David,,Lindgren","david.lindgren@med.lu.se","Molecular Pathology","Dep of Laboratory Medicine. Malmö","Lund University","Entrance 78, 3rd floor, UMAS","Malmö","SE-20502","Sweden","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM497nnn/GSM497754/GSM497754.gpr.gz","19889"
"GSM497755","UC_0162_1_RAP_27k_h1","GSM497755","Public on Jun 14 2010","Jan 15 2010","Jan 19 2010","RNA","2","Urinary bladder tumor UC_0162_1","Homo sapiens","sample histology: Urothelial carcinoma","tumor stage: Ta","tumor grade: G1","dead of disease: NO","follow up time (months): 54.3","tat1 progress^to minv/cystectomy/dead: NO","","","total RNA","Tissue homogenization and RNA recovery using TRIzol reagent (Invitrogen), followed by purification of total RNA using RNeasy kit (Qiagen).","Cy3","1.5 microrgram of sample and reference aRNA, amplified using the MessageAmp aRNA Kit (Ambion), were labeled using the CyScribe Post-Labeling Kit (Amersham Biosciences) followed by purification using the Cyscribe GFX Purification Kit (Amersham)","9606","Stratagene Universal Human Reference","Homo sapiens","reference: RNA pooled from ten human cell lines","total RNA","Tissue homogenization and RNA recovery using TRIzol reagent (Invitrogen), followed by purification of total RNA using RNeasy kit (Qiagen).","Cy5","1.5 microrgram of sample and reference aRNA, amplified using the MessageAmp aRNA Kit (Ambion), were labeled using the CyScribe Post-Labeling Kit (Amersham Biosciences) followed by purification using the Cyscribe GFX Purification Kit (Amersham)","9606","Samples were dissolved in 42 mul of Universal Hybridization Solution (Corning, Acton, MA, USA) and hybridizations were carried out in a CMT-Hybridization Chamber (Corning) for 18 h at 42°C. Pre-hybridization of slides and post-hybridization washes were performed as described in the Universal Hybridization Kit (Corning)","Fluorescence was recorded using an Agilent G2565AA microarray scanner (Agilent Technologies). Image analysis on scanned arrays was performed with GenePix 4.0 (Axon Instruments)","UC_0162_1_RAP_27k_h1","","Data was processed in the BioArray Software Environment (BASE). For each channel, the Mean FG - Median BG intensity value was used. Features flagged bad, missing or saturated during image analysis were removed. Poorly measured features with ch1 or ch2 intensities <15 were removed. Data was normalized using pin-based LOWESS algorithm.","GPL3883","David,,Lindgren","david.lindgren@med.lu.se","Molecular Pathology","Dep of Laboratory Medicine. Malmö","Lund University","Entrance 78, 3rd floor, UMAS","Malmö","SE-20502","Sweden","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM497nnn/GSM497755/GSM497755.gpr.gz","19889"
"GSM497756","UC_0165_1_RAP_27k_h1","GSM497756","Public on Jun 14 2010","Jan 15 2010","Jan 19 2010","RNA","2","Urinary bladder tumor UC_0165_1","Homo sapiens","sample histology: Urothelial carcinoma","tumor stage: Ta","tumor grade: G2","dead of disease: NO","follow up time (months): 57.9","tat1 progress^to minv/cystectomy/dead: NO","","","total RNA","Tissue homogenization and RNA recovery using TRIzol reagent (Invitrogen), followed by purification of total RNA using RNeasy kit (Qiagen).","Cy3","1.5 microrgram of sample and reference aRNA, amplified using the MessageAmp aRNA Kit (Ambion), were labeled using the CyScribe Post-Labeling Kit (Amersham Biosciences) followed by purification using the Cyscribe GFX Purification Kit (Amersham)","9606","Stratagene Universal Human Reference","Homo sapiens","reference: RNA pooled from ten human cell lines","total RNA","Tissue homogenization and RNA recovery using TRIzol reagent (Invitrogen), followed by purification of total RNA using RNeasy kit (Qiagen).","Cy5","1.5 microrgram of sample and reference aRNA, amplified using the MessageAmp aRNA Kit (Ambion), were labeled using the CyScribe Post-Labeling Kit (Amersham Biosciences) followed by purification using the Cyscribe GFX Purification Kit (Amersham)","9606","Samples were dissolved in 42 mul of Universal Hybridization Solution (Corning, Acton, MA, USA) and hybridizations were carried out in a CMT-Hybridization Chamber (Corning) for 18 h at 42°C. Pre-hybridization of slides and post-hybridization washes were performed as described in the Universal Hybridization Kit (Corning)","Fluorescence was recorded using an Agilent G2565AA microarray scanner (Agilent Technologies). Image analysis on scanned arrays was performed with GenePix 4.0 (Axon Instruments)","UC_0165_1_RAP_27k_h1","","Data was processed in the BioArray Software Environment (BASE). For each channel, the Mean FG - Median BG intensity value was used. Features flagged bad, missing or saturated during image analysis were removed. Poorly measured features with ch1 or ch2 intensities <15 were removed. Data was normalized using pin-based LOWESS algorithm.","GPL3883","David,,Lindgren","david.lindgren@med.lu.se","Molecular Pathology","Dep of Laboratory Medicine. Malmö","Lund University","Entrance 78, 3rd floor, UMAS","Malmö","SE-20502","Sweden","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM497nnn/GSM497756/GSM497756.gpr.gz","19889"
"GSM497757","UC_0168_1_RAP_27k_h1","GSM497757","Public on Jun 14 2010","Jan 15 2010","Jan 19 2010","RNA","2","Urinary bladder tumor UC_0168_1","Homo sapiens","sample histology: Urothelial carcinoma","tumor stage: Ta","tumor grade: G1","dead of disease: NO","follow up time (months): 56.6","tat1 progress^to minv/cystectomy/dead: NO","","","total RNA","Tissue homogenization and RNA recovery using TRIzol reagent (Invitrogen), followed by purification of total RNA using RNeasy kit (Qiagen).","Cy3","1.5 microrgram of sample and reference aRNA, amplified using the MessageAmp aRNA Kit (Ambion), were labeled using the CyScribe Post-Labeling Kit (Amersham Biosciences) followed by purification using the Cyscribe GFX Purification Kit (Amersham)","9606","Stratagene Universal Human Reference","Homo sapiens","reference: RNA pooled from ten human cell lines","total RNA","Tissue homogenization and RNA recovery using TRIzol reagent (Invitrogen), followed by purification of total RNA using RNeasy kit (Qiagen).","Cy5","1.5 microrgram of sample and reference aRNA, amplified using the MessageAmp aRNA Kit (Ambion), were labeled using the CyScribe Post-Labeling Kit (Amersham Biosciences) followed by purification using the Cyscribe GFX Purification Kit (Amersham)","9606","Samples were dissolved in 42 mul of Universal Hybridization Solution (Corning, Acton, MA, USA) and hybridizations were carried out in a CMT-Hybridization Chamber (Corning) for 18 h at 42°C. Pre-hybridization of slides and post-hybridization washes were performed as described in the Universal Hybridization Kit (Corning)","Fluorescence was recorded using an Agilent G2565AA microarray scanner (Agilent Technologies). Image analysis on scanned arrays was performed with GenePix 4.0 (Axon Instruments)","UC_0168_1_RAP_27k_h1","","Data was processed in the BioArray Software Environment (BASE). For each channel, the Mean FG - Median BG intensity value was used. Features flagged bad, missing or saturated during image analysis were removed. Poorly measured features with ch1 or ch2 intensities <15 were removed. Data was normalized using pin-based LOWESS algorithm.","GPL3883","David,,Lindgren","david.lindgren@med.lu.se","Molecular Pathology","Dep of Laboratory Medicine. Malmö","Lund University","Entrance 78, 3rd floor, UMAS","Malmö","SE-20502","Sweden","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM497nnn/GSM497757/GSM497757.gpr.gz","19889"
"GSM497758","UC_0172_1_RAP_27k_h2","GSM497758","Public on Jun 14 2010","Jan 15 2010","Jan 19 2010","RNA","2","Urinary bladder tumor UC_0172_1","Homo sapiens","sample histology: Urothelial carcinoma","tumor stage: Ta","tumor grade: G2","dead of disease: NO","follow up time (months): 57.1","tat1 progress^to minv/cystectomy/dead: NO","","","total RNA","Tissue homogenization and RNA recovery using TRIzol reagent (Invitrogen), followed by purification of total RNA using RNeasy kit (Qiagen).","Cy3","1.5 microrgram of sample and reference aRNA, amplified using the MessageAmp aRNA Kit (Ambion), were labeled using the CyScribe Post-Labeling Kit (Amersham Biosciences) followed by purification using the Cyscribe GFX Purification Kit (Amersham)","9606","Stratagene Universal Human Reference","Homo sapiens","reference: RNA pooled from ten human cell lines","total RNA","Tissue homogenization and RNA recovery using TRIzol reagent (Invitrogen), followed by purification of total RNA using RNeasy kit (Qiagen).","Cy5","1.5 microrgram of sample and reference aRNA, amplified using the MessageAmp aRNA Kit (Ambion), were labeled using the CyScribe Post-Labeling Kit (Amersham Biosciences) followed by purification using the Cyscribe GFX Purification Kit (Amersham)","9606","Samples were dissolved in 42 mul of Universal Hybridization Solution (Corning, Acton, MA, USA) and hybridizations were carried out in a CMT-Hybridization Chamber (Corning) for 18 h at 42°C. Pre-hybridization of slides and post-hybridization washes were performed as described in the Universal Hybridization Kit (Corning)","Fluorescence was recorded using an Agilent G2565AA microarray scanner (Agilent Technologies). Image analysis on scanned arrays was performed with GenePix 4.0 (Axon Instruments)","UC_0172_1_RAP_27k_h2","","Data was processed in the BioArray Software Environment (BASE). For each channel, the Mean FG - Median BG intensity value was used. Features flagged bad, missing or saturated during image analysis were removed. Poorly measured features with ch1 or ch2 intensities <15 were removed. Data was normalized using pin-based LOWESS algorithm.","GPL3883","David,,Lindgren","david.lindgren@med.lu.se","Molecular Pathology","Dep of Laboratory Medicine. Malmö","Lund University","Entrance 78, 3rd floor, UMAS","Malmö","SE-20502","Sweden","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM497nnn/GSM497758/GSM497758.gpr.gz","19889"
"GSM497759","UC_0173_1_RAP_27k_h1","GSM497759","Public on Jun 14 2010","Jan 15 2010","Jan 19 2010","RNA","2","Urinary bladder tumor UC_0173_1","Homo sapiens","sample histology: Urothelial carcinoma","tumor stage: Ta","tumor grade: G1","dead of disease: NO","follow up time (months): 45.8","tat1 progress^to minv/cystectomy/dead: NO","","","total RNA","Tissue homogenization and RNA recovery using TRIzol reagent (Invitrogen), followed by purification of total RNA using RNeasy kit (Qiagen).","Cy3","1.5 microrgram of sample and reference aRNA, amplified using the MessageAmp aRNA Kit (Ambion), were labeled using the CyScribe Post-Labeling Kit (Amersham Biosciences) followed by purification using the Cyscribe GFX Purification Kit (Amersham)","9606","Stratagene Universal Human Reference","Homo sapiens","reference: RNA pooled from ten human cell lines","total RNA","Tissue homogenization and RNA recovery using TRIzol reagent (Invitrogen), followed by purification of total RNA using RNeasy kit (Qiagen).","Cy5","1.5 microrgram of sample and reference aRNA, amplified using the MessageAmp aRNA Kit (Ambion), were labeled using the CyScribe Post-Labeling Kit (Amersham Biosciences) followed by purification using the Cyscribe GFX Purification Kit (Amersham)","9606","Samples were dissolved in 42 mul of Universal Hybridization Solution (Corning, Acton, MA, USA) and hybridizations were carried out in a CMT-Hybridization Chamber (Corning) for 18 h at 42°C. Pre-hybridization of slides and post-hybridization washes were performed as described in the Universal Hybridization Kit (Corning)","Fluorescence was recorded using an Agilent G2565AA microarray scanner (Agilent Technologies). Image analysis on scanned arrays was performed with GenePix 4.0 (Axon Instruments)","UC_0173_1_RAP_27k_h1","","Data was processed in the BioArray Software Environment (BASE). For each channel, the Mean FG - Median BG intensity value was used. Features flagged bad, missing or saturated during image analysis were removed. Poorly measured features with ch1 or ch2 intensities <15 were removed. Data was normalized using pin-based LOWESS algorithm.","GPL3883","David,,Lindgren","david.lindgren@med.lu.se","Molecular Pathology","Dep of Laboratory Medicine. Malmö","Lund University","Entrance 78, 3rd floor, UMAS","Malmö","SE-20502","Sweden","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM497nnn/GSM497759/GSM497759.gpr.gz","19889"
"GSM497760","UC_0179_1_RAP_27k_h1","GSM497760","Public on Jun 14 2010","Jan 15 2010","Jan 19 2010","RNA","2","Urinary bladder tumor UC_0179_1","Homo sapiens","sample histology: Upper urinary tract urothelial carcinoma","tumor stage: Ta","tumor grade: G3","","","","","","total RNA","Tissue homogenization and RNA recovery using TRIzol reagent (Invitrogen), followed by purification of total RNA using RNeasy kit (Qiagen).","Cy3","1.5 microrgram of sample and reference aRNA, amplified using the MessageAmp aRNA Kit (Ambion), were labeled using the CyScribe Post-Labeling Kit (Amersham Biosciences) followed by purification using the Cyscribe GFX Purification Kit (Amersham)","9606","Stratagene Universal Human Reference","Homo sapiens","reference: RNA pooled from ten human cell lines","total RNA","Tissue homogenization and RNA recovery using TRIzol reagent (Invitrogen), followed by purification of total RNA using RNeasy kit (Qiagen).","Cy5","1.5 microrgram of sample and reference aRNA, amplified using the MessageAmp aRNA Kit (Ambion), were labeled using the CyScribe Post-Labeling Kit (Amersham Biosciences) followed by purification using the Cyscribe GFX Purification Kit (Amersham)","9606","Samples were dissolved in 42 mul of Universal Hybridization Solution (Corning, Acton, MA, USA) and hybridizations were carried out in a CMT-Hybridization Chamber (Corning) for 18 h at 42°C. Pre-hybridization of slides and post-hybridization washes were performed as described in the Universal Hybridization Kit (Corning)","Fluorescence was recorded using an Agilent G2565AA microarray scanner (Agilent Technologies). Image analysis on scanned arrays was performed with GenePix 4.0 (Axon Instruments)","UC_0179_1_RAP_27k_h1","This is one of two samples that were hybridized to both 27k and 35k platforms. They were only used for merging of the two expression datasets.","Data was processed in the BioArray Software Environment (BASE). For each channel, the Mean FG - Median BG intensity value was used. Features flagged bad, missing or saturated during image analysis were removed. Poorly measured features with ch1 or ch2 intensities <15 were removed. Data was normalized using pin-based LOWESS algorithm.","GPL3883","David,,Lindgren","david.lindgren@med.lu.se","Molecular Pathology","Dep of Laboratory Medicine. Malmö","Lund University","Entrance 78, 3rd floor, UMAS","Malmö","SE-20502","Sweden","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM497nnn/GSM497760/GSM497760.gpr.gz","19889"
"GSM497761","UC_0192_1_RAP_27k_h1","GSM497761","Public on Jun 14 2010","Jan 15 2010","Jan 19 2010","RNA","2","Urinary bladder tumor UC_0192_1","Homo sapiens","sample histology: Urothelial carcinoma","tumor stage: Ta","tumor grade: G2","dead of disease: NO","follow up time (months): 48.7","tat1 progress^to minv/cystectomy/dead: NO","","","total RNA","Tissue homogenization and RNA recovery using TRIzol reagent (Invitrogen), followed by purification of total RNA using RNeasy kit (Qiagen).","Cy3","1.5 microrgram of sample and reference aRNA, amplified using the MessageAmp aRNA Kit (Ambion), were labeled using the CyScribe Post-Labeling Kit (Amersham Biosciences) followed by purification using the Cyscribe GFX Purification Kit (Amersham)","9606","Stratagene Universal Human Reference","Homo sapiens","reference: RNA pooled from ten human cell lines","total RNA","Tissue homogenization and RNA recovery using TRIzol reagent (Invitrogen), followed by purification of total RNA using RNeasy kit (Qiagen).","Cy5","1.5 microrgram of sample and reference aRNA, amplified using the MessageAmp aRNA Kit (Ambion), were labeled using the CyScribe Post-Labeling Kit (Amersham Biosciences) followed by purification using the Cyscribe GFX Purification Kit (Amersham)","9606","Samples were dissolved in 42 mul of Universal Hybridization Solution (Corning, Acton, MA, USA) and hybridizations were carried out in a CMT-Hybridization Chamber (Corning) for 18 h at 42°C. Pre-hybridization of slides and post-hybridization washes were performed as described in the Universal Hybridization Kit (Corning)","Fluorescence was recorded using an Agilent G2565AA microarray scanner (Agilent Technologies). Image analysis on scanned arrays was performed with GenePix 4.0 (Axon Instruments)","UC_0192_1_RAP_27k_h1","","Data was processed in the BioArray Software Environment (BASE). For each channel, the Mean FG - Median BG intensity value was used. Features flagged bad, missing or saturated during image analysis were removed. Poorly measured features with ch1 or ch2 intensities <15 were removed. Data was normalized using pin-based LOWESS algorithm.","GPL3883","David,,Lindgren","david.lindgren@med.lu.se","Molecular Pathology","Dep of Laboratory Medicine. Malmö","Lund University","Entrance 78, 3rd floor, UMAS","Malmö","SE-20502","Sweden","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM497nnn/GSM497761/GSM497761.gpr.gz","19889"
"GSM497762","UC_0194_1_RAP_27k_h2","GSM497762","Public on Jun 14 2010","Jan 15 2010","Jan 19 2010","RNA","2","Urinary bladder tumor UC_0194_1","Homo sapiens","sample histology: Urothelial carcinoma","tumor stage: Ta","tumor grade: G2","dead of disease: NO","follow up time (months): 19.2","tat1 progress^to minv/cystectomy/dead: NO","","","total RNA","Tissue homogenization and RNA recovery using TRIzol reagent (Invitrogen), followed by purification of total RNA using RNeasy kit (Qiagen).","Cy3","1.5 microrgram of sample and reference aRNA, amplified using the MessageAmp aRNA Kit (Ambion), were labeled using the CyScribe Post-Labeling Kit (Amersham Biosciences) followed by purification using the Cyscribe GFX Purification Kit (Amersham)","9606","Stratagene Universal Human Reference","Homo sapiens","reference: RNA pooled from ten human cell lines","total RNA","Tissue homogenization and RNA recovery using TRIzol reagent (Invitrogen), followed by purification of total RNA using RNeasy kit (Qiagen).","Cy5","1.5 microrgram of sample and reference aRNA, amplified using the MessageAmp aRNA Kit (Ambion), were labeled using the CyScribe Post-Labeling Kit (Amersham Biosciences) followed by purification using the Cyscribe GFX Purification Kit (Amersham)","9606","Samples were dissolved in 42 mul of Universal Hybridization Solution (Corning, Acton, MA, USA) and hybridizations were carried out in a CMT-Hybridization Chamber (Corning) for 18 h at 42°C. Pre-hybridization of slides and post-hybridization washes were performed as described in the Universal Hybridization Kit (Corning)","Fluorescence was recorded using an Agilent G2565AA microarray scanner (Agilent Technologies). Image analysis on scanned arrays was performed with GenePix 4.0 (Axon Instruments)","UC_0194_1_RAP_27k_h2","","Data was processed in the BioArray Software Environment (BASE). For each channel, the Mean FG - Median BG intensity value was used. Features flagged bad, missing or saturated during image analysis were removed. Poorly measured features with ch1 or ch2 intensities <15 were removed. Data was normalized using pin-based LOWESS algorithm.","GPL3883","David,,Lindgren","david.lindgren@med.lu.se","Molecular Pathology","Dep of Laboratory Medicine. Malmö","Lund University","Entrance 78, 3rd floor, UMAS","Malmö","SE-20502","Sweden","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM497nnn/GSM497762/GSM497762.gpr.gz","19889"
